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1. INTRODUCTION
The skin of an average adult body covers a surface area of approximately 2 m2 
and weighs more than 10% of the total body mass [1]. The skin separates the vital 
organs from the external environment and acts as a barrier against desiccation and 
various environmental inﬂuences. It plays a crucial role in the regulation of the body 
temperature and serves as a sensory organ transmitting external environmental 
information, such as pain and heat [2, 3].
Microscopically, the skin is a multilayered organ composed of many histological 
layers. It is generally subdivided into three layers: The epidermis, the dermis and the 
hypodermis [4]. The uppermost nonviable layer of the epidermis, the stratum corneum, 
has been demonstrated to constitute the principal barrier to percutaneous penetration 
[5, 6]. The excellent barrier properties of the stratum corneum can be ascribed to 
its unique structure and composition. The viable epidermis is situated beneath the 
stratum corneum and is responsible for generation of the stratum corneum. The dermis 
is directly adjacent to the epidermis and is composed of a matrix of connective tissue, 
which renders the skin its elasticity and resistance to deformation. The blood vessels 
that are present in the dermis provide the skin with nutrients and oxygen [4]. The 
hypodermis or subcutaneous fat tissue is the lowermost layer of the skin. It supports 
the dermis and epidermis and provides thermal isolation and mechanical protection of 
the body.
The outer layer of the skin forms an effective barrier to retain water within the 
body and keep exogenous compounds out of the body. As a result, the major problem 
in dermal and transdermal drug delivery is the low penetration of drug compounds 
through the stratum corneum. Dermal drug delivery comprises the topical application 
of drugs for the local treatment of skin diseases. It requires the permeation of a drug 
through the outer skin layers to reach its site of action within the skin, with little or no 
systemic uptake. The application of drugs to the skin for systemic therapy is referred 
to as transdermal drug delivery. Hence, it is required that a pharmacologically potent 
drug reaches the dermis where it can be taken up by the systemic blood circulation. 
In either case, the drug has to cross the outermost layer of the skin, the stratum 
corneum.
In the ﬁrst part of this chapter, the formation and structure of the stratum corneum 
will be discussed. The second part describes the composition and organisation of the 
intercellular stratum corneum lipids in vivo and in vitro. In the third part of this chapter 
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some diffusion characteristics and penetration models, which are currently used to 
predict the in vitro and in vivo penetration of drugs through the skin, will be discussed. 
Finally, the objective and outline of this thesis will be presented. 
2. KERATINOCYTE TERMINAL DIFFERENTIATION
2.1 The viable epidermis
The epidermis is approximately 100 to 150 µm thick and consists of various 
layers, characterised by different stages of differentiation. Figure 1 shows a schematic 
representation of the four layers present in the epidermis: stratum basale (or basal 
layer), stratum spinosum (or spinous layer), stratum granulosum (or granular layer), 
and stratum corneum (or corniﬁed layer). The main cell type in the viable epidermis is 
the keratinocyte, which contains keratin ﬁlaments and constitutes for approximately 
90% of the tissue [7]. Other more sparingly distributed cells in the viable epidermis 
are melanocytes for pigment formation, Merkell cells for sensory reception and the 
antigen-presenting Langerhans cells. 
Figure 1 - Schematic overview of the different cell layers in the epidermis.
The innermost layer of the epidermis, the stratum basale, consists of a single 
layer of columnar-shaped, undifferentiated stem cells. Mitosis of these cells constantly 
renews the epidermis and this proliferation compensates the loss of dead stratum 
corneum cells (corneocytes) from the skin surface. As the cells produced by the basal 
layer move upwards, they alter morphologically as well as histochemically to form the 
outermost layer the stratum corneum. Over a 4 to 5 week period the entire epidermis 
is renewed [8]. 
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At the spinous layer, the cells appear to be nearly round in shape. They still contain 
a nucleus and organelles, but contain more keratin ﬁlament bundles and are connected 
by more desmosomes than the basal cells. Desmosomes are specialised structures that 
are involved in intercellular adhesion between adjacent keratinocytes. They create a 
transcellular network of keratin ﬁlaments and are therefore crucial for tissue integrity 
[9, 10]. From the basal side of the stratum spinosum to the stratum granulosum, the 
keratinocytes ﬂatten and some cell organelles disappear. In the upper spinous regions, 
two types of intracellular granules are formed: keratohyalin granules and membrane-
bound granules. Keratohyalin granules are electron dense, irregularly shaped granules, 
which are predominantly composed of proﬁlaggrin, loricrin and keratin [11, 12]. 
Membrane-bound granules, often referred to as lamellar bodies or membrane-coated 
granules, are round to ovoid in shape, measure about 0.2 µm and contain ﬂattened 
lamellar disks. They were ﬁrst observed by Selby in the late 1950s [13] and were later 
described in detail by others [14-16]. Lipid analysis of isolated lamellar bodies revealed 
that these organelles are mainly enriched in polar lipids, including glucosylsphingolipids, 
phospholipids, free sterols and cholesterol sulphate, which are present as lipid stacks. 
Furthermore, they contain catabolic enzymes, like acid hydrolases, sphingomyelinase 
and phospholipase A2 [17-19].
The stratum granulosum is the last cell layer of the viable epidermis and contains 
highly differentiated keratinocytes. The lamellar bodies, which have been formed in the 
stratum spinosum, migrate to the apical periphery of the uppermost granular cells and 
eventually fuse with the membrane of the keratinocyte. Via exocytosis their content 
is extruded into the intercellular space at the stratum granulosum-stratum corneum 
interface. The lipids derived from the lamellar bodies are essential for the formation of 
the stratum corneum barrier.
2.2 The stratum corneum
The outermost layer of the skin, the corniﬁed layer or stratum corneum, has been 
identiﬁed as the principal diffusion barrier for substances, including water [5, 6]. It is 
approximately 10 to 15 µm thick when dry, but swells to several times this thickness 
when fully hydrated [20]. It contains 10 to 25 layers of parallel to the skin surface 
lying nonviable cells, the corneocytes, which are surrounded by a cell envelope and are 
embedded in a lipid matrix. This architecture is often modelled as a wall-like structure, 
with the corneocytes as protein “bricks” embedded in a lipid “mortar” [21]. Similarly 
as the viable epidermis, desmosomes (corneodesmosomes) contribute to the cell 
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cohesion.
During the transition of the mature keratinocyte into the corneocyte, proﬁlaggrin 
that is released from the keratohyalin granules is dephosphorylated and proteolytically 
processed to ﬁlaggrin monomers. Filaggrin is responsible for the formation of extensive 
disulphide bonds between keratin ﬁbres. This aggregation results in a macrostructure 
of keratin ﬁbres, which ultimately ﬁll the interior of the corneocytes. Subsequently, 
ﬁlaggrin is degraded into free amino acids and their derivatives, which contribute to 
the hydration of the stratum corneum [reviewed in 22].
The corneocytes are entirely enveloped in a uniform 12 nm thick proteinaceous 
layered structure. This corniﬁed envelope is formed via a complex, but well-organised 
process during terminal differentiation. Several precursor proteins, including involucrin, 
loricrin and corniﬁne [23, 24], are cross-linked by the action of calcium dependent 
transglutaminases, resulting in a very rigid and stable structure. The protein envelope 
has a lipoidal exterior formed by a monolayer of lipids. These lipids are covalently 
bound to the corniﬁed envelope proteins, most abundantly to involucrin, and mainly 
consist of long chain (C30-C34) ω-hydroxy fatty acids, linked to sphingosine and 6-
hydroxysphingosine, respectively [25, 26]. A number of possible roles for the covalently 
bound lipids have been hypothesised [27]: (i) The covalently bound lipids are assumed 
to play an important role in the organisation of the intercellular lipids by acting as 
a substrate that facilitates the orientation of the lamellae parallel to the corneocyte 
surface. (ii) The covalently bound lipids may facilitate the interaction of the hydrophilic 
interior of corneocytes with the intercellular lipid domain. (iii) The covalently bound 
lipids may stabilise the stratum corneum structure and the cohesiveness with the 
intercellular lipids. (iv) The covalently bound lipids may provide a permeability barrier 
around each corneocyte to impede diffusion of substances across the envelope.
The corniﬁed envelope has an unusual high resistance to proteolytic enzymes and 
organic solvents. Lipid extraction causes collapse of the intercellular spaces, but does 
not result in disintegration of the cells. Instead, the covalently bound lipids interdigitate 
to close the intercellular space and hold together the cell layers [25-27]. Abnormalities 
in the process of envelope formation strongly inﬂuence the structural and functional 
integrity of the corniﬁed envelope. For instance, in lamellar ichthyosis a genetic 
deﬁciency of transglutaminase 1 activity is observed [28, 29]. Transglutaminase 1 
is not only involved in the cross-linking process of the precursor proteins, but is the 
only transglutaminase that is capable to covalently attach the lipids onto the proteins. 
Hence, mutations in transglutaminase 1 result in severe defects in the formation of 
14 Chapter 1
the skin barrier. The amount of protein-bound ω-hydroxyceramides is also signiﬁcantly 
reduced in atopic dermatitis [30]. 
Just prior to the formation of the corniﬁed envelope, the content of the lamellar bodies 
is discharged into the intercellular space. After extrusion, the polar glucosylceramides 
are enzymatically converted into ceramides, whereas the phospholipids are catabolised 
into saturated fatty acids. The stacks of disks rearrange parallel to the corneocytes and 
join edge-to-edge to form multiple, continuous intercellular lipid sheets or lamellae 
[27]. These lamellae have been visualised by electron microscopy using ruthenium 
post-ﬁxation and have a unique structure of alternating broad-narrow-broad sequences 
of electron lucent bands. The lipids from which the intercellular lamellae are composed 
are highly unusual. The major lipid classes present are ceramides, cholesterol and 
free fatty acids. In addition, minor amounts of cholesterol sulphate are present. The 
composition and molecular organisation of the intercellular lipids will be discussed in 
more detail in the next section.
2.3 Desquamation
The thickness of the stratum corneum is fairly constant at a given body site. This 
implies that a fraction of the most superﬁcial parts of the stratum corneum must 
be continuously shed at a rate that balances the production of cells at the stratum 
granulosum-stratum corneum interface. Although the process that allows cell shedding 
is not yet fully understood, proteolytic degradation of corneodesmosomes in the upper 
layers of the stratum corneum is a prerequisite for desquamation [31]. Glycosidases 
and trypsin- and chymotrypsin-like proteases are implicated to be involved in 
corneodesmosomal degradation [reviewed in 22]. However, the deﬁnitive identiﬁcation 
of the proteolytic enzymes involved remains a challenge.
The hydration state of the stratum corneum is crucial for the activity of the 
desquamatory enzymes, as it has been demonstrated that corneodesmosomal 
degradation is inhibited at low environmental humidity [32]. Another known major 
factor that inﬂuences desquamation is the level of cholesterol sulphate in the superﬁcial 
layers of the stratum corneum. Although the exact mechanism by which excess 
cholesterol sulphate inhibits desquamation and its hydrolysis promotes desquamation 
is still under investigation, it has been demonstrated that cholesterol sulphate inhibits 
some of the activity of proteases that are involved in corneodesmosome breakdown 
[33]. In addition, cholesterol sulphate affects the organisation of the lipid lamellae 
[34, 35]. As the activity of desquamatory enzymes may be affected by the physical 
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properties of the lamellar lipids, the desquamation process may also be indirectly 
inﬂuenced by cholesterol sulphate. 
A normal desquamation is very important to maintain a normal stratum corneum 
function and skin appearance. Disturbances in the desquamation process, due to 
a decreased rate of cell shedding, result in the accumulation of scales on the skin 
surface and a consequent thickening of the stratum corneum. A clinical example of a 
disturbed desquamation process is the skin disorder recessive X-linked ichthyosis, in 
which a thickening of the stratum corneum is observed due to a cholesterol sulphatase 
deﬁciency [35, 36]. 
3. STRATUM CORNEUM BARRIER LIPIDS
3.1 Penetration pathways through the stratum corneum
A compound may use two diffusional routes to penetrate normal intact human 
skin: the transappendageal route and the transepidermal route. The transappendageal 
route involves transport via the sweat glands or the pilosebaceous units (hair follicles 
with their associated sebaceous glands). This route circumvents penetration through 
the stratum corneum and is therefore known as shunt route. The transappendageal 
route is considered to be less important than the transepidermal route because of its 
relatively small area, approximately 0.1% of the total skin area [3]. However, recent 
studies have demonstrated the possibility of speciﬁcally targeting certain compounds 
to the pilosebaceous structures [37, 38]. The rate of success largely depends on the 
lipophilicity of the permeant and the composition of the vehicle. The appendageal route 
is further of importance during electrically enhanced transport, such as iontophoresis 
[39].
Compounds that penetrate the stratum corneum via the transepidermal route may 
follow a transcellular (or intracellular) or intercellular pathway (see Fig. 2). Because of 
the highly impermeable character of the corniﬁed envelope (see previous section), the 
tortuous intercellular pathway has been suggested to be the route of preference for 
most drug molecules [40]. This is conﬁrmed by several microscopic transport studies, 
in which compounds have been visualised in the intercellular space of the stratum 
corneum [41-43]. Moreover, it has been demonstrated that drug permeation across 
stratum corneum increases many folds after lipid extraction [44]. Hence, knowledge of 
the structure and physical properties of the intercellular lipids is crucial to increase our 
insight in the skin barrier function. 
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Figure 2 - Two possible transepidermal penetration pathways. The intercellular route only involves 
transport along the lipid lamellae, whereas the transcellular route crosses the corneocytes and intervening 
lipids.
3.2 Composition of the intercellular lipids in the stratum corneum
The lipid composition changes considerably during terminal differentiation. After 
extrusion from the lamellar bodies, the polar lipid precursors are enzymatically 
converted into more hydrophobic lipids. As a result, phospholipids are almost absent 
in the stratum corneum. The lipid lamellae, which surround the corneocytes, are 
predominantly composed of ceramides, cholesterol and free fatty acids. It is generally 
assumed that these lipids are present in nearly equimolar ratios. However, inspection 
of literature data shows that there is a high inter-individual variability in the lipid 
composition [45]. 
Figure 3 illustrates the various classes of ceramides present in human and pig 
stratum corneum. Ceramides are structurally heterogeneous and consist of two long 
saturated hydrocarbon chains and a small polar head group with several functional 
groups. Each of the 9 ceramides (CER1-CER9) identiﬁed in human stratum corneum 
[46-49] contains a sphingoid base and a fatty acid, which are linked by an amide bond 
between the carboxyl group of the fatty acid and the amino group of the base. The 
sphingoid moiety can be sphingosine (S), phytosphingosine (P) or 6-hydroxysphingosine 
(H), whereas the fatty acid moiety is non-hydroxylated (N) or α-hydroxylated (A) with 
chain lengths of predominantly 24 to 26 hydrocarbon atoms. The most remarkable 
ceramides are the acylceramides (CER1, CER4 and CER9). These ceramides consist 
of an unusual long ω-hydroxy fatty acid of 30 to 34 hydrocarbon atoms to which 
unsaturated linoleic acid is ester-linked (EO). As an essential fatty acid, linoleate has to 
be derived from our diet, but it may also be recycled within the epidermis [50, 51]. 
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Figure 3 - Molecular structures of the ceramides (CER) present in human stratum corneum and pig 
stratum corneum. 
The composition of the free fatty acids is also unique. In both human and pig 
stratum corneum, the free fatty acids fraction mainly consists of long and saturated 
hydrocarbon chains [52, 53]. Oleic and linoleic acid are the only unsaturated free fatty 
acids detected in the stratum corneum. There are various sterols present in human 
stratum corneum, of which cholesterol predominates. Cholesterol is the only major lipid 
class that is present in both plasma membranes and the intercellular lipid lamellae. 
Cholesterol is synthesised in the epidermis and this synthesis is independent of the 
hepatic one. A minor fraction is sulphated to form cholesterol sulphate. Although it is 
present in only small amounts (typically 2-5% w/w), cholesterol sulphate is considered 
to play an important role in the desquamation process of the stratum corneum (see 
section 2.2 of this chapter). 
3.3 Lipid organisation
3.3.1 In vivo
The intercellular lipid lamellae were ﬁrst visualised in the early 1970s using freeze 
fracture electron microscopy [54]. However, they could not be visualised in transmission 
electron microscopy. It is now well recognised that the saturated nature of the stratum 
corneum lipids does not permit a chemical reaction with the osmium tetroxide that is 
routinely used in the preparation of specimens for transmission electron microscopy. 
However, the use of ruthenium tetroxide as a post-ﬁxation agent made it possible to 
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visualise the unique lamellar arrangement of the intercellular lipids [55, 56]: multiple 
lamellae, consisting of a broad-narrow-broad sequence of electron lucent bands, exist 
throughout the depth in the stratum corneum. Measurements of the broad-narrow-
broad sequence of electron lucent bands reveal the presence of a 13 nm phase. 
This periodicity could be conﬁrmed by small-angle X-ray diffraction studies on 
human, pig and mouse stratum corneum [57-61]. However, besides a 13 nm lamellar 
phase, indicated as the long periodicity phase, a second lamellar phase could be 
demonstrated. The periodicity of this phase is approximately 6 nm and this phase is 
therefore indicated as the short periodicity phase. In contrast to the short periodicity 
phase, the long periodicity phase is only identiﬁed in the stratum corneum and not 
in other biological membranes. Due to its characteristic periodicity, it is generally 
suggested that this phase plays an important role in the skin barrier function.
Besides the lamellar organisation, the crystallinity of the intercellular lipids is 
also of crucial importance for the barrier function of human skin. The packing density 
decreases in the order orthorhombic>hexagonal>liquid. As a result, the orthorhombic 
packing is the least permeable structure, whereas the liquid phase is highly permeable. 
Wide-angle X-ray diffraction studies reveal that the lipids in human stratum corneum 
are predominantly packed in an orthorhombic lattice, although the presence of a 
coexisting hexagonal packing could not be excluded [62]. In addition, it could not be 
concluded whether a liquid phase coexists, as its broad reﬂection in the diffraction 
pattern was overlapped by the reﬂections attributed to keratin, which is present in 
the corneocytes. Electron diffraction and fourier transformed infrared studies on tape-
stripped stratum corneum have conﬁrmed that the bulk of the stratum corneum lipids 
forms an orthorhombic phase. However, near the skin surface an increased fraction 
of lipids is in a hexagonal state [63, 64]. It is suggested that this transition from an 
orthorhombic to a hexagonal packing is caused by interaction of the intercellular lipids 
with sebum. Sebum is excreted by the sebaceous glands and forms a protective layer, 
which covers the skin surface. It consists of neutral, polar lipids that contain primarily 
tri-glycerides, short-chain free fatty acids, wax esters, and squalene, as well as small 
amounts of cholesterol and cholesteryl esters [65].
3.3.2 In vitro
To further increase our insight in the stratum corneum barrier function, stratum 
corneum lipid models have been developed. The main advantage of these lipid models 
is that the composition of the mixtures can be systematically altered, which allows 
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studying the individual role of the various lipid classes in the stratum corneum lipid 
organisation. Furthermore, proteins (keratin) are absent. This considerably facilitates 
the interpretation of the results. Equimolar mixtures of the commercially available 
bovine brain ceramide type III (structurally similar to CER2, but with shorter fatty acid 
chain lengths [66]), cholesterol and palmitic acid have been extensively studied. Using 
NMR, it has been demonstrated that the majority of these lipids forms an orthorhombic 
phase, whereas a small portion forms a more mobile phase [67, 68]. FTIR studies 
on similar stratum corneum lipid models, containing bovine brain ceramide type IV, 
synthetic CER2 or synthetic CER5, conﬁrm the presence of orthorhombic lattices [69-
71]. However, small-angle X-ray diffraction studies reveal that mixtures prepared with 
these (semi-)synthetic ceramides do not form the characteristic long periodicity phase 
[72]. This can most likely be ascribed to the structure of the ceramides and the chain 
length of the fatty acid, which both do not mimic the in vivo situation.
In contrast to mixtures prepared with synthetic ceramides, hydrated mixtures of 
cholesterol and puriﬁed ceramides isolated from human or pig stratum corneum do 
resemble the characteristic stratum corneum lipid organisation. Over a wide molar 
range (0.4 to 2), two lamellar phases with periodicities of 5.2 and 12.2 nm are formed in 
mixtures prepared with cholesterol and pig ceramides [73]. Addition of long-chain free 
fatty acids increases the packing density and induces a hexagonal to an orthorhombic 
transition. In addition, free fatty acids slightly increase the periodicity of the long 
periodicity phase to 13 nm. Additional studies revealed that the lipid organisation in 
equimolar mixtures of cholesterol and pig ceramides is insensitive to the composition of 
the ceramides [74]. The only exception is CER1, as the formation of the long periodicity 
phase is dramatically decreased in the absence of CER1 [75-77]. This demonstrates 
that CER1 is of crucial importance for proper lipid organisation in stratum corneum. 
The role of the fatty acid, which is linked to the ω-hydroxy fatty acid of CER1, on the 
lipid phase behaviour was elucidated in an additional study [78]. This was performed 
with equimolar mixtures of cholesterol, free fatty acids and isolated human ceramides, 
in which native CER1 was replaced by synthetic CER1 linoleate, CER1 oleate or CER1 
stearate. The results show that the degree of saturation of the fatty acid chain of CER1 
highly affects the lamellar and lateral lipid organisation. The long periodicity phase is 
predominantly present in mixtures prepared with CER1 linoleate, to a lesser extent 
in mixtures prepared with CER1 oleate and absent in mixtures prepared with CER1 
stearate. Concerning the lateral packing, besides the hexagonal and orthorhombic 
packing, a small fraction of lipids forms a ﬂuid phase. The formation of this ﬂuid phase 
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decreases in the order CER1 oleate>CER1 linoleate>CER1 stearate, indicating that the 
formation of the long periodicity phase correlates with the presence of a ﬂuid phase 
and that for the formation of the 13 nm phase a certain optimal amount of lipids should 
be present in a ﬂuid phase [78].
Cholesterol sulphate is another intercellular lipid. Addition of low levels of cholesterol 
sulphate, as observed in normal healthy stratum corneum, to lipid mixtures has little 
effect on the phase behaviour at room temperature. However, addition of high levels 
of cholesterol sulphate, as observed in the skin disease recessive X-linked ichthyosis, 
promotes the formation of the long periodicity phase, induces the formation of a ﬂuid 
phase and increases the solubility of cholesterol in the lamellar phases [79, 80]. 
Figure 4 - Lipid organisation in the 13 nm lamellar phase according to the sandwich model. 
Various models have been proposed to describe the molecular organisation of 
intercellular stratum corneum lipids, such as the stacked monolayer model [81], 
the domain mosaic model [82], the single gel phase model [83] and the sandwich 
model [78, 84]. According to the sandwich model (see Fig. 4) the lipids within the 
long periodicity phase are organised in a tri-layer structure: two broad layers with a 
crystalline (orthorhombic) structure are separated by a narrow central lipid layer with 
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ﬂuid domains. This broad-narrow-broad pattern of hydrocarbon chains corresponds 
to the images obtained with electron microscopy of the stratum corneum intercellular 
lamellae. Cholesterol and the linoleic acid moiety of the acylceramides CER1, CER4 
and CER9 are proposed to be located in the central narrow layer, whereas crystalline 
packed ceramides are present on both sides of this central layer [78]. Due to their 
unusual long structure, the acylceramides are able to span a layer and extend into 
another layer. The acylceramides are therefore thought to contribute to the stability of 
the 13 nm phase. The central, non-continuous ﬂuid phase may be of importance for 
proper elasticity of the lamellae and for the enzyme activity in the stratum corneum, 
as enzymes are unlikely to be active in crystalline phases.    
3.4 Altered lipid composition and organisation in diseased and dry skin
There are several genetic skin diseases with known defects in the lipid metabolism. 
Atopic dermatitis, lamellar ichthyosis and psoriasis have been the most widely studied 
with respect to epidermal barrier function and alterations in the lipid proﬁle. Deviations 
in the lipid proﬁle have been linked with an impaired stratum corneum barrier function. 
Atopic dermatitis is characterised by inﬂammatory, dry and easily irritable skin and 
overall reduced levels of ceramides in the stratum corneum [85-87]. In particular 
a signiﬁcant decrease in the CER1, level is observed, whereas the levels of oleate, 
which is esteriﬁed to CER1 are elevated [86]. Both aberrations may be responsible 
for the reduced order of the lamellar phases as observed with freeze fracture electron 
microscopy [88]. It has further been established that, in comparison to healthy stratum 
corneum, the fraction of lipids that forms a hexagonal packing is increased [88]. A 
recent study reveals that the level of free fatty acids with more than 24 carbon atoms 
is remarkably reduced in both lesion and nonlesion parts of atopic skin as compared 
to healthy skin [30]. Previous X-ray diffraction studies on mixtures prepared with 
isolated ceramides reveal that long-chain fatty acids are required for the formation 
of the orthorhombic packing. In addition, it was demonstrated that the fraction of 
lipids that forms a hexagonal packing is increased at reduced CER1 levels [73, 76]. 
Both observations may explain the decreased packing density of the lipids in atopic 
dermatitis. 
Lamellar ichthyosis is a rare skin disorder that is characterised by thick plate-like 
scales, skin dryness and variable redness. Characteristics of this skin disorder are 
signiﬁcantly reduced levels of free fatty acids and an altered overall ceramide proﬁle, 
without signiﬁcant changes in the CER1 content [89]. These changes in lipid proﬁle likely 
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explain the altered lamellar organisation in lamellar ichthyosis, as observed by X-ray 
diffraction [89]. Transmission electron microscopy studies using ruthenium tetroxide 
as a post-ﬁxation agent further showed that in the intercellular space irregularly 
distributed lipid lamellae are present with areas containing excessive numbers of 
lamellae [90]. Concerning the lateral lipid organisation, it has been established that the 
lateral packing is predominantly hexagonal rather than orthorhombic [88]. This latter 
observation can be associated with reduced levels of free fatty acids. 
Psoriasis is a chronic skin disorder, in which an abnormally fast transition of basal 
cells into corneocytes results in a thickening of the stratum corneum. Transmission 
electron microscopy studies show an aberrant stratum corneum lipid ultrastructure 
in psoriatic skin [91], which is expected to be related to abnormalities in the lipid 
proﬁle. Particularly, a signiﬁcant reduction in CER1 and a predominance of sphingosine 
ceramides at the expense of phytosphingosine ceramides are reported in psoriatic 
stratum corneum [92, 93]. 
In recessive X-linked ichthyosis, the amount of cholesterol sulphate in the stratum 
corneum is increased due to a deﬁciency in cholesterol sulphatase deﬁciency [35, 36]. 
Lipid analysis of scales reveals a nearly 10-fold increase in the cholesterol sulphate to 
free cholesterol ratio as compared to healthy stratum corneum [94]. Previous X-ray 
diffraction studies on isolated ceramide mixtures revealed that increased cholesterol 
sulphate levels induce the formation of a ﬂuid phase, which is likely to reduce the skin 
barrier function [80]. 
Abnormalities in the lipid composition and organisation have also been established 
in dry skin. Interestingly, pronounced seasonal changes in the stratum corneum lipid 
proﬁle have been reported. During the winter months, decreased levels of all major 
lipid species are observed [95]. In addition, the CER1 linoleate to CER1 oleate ratio 
considerably drops from 1.74 in summer to 0.51 in winter. These changes may explain 
the disorganised lipid lamellae, which are observed in winter xerosis [96]. Similarly 
as psoriatic skin, dry skin contains reduced levels of phytosphingosine ceramides and 
increased levels of sphingosine ceramides [97]. One of the suggested pathways for 
the phytosphingosine biosynthesis involves the addition of water to the corresponding 
sphingosine double bond. The observed changes in the sphingosine to phytosphingosine 
ceramide ratio may therefore be caused by disturbed water availability, associated with 
dry skin [92]. 
All the aforementioned changes in lipid composition and organisation in diseased 
and dry skin likely contribute to an impaired stratum corneum barrier function and 
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increased susceptibility to dry skin. However, as previously indicated, abnormalities 
in the process of envelope formation may also inﬂuence the stratum corneum barrier 
integrity. Therefore, more information is required to elucidate the precise mechanisms 
by which stratum corneum structure and function are altered.
4. DRUG TRANSPORT THROUGH THE SKIN
4.1 Diffusion characteristics
Skin permeation is a complex multistep process. Initially, a drug must be released 
from the vehicle and partition into the stratum corneum before it can diffuse through 
the stratum corneum. Subsequently, the drug needs to partition from the lipophilic 
stratum corneum environment into the more hydrophilic viable tissue, where the drug 
is eventually taken up by the blood circulation. As described in the previous section, 
the stratum corneum represents the main barrier to diffusion of drugs through the 
skin. The passive diffusion process of a drug through the stratum corneum can most 
simply be described by Fick’s law [6, 98]:
J = (K*D*Cd)/h 
In this equation, J represents the ﬂux of the permeant through the stratum corneum 
(µg/cm2/s), K the partition coefﬁcient of the permeant between the stratum corneum 
and the vehicle, D the diffusion coefﬁcient of the permeant in the stratum corneum 
(cm2/s), Cd the concentration of the permeant in the vehicle (µg/cm
3) and h the length 
of the pathway through the stratum corneum (cm). The equation will only hold for 
steady state conditions, assuming that the stratum corneum is a homogeneous barrier 
and the concentration of the drug in the acceptor phase is negligible.
Permeation data of drugs such as steady state ﬂux, lag time and diffusion coefﬁcient 
are often obtained from in vitro permeation experiments. When the dose delivered to 
the skin is “inﬁnite”, there will ﬁrst be a lag period in which the concentration gradient 
across the stratum corneum is established. After this lag time, the ﬂux will become 
constant, provided that there is no permeability change in the stratum corneum and the 
drug concentration in the donor compartment is constant. The constant ﬂux is referred 
to as the steady state ﬂux. A typical proﬁle of the cumulative amount of penetrated 
drug versus time is illustrated in Figure 5. The steady state ﬂux can be determined 
from the linear part of the plot. Together with the pharmacokinetic parameters of a 
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drug, it determines whether or not therapeutic plasma levels will be achieved in vivo. 
The lag time, indicative for the time required before the steady state ﬂux is reached, 
can be determined by extrapolation of this curve to the intercept with the time axis.
Diffusion is a process of mass transfer of individual molecules due to a concentration 
gradient and random molecular motion [99]. The concentration gradient in the stratum 
corneum provides the driving force for diffusion. To obtain a high initial concentration 
in the ﬁrst layers of the stratum corneum, a drug should have a high tendency to 
leave the vehicle and migrate into the stratum corneum. The relative afﬁnity of a drug 
compound for the stratum corneum and the vehicle is expressed in the value of the 
partition coefﬁcient, K. As the stratum corneum acts as a lipophilic diffusional barrier, 
a high lipid solubility (logPoct/water of about 1-3 [100]) and a low but sufﬁcient solubility 
in the vehicle are necessary for a maximal input of the drug into the stratum corneum. 
However, it should be noted that once the drug has crossed the stratum corneum, it 
must partition into and pass the underlying viable epidermis, dermis and circulatory 
system. As these tissues are more hydrophilic than the stratum corneum, they should 
be taken into consideration as part of the barrier for extremely lipophilic drugs [2]. It 
is generally considered that the wash out by the blood circulation is sufﬁciently fast as 
not to be a rate-limiting factor in the absorption of drugs.
Figure 5 –Typical permeation proﬁle of a drug diffusing through the skin
The diffusion coefﬁcient or diffusivity, D, is a rough measure of the ease with which 
a molecule can move through a medium, in this case the stratum corneum [99]. It is 
dependent on the properties of the drug (e.g. size, shape, polarity) and the degree 
of interaction between the permeant and the stratum corneum. K, D and h are often 
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expressed in the permeability coefﬁcient P:
P = (K*D)/h
Thus, when the donor concentration and the ﬂux of the drug are known, the permeability 
coefﬁcient can be determined. It is this parameter that is widely used to characterise 
the percutaneous absorption of many drug compounds under steady state conditions.
4.2 In vitro penetration studies
In vitro transport studies are often used to predict the penetration of possible 
drug candidates through the skin in vivo. Diffusion cells generally comprise a donor 
compartment and an acceptor compartment, separated by a piece of epidermis or 
stratum corneum, isolated from excised skin. Static and ﬂow-through diffusion cells 
are both acceptable to obtain permeation data. However, the in vivo situation is more 
closely resembled using a ﬂow-through cell, as the acceptor solution is continuously 
replaced (see Fig. 6). This prevents accumulation of the permeating compound in the 
acceptor compartment, which would decrease the concentration gradient and hence 
the ﬂux through the skin [101, 102]. 
The composition, viscosity and pH of the donor solution may have signiﬁcant 
effects on the drug permeation. Moreover, penetration enhancers can be incorporated 
into the donor solution, which enhance drug transport across the stratum corneum. An 
ideal penetration enhancer locally and reversibly reduces the barrier resistance of the 
stratum corneum, without irritating or damaging the skin.
The acceptor solution used in diffusion cells should not only act as an acceptor 
for permeating drugs but should also provide the environment for the skin membrane 
to function at physiological temperature, pH and osmotic strength. To maintain sink 
conditions, the concentration of the drug in the acceptor solution should always be 
less than 10% of its saturated concentration. The appropriate total volume of the 
acceptor ﬂuid depends on the solubility and analytical detectability of the permeant. 
For lipophilic compounds, serum albumin or other solubility enhancing components 
may be added to the acceptor solution. However, their effects on the skin and stratum 
corneum integrity should be considered.
Ideally, one would like to use epidermis or stratum corneum, isolated from excised 
human skin to evaluate penetration properties of drug candidates. However, this 
approach has a number of limitations. Human skin is only available in limited quantities 
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from surgical or post-mortem sources. In various countries the use of excised human 
skin is even prohibited. Furthermore, the age, race, body site and skin condition of 
the donor cannot be controlled, which results in considerable permeability variations 
within and between individuals [103]. As it is rather difﬁcult to obtain human skin on 
a regular basis, various published papers used skin that was stored in the freezer prior 
to the diffusion studies. However, large ice crystals and osmotic pressure differences, 
which are induced during freezing and subsequent thawing of the skin, damage the 
skin structure and decrease its barrier integrity [104].
4.3 Models for human skin
4.3.1 Animal skin
The quest to circumvent the aforementioned problems has prompted an extensive 
search for reliable in vitro penetration models. Many studies have been performed to 
investigate the suitability of animal skin as a model for human skin. Various animal 
species have been studied, such as the mouse, rabbit, guinea pig, rat, pig and snake. 
The available information in literature on comparative penetration studies using human 
and animal skin is sometimes contradictory. The permeability coefﬁcients for some 
compounds are almost similar to those across human skin, whereas others differ 
greatly [105]. Rodent skin is usually much more permeable than human skin [105, 
106]. As a result, the skin permeability can be considerably overestimated when data 
is directly extrapolated to humans. Differences in the barrier integrity between human 
and rodent skin can be explained by signiﬁcant morphological differences. In particular 
the presence of many hair follicles and sebaceous glands, altered composition and 
organisation of the intercellular stratum corneum lipids and altered stratum corneum 
thickness may account for the increased permeability of rodent skin. Another problem 
with rodent skin, in particular hairless mouse, is its susceptibility to hydration effects. 
After prolonged exposure to an aqueous donor and acceptor solution, the barrier 
integrity of rodent skin decreases many folds [107, 108]. Rodent skin should therefore 
be used with caution as a predictive in vitro model for human skin. Nevertheless, 
many patents are issued based on data collected using rodent skin. The utility of these 
patents for the clinical practice may therefore be limited. 
Another alternative to human skin is shed snake skin. In contrast to rodent skin, 
shed snake skin tends to underestimate the permeability coefﬁcients, in particular of 
ionised compounds and during iontophoresis [109-112]. Snake skin lacks appendages 
such as hair follicles, which may account for the observed differences in barrier function 
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between human and snake skin. 
Pig skin has been postulated as the most suitable predictive in vitro animal model 
for human skin. The epidermal thickness, morphology and the stratum corneum lipid 
composition and organisation have been reported to be similar to human skin [61, 
113]. The ﬂux values of various permeants through pig skin are of the same order of 
magnitude as through human skin, with differences of at most 3-fold [105, 114-117]. 
Therefore, severe overestimation or underestimation of the permeability of human skin 
appears unlikely.
4.3.2 Reconstructed epidermis
Another alternative for human skin is reconstructed human skin, which is generated 
in vitro by growing differentiated keratinocytes cultures on a dermal substrate at the 
air-liquid interface. Marked progress in the culture techniques [118-121] has led to 
various skin reconstructs of which the morphological features closely resemble those of 
native epidermis. Examination of these reconstructed skin models showed the presence 
of all strata, including the stratum corneum. Ultrastructural analysis of the corniﬁed 
envelope proteins and covalently bound lipids further reveal great compositional 
similarities between native and reconstructed skin. Furthermore, all major lipid 
classes are synthesised under in vitro conditions and the lipids organise parallel to the 
corneocyte surface according to a broad-narrow-broad sequence of electron lucent 
bands [reviewed in 122]. 
Despite the high degree of similarity between native and reconstructed epidermis, 
some differences in the lipid composition and organisation have been observed. In 
reconstructed epidermis, the amount of free fatty acids is reduced and the major acyl 
chain lengths are shorter than in native stratum corneum [49, 123]. In addition, the 
content of linoleic acid in CER1 is lower and the total ceramide proﬁle deviates from 
that of native stratum corneum. Investigation of reconstructed epidermis with small- 
angle X-ray diffraction revealed the presence of a lamellar phase with a long periodicity 
of 12 nm. However, in contrast to native stratum corneum, the short periodicity phase 
is missing [119, 123, 124]. Furthermore, the lateral packing in reconstructed skin is 
predominantly hexagonal instead of orthorhombic [124, 125].
All these differences may explain the increased permeability of reconstructed 
epidermis in comparison to human skin. Penetration studies performed with various 
substances typically show 5 to 20-fold higher ﬂuxes through cultured skin than 
through human skin [105, 126-130]. However, differences up to 50-fold have been 
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reported. This indicates that the permeability of cultured skin is equivalent, although 
sometimes even inferior, to that of mouse, rat or guinea pig skin. Taking into account 
the excellent reproducibility of skin culture models [131], reconstructed epidermis 
may be a promising percutaneous penetration model when the culture conditions are 
further improved to minimise differences in the lipid composition and organisation as 
compared to native skin. 
4.3.3 Synthetic membranes
Synthetic polymeric membranes such as Silastic® (polydimethylsiloxane), Carbosil 
(polydimethylsiloxane-polycarbonate block copolymer), pHEMA (poly(2-hydroxyethyl
methacrylate), or cellulose acetate have also been used as an alternative permeability 
model for human skin [132-134]. However, inspection of literature reveals that their 
predictability is rather limited. Although interesting correlations have been reported 
for silicone membranes and excised human epidermis, the former appears to be 10 to 
100 times more permeable [134, 135]. Cellulose acetate and pHEMA membranes show 
permeability proﬁles that are not representative for transport across excised stratum 
corneum [134]. The fact that permeability coefﬁcients cannot be predicted adequately 
when using artiﬁcial polymeric membranes is likely due to their simplicity and non-
resemblance with the stratum corneum structure. 
Another attempt has been to reconstitute stratum corneum lipids on a porous 
membrane. As the major transport route of substances is through the intercellular 
lipid matrix of the stratum corneum, it is reasonable to suggest that a membrane 
containing these lipids would be a relevant model for permeation studies. The use 
of synthetic lipids is a prerequisite, as the isolation and separation of lipids from the 
stratum corneum is a time-consuming and laborious procedure. Various papers report 
the use of model membranes prepared with the commercially available bovine brain 
ceramide type III or IV [136-141]. However, as discussed in section 3.3 of this chapter, 
those lipid membranes bear little resemblance to human stratum corneum, as the 
characteristic long periodicity phase is not formed in mixtures composed of cholesterol, 
free fatty acids and bovine brain ceramides [72, 138]. Furthermore, no data on the 
orientation of the lamellae have been reported. Although the available information in 
literature about their use as percutaneous penetration model is somewhat limited, 
these lipid membranes are reported to have similar permeability properties as guinea 
pig skin [140, 141]. However, as stated previously, rodent skin is usually much more 
permeable than human skin.
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5. THIS THESIS
5.1 Objectives of this thesis
In vitro transport studies are frequently used to predict the drug transport through 
the skin in vivo. However, this approach is hampered by the low availability of excised 
human skin, large inter- and intra-individual variations and the lack of alternative skin 
models that closely mimic the barrier properties of native human skin. The intercellular 
lipids in the stratum corneum have been demonstrated to represent the major barrier 
to the diffusion of substances through the skin. As described in this chapter, diseased 
and dry skin often show a defective barrier function at the diseased state, which is at 
least partially due to deviations in the lipid proﬁle and organisation. Although a number 
of topical products are specially designed for these skin types, reproducible in vitro 
models are currently lacking. 
The present thesis will outline the development of a skin barrier model, consisting 
of synthetic stratum corneum lipids on a porous substrate, which can be used in 
diffusion studies to predict drug transport through the skin (see Fig. 6). The skin 
lipid membrane can be used for large-scale screening of formulations, will circumvent 
problems related to stratum corneum sheets isolated from human or animal skin and 
may allow studying the effects of temperature or different agents on permeability 
and membrane organisation. Another advantage of this so-called stratum corneum 
substitute is that its lipid composition can be accurately chosen and modiﬁed. In this 
way the lipid organisation in diseased and dry skin may also be imitated, which provides 
unique possibilities to more adequately predict the permeability of diseased and dry 
skin to drug candidates. 
Figure 6 – Schematic representation of the stratum corneum substitute (SCS) in a diffusion cell.
30 Chapter 1
The objectives of this thesis are:
(i) Selection of a synthetic ceramide mixture that mimics the phase behaviour 
of the intercellular lipids in human stratum corneum.
(ii) Preparation of a homogeneous stratum corneum substitute in terms of 
lipid composition, organisation, orientation and layer thickness.
(iii) Evaluation of the permeability barrier of the stratum corneum substitute.
5.2 Outline of this thesis
In the ﬁrst part of this thesis the lamellar and lateral organisation in various 
synthetic lipid mixtures were studied with small-angle and wide-angle X-ray diffraction, 
whereas the second part describes the preparation and characterisation of the stratum 
corneum substitute. 
Chapter 2 describes the phase behaviour of four (semi)-synthetic ceramides, either 
single or in a mixture with cholesterol, or cholesterol and free fatty acids. The effects of 
compositional changes on the phase behaviour of the lipid mixtures were systematically 
examined. Chapter 3 and 4 are follow-ups of the study described in chapter 2. In these 
chapters the importance of the equilibration temperature during sample preparation, 
the ratio between the individual ceramides and the presence of free fatty acids in the 
lipid mixture for the formation of the 13 and 6 nm lamellar phases are reported. The 
importance of acylceramide type and relative content for proper lipid organisation in 
this lipid mixture is demonstrated in chapter 5. Furthermore, a ceramide mixture that 
mimics the composition of the ceramides in pig stratum corneum has been studied, of 
which the results are reported in chapter 6. Special focus in this chapter is addressed 
to the role of free fatty acids on the lipid organisation and the sensitivity of the lipid 
organisation towards exclusion or replacement of certain ceramide classes. 
In Chapter 7 the application method, which was selected and constructed to spray 
the lipids onto a porous substrate, is introduced. The stratum corneum substitute is 
subsequently characterised in terms of lipid distribution, uniformity of the lipid layer and 
organisation and orientation of the lipid lamellae. The barrier integrity of the stratum 
corneum substitute is reported in chapter 8. Passive diffusion studies are performed 
with three structurally related substances, using isolated human stratum corneum as 
a control sample. The inﬂuences of lipid layer thickness, permeant lipophilicity and 
altered lipid composition on the diffusion characteristics are investigated. 
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ABSTRACT
The lipid lamellae present in the outermost layer of the skin, the stratum corneum, 
form the main barrier for diffusion of molecules across the skin. The main lipid classes 
in stratum corneum are cholesterol, free fatty acids and at least 9 classes of ceramides, 
referred to as CER1 to CER9. In the present study the phase behaviour of four synthetic 
ceramides, either single or mixed with cholesterol or cholesterol and free fatty acids, 
has been studied using small-angle and wide-angle X-ray diffraction. The lipid mixtures 
show complex phase behaviour with coexistence of several phases. The results further 
reveal that the presence of synthetic CER1 as well as a proper composition of the other 
ceramides in the mixture are crucial for the formation of a phase with a long periodicity, 
characteristic for the stratum corneum lipid phase behaviour. Only a mixture containing 
synthetic CER1, CER3, cholesterol and free fatty acids shows similar phase behaviour 
to that of stratum corneum.
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1. INTRODUCTION
For the majority of chemicals, the barrier function of the skin is unquestionably 
attributed to its superﬁcial layer, the stratum corneum. Stratum corneum consists of 
keratin-ﬁlled corneocytes, organised in a matrix of highly ordered multi-lamellar lipid 
sheets. This is often referred to as a brick wall-like structure, with the corneocytes 
forming the bricks and the intercellular lipids representing the mortar [1]. Several 
microscopic transport studies have demonstrated that the lipid matrix is the major 
rate-limiting pathway by which most drugs traverse the stratum corneum [2-4]. For 
this reason, the structure and physical properties of the stratum corneum lipids are 
considered to play an essential role in the skin barrier function. 
The lipid composition in stratum corneum is unique. Unlike biological membranes, 
it is almost devoid of phospholipids and the major constituents are ceramides, 
cholesterol and long-chain free fatty acids. At least 9 different classes of ceramides 
have been identiﬁed in human stratum corneum [5-8], which are referred to as CER1 
to CER9. The ceramides are composed of a sphingosine, a phytosphingosine or a 6-
hydroxysphingosine base to which nonhydroxy or α-hydroxy fatty acid is linked. These 
fatty acids have a chain length distribution with 24 (C24) and 26 (C26) carbon atoms 
being the most abundantly present. CER1, CER4 and CER9 are unique in structure 
since these acylceramides contain linoleic acid bound to an ω-hydroxy fatty acid with a 
chain length of 30 to 32 carbon atoms. 
X-ray diffraction studies on stratum corneum have demonstrated that the stratum 
corneum lipids are structured in two coexisting crystalline lamellar phases with 
periodicities of approximately 6 nm (referred to as the short periodicity phase: SPP) 
and 13 nm (referred to as the long periodicity phase: LPP), respectively [9-11]. The 
presence of the 13 nm lamellar phase and the crystalline nature of the lipid packing are 
believed to be critical for an adequate skin barrier function. 
Several studies have been performed in order to attempt reproduction of the 
stratum corneum lipid organisation, using a model system prepared with isolated pig 
or human ceramides, cholesterol and free fatty acids. It was found that the phase 
behaviour of isolated ceramides mixed with cholesterol in a wide range of molar ratios 
was similar to that of native stratum corneum [12-14]. Mixtures prepared with isolated 
pig ceramides showed the presence of two lamellar phases with periodicities of 5.2 
and 12.2 nm, whereas the repeat distances of both phases were 5.4 and 12.8 nm 
in mixtures containing human ceramides. The lamellar organisation in lipid mixtures 
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prepared with cholesterol, ceramides and free fatty acids resembled that of stratum 
corneum even closer. Addition of free fatty acids to equimolar mixtures of cholesterol 
and ceramides induced a phase transition from a hexagonal to an orthorhombic packing 
[15]. In addition, the presence of CER1 was shown to be crucial for the formation of 
the LPP. 
Other studies have described the phase behaviour of stratum corneum lipid models 
based on synthetic ceramides. The majority of those studies focused on equimolar 
mixtures containing cholesterol, palmitic acid and the commercially available bovine 
brain ceramide type III (ΣCERIII, see Fig. 1), which is structurally similar to the most 
abundant CER2 in stratum corneum. Using nuclear magnetic resonance, it was found 
that at physiological temperatures the lipids predominantly form crystalline phases 
[16, 17]. In addition, several fourier transform infrared spectroscopy measurements 
showed that both ceramides and palmitic acid phase-separate into crystalline domains 
with an orthorhombic chain packing [18-20]. Similarly, domains enriched in cholesterol, 
ceramides, or palmitic acid were detected with Raman microscopy [21]. In mixtures 
consisting of cholesterol, hexadecanoic acid and either synthetic CER2 or CER5 it was 
also observed that the lipids were not properly mixed in one orthorhombic lattice, but 
coexisted in various phases [22]. The lipid composition of those models differs from 
that of the intact stratum corneum with respect to the molecular structure of the 
individual ceramides and the chain length of the free fatty acids. Stratum corneum 
mainly contains long-chain free fatty acids [23], while palmitic acid is only present in 
very small amounts. However, despite the simplicity of those model mixtures, some 
features of the stratum corneum lateral organisation appeared to be reproduced. 
Concerning the lamellar organisation, small-angle X-ray diffraction studies revealed 
that the characteristic LPP is not present in mixtures consisting of bovine brain ceramide 
type III, cholesterol and palmitic acid [12, 24]. In one paper the observed formation of 
a 10.4 nm lamellar phase in a mixture of bovine brain ceramide type III and cholesterol 
was attributed to the formation of a double-bilayer structure [25]. It is a matter of 
debate to consider this phase as representative for stratum corneum, since its repeat 
distance noticeably differs from that of the LPP in stratum corneum. Moreover, the LPP 
is most likely not a double-bilayer structure, but a tri-layer structure [14].
The main objective of the present study was to prepare a lipid mixture with 
synthetic ceramides that would mimic the stratum corneum lipid phase behaviour with 
respect to the lamellar and lateral arrangement. The phase behaviour of four synthetic 
ceramides (see Fig. 1), either single or in a mixture with cholesterol (CHOL:CER) or 
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cholesterol and free fatty acids (CHOL:CER:FFA) were therefore investigated using 
small-angle X-ray diffraction (SAXD) and wide-angle X-ray diffraction (WAXD). The 
effects of compositional changes, including the addition of synthetic CER1, on the 
phase behaviour of the lipid mixtures were systematically examined.
2. MATERIALS AND METHODS
2.1 Materials
Palmitic acid, stearic acid, arachidic acid, behenic acid, tricosanoic acid, lignoceric 
acid, cerotic acid, cholesterol and ceramides modiﬁed from bovine brain sphingomyelin 
(type III and IV) were purchased from Sigma-Aldrich Chemie GmbH (Schnelldorf, 
Germany). N-(30-Linoleoyloxy-triacontanoyl)-sphingosine (synthetic ceramide1(C30)-
linoleate) was a gift from Beiersdorf AG (Hamburg, Germany). N-Tetracosanoyl-
phytosphingosine (synthetic ceramide 3(C24)) and N-Stearoyl-phytosphingosine 
(synthetic ceramide 3(C16)) were generously provided by Cosmoferm B.V. (Delft, the 
Netherlands). All organic solvents used were of analytical grade and manufactured by 
Labscan Ltd (Dublin, Ireland). 
Figure 1 - The molecular structures of the ceramides used in the study. The acyl chain lengths of 
CER1(C30), CER3(C16) and CER3(C24) are well-deﬁned, whereas bovine brain ceramide type III and 
IV (ΣCERIII and ΣCERIV) show a chain length distribution with C18 and C24 as the most abundantly 
present.
2.2 Methods 
2.2.1 Preparation of lipid mixtures
For the preparation of the three component mixtures (CHOL:CER:FFA), the following 
free fatty acid mixture was used: C16:0, C18:0, C20:0, C22:0, C23:0, C24:0 and C26:0 
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at molar ratios of respectively 1.3, 3.3, 6.7, 41.7, 5.4, 36.8 and 4.7, respectively. 
Appropriate amounts of individual lipids dissolved in chloroform:methanol 2:1 (v/v) 
were combined to yield lipid mixtures of approximately 1.5 mg total dry weight at the 
desired composition at a total lipid concentration of 7 mg/ml. A Camag Linomat IV 
was used to apply the lipid mixtures onto mica. This was done at a rate of 4.3 µl/min 
under a continuous nitrogen ﬂow. The samples were equilibrated for 10 minutes at 
60°C and subsequently hydrated with an acetate buffer of pH 5.0. Finally, the samples 
were homogenised by 10 successive freeze-thawing cycles between –20°C and room 
temperature, during which the samples were stored under gaseous nitrogen. 
2.2.2 Small-angle X-ray diffraction analysis
All measurements were performed at the European Synchrotron Radiation Facility 
(ESRF, Grenoble), using the Dutch-Belgian beamline (BM26B). A more detailed 
description of this beamline has been given elsewhere [26]. The X-ray wavelength and 
the sample-to-detector distance were 1.24Å and 1.7m, respectively. Diffraction data 
were collected on a two-dimensional multiwire gas-ﬁlled area detector. The spatial 
calibration of this detector was performed using silver behenate. The samples were 
mounted in a specially designed sample holder with mica windows. All measurements 
were recorded at room temperature for a period of 10 minutes. 
SAXD provides information about the larger structural units in the sample, such as 
the repeat distance of a lamellar phase. The scattering intensity I (in arbitrary units) 
was measured as a function of the scattering vector q (in reciprocal nm). The latter 
is deﬁned as q=(4�sinθ)/λ, in which θ is the scattering angle and λ is the wavelength. 
From the positions of a series of equidistant peaks (qn), the periodicity, or d-spacing, 
of a lamellar phase was calculated using the equation qn=2n�/d, n being the order 
number of the diffraction peak. 
2.2.3 Wide-angle X-ray diffraction analysis
WAXD provides information about the smaller structural units, like the lateral 
packing of the lipids within the lamellae. Diffraction data were collected on a microstrip 
gas chamber detector with an opening angle of 60° [27]. The sample-to-detector 
distance was 36 cm and the X-ray wavelength was 1.24Å. The spatial calibration of the 
detector was performed with a mixture of silicium and cholesterol. 
The SAXD and WAXD data were collected simultaneously. 
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3. RESULTS
3.1 Lamellar ordering of single CER, CHOL:CER mixtures and CHOL:CER:FFA 
mixtures
The spacings derived from the diffraction data and the corresponding phases of 
the lipid mixtures studied are summarised in Table 1. One phase with a periodicity of 
5.26 nm, of which the ﬁrst, second and third order diffraction peaks were located at 
q = 1.19, 2.40 and 3.61 nm-1 is present in bovine brain ceramide type III (ΣCERIII). 
In the equimolar CHOL:ΣCERIII mixture, the periodicity of this phase slightly shifts to 
5.15 nm. In addition, phase-separated cholesterol is present, which can be deduced 
from the peaks located at 1.87 and 3.74 nm-1. The latter peak is not symmetric, but 
exhibits a shoulder at the left-hand side, which can be ascribed to the third order peak 
of the 5.15 nm phase. From Figure 2, in which the diffraction patterns of the equimolar 
mixtures CHOL:ΣCERIII and CHOL:ΣCERIII:FFA are plotted, it can be observed that 
addition of an equimolar amount of free fatty acids to the binary mixture does not 
signiﬁcantly change the positions or intensities of the diffraction peaks. However, in the 
ternary mixture an additional reﬂection is observed at q = 3.26 nm-1, which is closely 
located to the third order diffraction peak of pure free fatty acids (data not shown). 
Similar results were obtained with mixtures prepared with ΣCERIV (compare 
conditions 1-3 with 4-6 in Table 1). Again, no LPP can be detected. The diffraction 
pattern of single ΣCERIV shows three reﬂections that can be ascribed to a 5.44 nm 
phase. The periodicity of this phase slightly reduces to 5.33 nm in the equimolar 
CHOL:ΣCERIV mixture and to 5.38 nm in the equimolar CHOL:ΣCERIV:FFA mixture. In 
Figure 2 - Diffraction patterns of the equimolar 
CHOL:ΣCERIII and CHOL:ΣCERIII:FFA mixtures. 
The inset is a magniﬁcation of the reﬂections in 
the q-range between 2 and 4 nm-1. The reﬂections 
indicated by Roman numbers are attributed to the 
ﬁrst, second and third order reﬂections of a SPP 
(repeat distance of 5.15 and 5.18 nm for the binary 
and ternary mixture, respectively), whereas the 
asterisk (*) denotes the two reﬂections attributed 
to crystalline cholesterol. The plus sign refers to 
the additional peak present in the ternary mixture 
at a spacing of 1.92 nm (q = 3.26 nm-1), likely due 
to phase-separated free fatty acids.
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addition, in the binary and ternary mixtures the two reﬂections of crystalline cholesterol 
are present. Again a small additional peak (at q = 3.24 nm-1) can be observed in the 
presence of free fatty acids. 
CER3(C16) shows more complex phase behaviour than ΣCER. In the diffraction 
pattern of single CER3(C16), two phases can be observed with periodicities of 4.03 and 
3.59 nm, respectively. The intensities of the two reﬂections attributed to the 4.03 nm 
phase are considerably smaller than the two strong reﬂections of the 3.59 nm phase. 
Addition of cholesterol to CER3(C16), achieving a molar ratio of CHOL:CER3(C16) 0.5:1 
results in a similar diffraction pattern (Fig. 3A). However, besides the 4.03 and 3.59 nm 
phases, crystalline cholesterol can be detected. A weak shoulder at the left-hand side of 
the peak at q = 3.74 nm-1 indicates the presence of another phase with a periodicity of 
about 3.44 nm (Fig. 3A; for explanation see below). In the equimolar CHOL:CER3(C16) 
mixture, two interesting features are observed. Crystalline CER3(C16) is still present, 
as indicated by the strong peak located at 1.75 nm-1. However, the phase with a repeat 
distance of 4.03 nm completely disappeared. Additionally, the presence of the phase 
with a periodicity of about 3.44 nm can clearly be derived from the asymmetry of the 
reﬂection located at q = 1.75 nm-1 and the presence of a strong second order peak at 
q = 3.66 nm-1. The shoulder present at the right-hand side of the reﬂection at q = 3.66 
nm-1 indicates that phase-separated cholesterol is also present. 
Figure 3 - Diffraction patterns of the CHOL:CER3 mixtures (A) CHOL:CER3(C16) at a molar ratio of 
0.5:1 and 1:1, (B) CHOL:CER3(C24) at a molar ratio of 0.5:1 and 1:1. The inset is a magniﬁcation 
of the reﬂections in the q-range between 2 and 4 nm-1. The diffraction peaks indicated by the letter C 
are attributed to the ﬁrst and second order reﬂections of two crystalline phases of CER3. The asterisk 
indicates the reﬂections of crystalline cholesterol, whereas *C denotes the diffraction peaks of the 3.44 
nm phase. 
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Figure 4 shows the diffraction pattern of the equimolar CHOL:CER3(C16):FFA mixture. 
Addition of free fatty acids to the CHOL:CER3(C16) mixture induces the formation of 
a 5.89 nm lamellar phase, of which the ﬁrst and third order peaks are apparent. In 
addition, crystalline CER3(C16) and crystalline cholesterol are present. In contrast 
to the CHOL:CER3(C16) mixtures, the phase with a spacing of about 3.44 nm is not 
present in the ternary mixture. Similarly as the observations made with ΣCER, addition 
of free fatty acids to the binary mixture results in the formation of a very weak shoulder 
at q = 3.29 nm-1, which might be ascribed to the third order diffraction peak of pure 
free fatty acids. 
In certain aspects the phase behaviour of CER3(C24) resembles that of CER3(C16). 
Single CER3(C24) also shows the presence of two phases. However, the periodicities 
are slightly increased as compared to those of CER3(C16). The reﬂections attributed 
to a 4.26 nm phase are weaker than the diffraction peaks of the phase with a repeat 
distance of 3.71 nm. Figure 3B shows the diffraction patterns of the CHOL:CER3(C24) 
mixture at a molar ratio of 0.5:1 and 1:1. In both mixtures, the 4.26 nm phase is not 
present, whereas the intensities of the reﬂections attributed to the 3.71 nm phase hardly 
change compared to single CER3(C24). In addition, the phase with a repeat distance 
of 3.44 nm is present in both mixtures. The intensities of the two reﬂections attributed 
to this phase increase with an increasing cholesterol fraction, which is similar to the 
observations made with CHOL:CER3(C16) mixtures. A weak shoulder at the right-hand 
side of the reﬂection at q = 3.66 nm-1 indicates that a small fraction of phase-separated 
Figure 4 - Diffraction patterns of the equimolar 
CHOL:CER3(C16):FFA and CHOL:CER3(C24):
FFA mixtures. The peaks indicated by Roman 
numbers are attributed to the reﬂections of the 
SPP (repeat distance of 5.89 nm and 5.28 nm 
in the mixture prepared with CER3(C16) and 
CER3(C24), respectively). The peaks indicated 
by the letter C are attributed to phase-separated 
CER3. C+ refers to the diffraction peaks of the 
3.82 nm phase, whereas the asterisk indicates 
the reﬂections of crystalline cholesterol. The 
plus sign refers to the additional peak present in 
the ternary mixture prepared with CER3(C16), 
likely due to phase-separated free fatty acids.
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cholesterol might be present in the equimolar CHOL:CER3(C24) mixture. In Figure 
4 the diffraction pattern of the equimolar CHOL:CER3(C24):FFA mixture is depicted. 
In the presence of free fatty acids a phase with a periodicity of 5.28 nm is formed, 
of which the ﬁrst and second order diffraction peaks are clearly visible. Furthermore, 
a phase with a repeating unit of 3.81 nm and crystalline cholesterol are present. In 
contrast to the CHOL:CER3(C24) mixtures, the phase with a repeat distance of 3.44 
nm is not present in the equimolar CHOL:CER3(C24):FFA mixture. The same trend was 
observed with the mixtures prepared with CER3(C16). 
 
3.2 Effect of addition of CER1 on the lamellar ordering 
The inﬂuence of synthetic CER1 on the phase behaviour was investigated by mixing 
CER1 with either ΣCERIII, ΣCERIV or CER3(C24) at a molar ratio of 0.1:0.9. As the acyl 
chain lengths in native ceramides are mainly C24 and C26, CER3(C16) was excluded 
from this part of the study. The ceramides were mixed either with cholesterol (CHOL:
CER) or cholesterol and free fatty acids (CHOL:CER:FFA) at an equimolar ratio. The 
spacings derived from the diffraction data and the corresponding phases of the lipid 
mixtures studied are summarised in Table 1. 
The diffraction patterns obtained with ΣCERIII and ΣCERIV are very similar and 
almost identical to those obtained in the absence of CER1 (e.g. compare condition 3 
with 16 and condition 16 with 18 in Table 1). In all samples a phase with a periodicity 
of about 5.4 nm and phase-separated cholesterol are present and addition of free fatty 
acids results in the formation of an additional peak. The diffraction curves do not show 
any indication for the presence of a LPP.
The diffraction pattern of the CHOL:[CER1:CER3] mixture also resembles the one 
obtained in the absence of CER1 (compare conditions 13 and 19 in Table 1). Both the 
3.78 nm phase and the 3.43 nm phase are indicated by the presence of the ﬁrst and 
second order diffraction peaks. The shoulder at the right-hand side of the reﬂection 
at 3.66 nm-1 suggests that phase-separated cholesterol is also present in the mixture. 
In Figure 5, the diffraction curve of the CHOL:[CER1:CER3]:FFA mixture is shown. 
Addition of free fatty acids to the binary mixture induced the formation of a phase with 
a repeat distance of 11.6 nm, indicated by peaks located at q = 0.54 nm-1 (ﬁrst order) 
and 1.62 nm-1 (third order). Furthermore, three reﬂections indicate the presence of a 
5.42 nm phase (SPP) and two reﬂections that of crystalline cholesterol. 
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Figure 5 - Diffraction pattern of the mixture 
CHOL:[CER1:CER3(C24)]:FFA at a molar ratio 
of 1:[0.1:0.9]:1. The inset is a magniﬁcation of 
the reﬂections in the q-range between 2 and 4 
nm-1. The peaks indicated by Arabic numbers are 
attributed to the ﬁrst and third order reﬂections 
of a lamellar phase with a repeat distance of 11.6 
nm. The ﬁrst, second and third order reﬂections 
of the SPP (periodicity of 5.42 nm) are indicated 
by Roman numbers. The asterisk denotes the 
reﬂections of crystalline cholesterol.
3.3 Lateral arrangement of CHOL:[CER1:CER3]:FFA mixture
Figure 6 shows the WAXD pattern of the CHOL:[CER1:CER3]:FFA mixture. Two 
strong 0.41 and 0.37 nm reﬂections indicate an orthorhombic lateral packing. The 
presence of a coexisting hexagonal or liquid phase cannot be deduced from these 
data. The lateral packing of the mixture in the absence of CER1 was also measured. 
The presence of the same reﬂections again suggests an orthorhombic chain packing 
(see Fig. 6).
Figure 6 - The lateral packing of the CHOL:[CER1:CER3(C24)]:FFA and CHOL:CER3(C24):FFA mixtures.
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4. DISCUSSION
The aim of this study was to prepare a lipid mixture with commercially available 
ceramides, which can be used as a model for studies on the stratum corneum lipid 
organisation. In this respect, the present study can be considered as a ﬁrst link 
between the phase behaviour of well-deﬁned synthetic ceramides mixtures and the 
more complex ceramide mixtures isolated from native stratum corneum. 
A widely used model to investigate the phase behaviour of the stratum corneum 
lipids is the equimolar mixture of cholesterol, ΣCERIII and palmitic acid. As previously 
mentioned, the formation of heterogeneous phase-separated domains in this mixture 
has frequently been reported [18-21]. Previous SAXD measurements performed with 
this mixture revealed the presence of several coexisting phases in the lipid mixture, 
among others phase-separated palmitic acid [24]. The results obtained in the present 
study show that in the equimolar CHOL:ΣCERIII:FFA mixture a diffraction peak is 
present that might be ascribed to phase-separated free fatty acids (the peak at q = 
3.26 nm-1 is at the same position as the third order reﬂection of the free fatty acids 
mixture). However, the peak intensity is rather weak and the ﬁrst and second order 
reﬂections cannot be detected. From these observations it can be concluded that, in 
contrast to palmitic acid, a mixture of free fatty acids with varying hydrocarbon chain 
lengths promotes almost complete mixing of ceramides, cholesterol and free fatty 
acids. Moreover, free fatty acids with varying chain lengths more closely represent the 
composition of the free fatty acids in native stratum corneum [23]. 
In the present study it was further observed that mixtures containing CER3 show 
complex phase behaviour. In CER3(C16) and CER3(C24) the coexistence of two phases 
was observed. This polymorphism has previously been reported by Dahlen and Pascher 
[28]. According to those authors, synthetic CER3(C24) can crystallise in six solid 
phases, depending on the thermal history of the samples. In ﬁve of the conﬁgurations, 
the ceramide molecules form a V-shaped structure, due to strong intermolecular 
headgroup hydrogen bonding. As a result, phytosphingosine and fatty acid chains form 
separate matrices. Within this structure, CER3(C24) organises into a tilted arrangement 
of the hydrocarbon chains. The differences in periodicities between the ﬁve phases 
depend on the tilt angles. The two phases found in the present study for CER3(C24) 
(repeat distances of 3.71 and 4.26 nm) can be explained by the presence of two of the 
aforementioned V-shaped crystal structures, as previously described by Dahlen and 
Pascher (periodicities of 3.73 and 4.30 nm). Under the experimental conditions used 
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in the present study, the more dense 3.7 nm packing of CER3(C24) was favoured, 
although a small fraction of CER3(C24) formed a 4.3 nm phase (less effective chain 
packing). Apparently, the free energy required for the formation of the 3.7 nm phase is 
very similar to the free energy required for the formation of the 4.3 nm phase. Hence 
a small difference in the experimental conditions (e.g. lipid composition, equilibration 
temperature) may result in increased formation of one phase at the expense of the 
other phase. This is most likely the reason why the 4.3 nm phase could not be detected 
in the binary or ternary samples. Similarly as described above, the presence of one or 
two phases in CER3(C16) can be explained.  
Addition of cholesterol to either CER3(C16) or CER3(C24) resulted in the formation 
of three phases, namely crystalline CER3, crystalline cholesterol and a phase with a 
periodicity close to that of cholesterol (3.44 nm). In a recent atomic force microscopy 
study on lipid monolayers it was demonstrated that small amounts of synthetic 
CER3(C16) and CER3(C24) were miscible in a cholesterol-rich phase [29]. The 3.44 
nm phase might therefore represent a cholesterol-rich phase with a small fraction of 
CER3.
The equimolar ternary mixture prepared with CER3(C16) showed the formation 
of a lamellar phase with a repeating unit of 5.89 nm. The components of this phase 
cannot be precisely deﬁned, but most likely comprise free fatty acids and a small 
fraction of CER3(C16) and cholesterol. This is based on the following observations: (i) 
The weak shoulder at q = 3.29 nm-1 is the only reﬂection that might be attributed to 
crystalline free fatty acids, indicating that only a very small fraction of free fatty acids 
might be present as a separate phase. (ii) In the absence of free fatty acids the 5.89 
nm phase is not formed. (iii) The 3.44 nm phase has disappeared, which indicates that 
these lipids are then present in another phase. However, a major fraction of CER3(C16) 
is still present as a crystalline phase, as can be deduced from the presence of two 
strong reﬂections at q = 1.76 and 3.50 nm-1 (ﬁrst and second order diffraction peaks 
of the 3.58 nm phase). Similar phase behaviour was observed for the equimolar CHOL:
CER3(C24):FFA mixture, although no strong reﬂections of phase-separated CER3(C24) 
phase could be detected. Instead, slightly broader and less intense diffraction peaks at 
q = 1.65 and 3.30 nm-1 were present, attributed to a phase with a periodicity of 3.81 
nm. This phase most likely consists of CER3(C24) and free fatty acids. As the chain 
lengths of the free fatty acids mixture are mainly C22 and C24, it is likely that the free 
fatty acids are at least partially miscible with CER3(C24) and consequently can form 
a separate phase with CER3(C24). However, the presence of cholesterol in this phase 
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cannot be excluded. 
It appears that for the formation of the LPP appropriate molar ratios of individual 
lipids are required. In particular, ceramides by themselves or mixtures of single 
ceramides with cholesterol (and free fatty acids) do not produce the characteristic LPP 
as detected in stratum corneum. The presence of CER1 seems to be crucial. These 
observations are in line with results obtained with ceramides isolated from native 
stratum corneum [12, 14, 30], where it was demonstrated that in the absence of CER1 
the LPP was hardly formed.
The results further show that, even in the presence of CER1, bovine brain ceramides 
(ΣCERIII or ΣCERIV) do not form the characteristic LPP when mixed with cholesterol or 
cholesterol and free fatty acids. This indicates that not only the presence of CER1, but 
also a proper composition of the other ceramides is important for LPP formation. In the 
lipid mixtures studied so far, only the CHOL:[CER1:CER3(C24)]:FFA mixture revealed 
the formation of the LPP. However, the intensities of the reﬂections attributed to this 
phase are relatively weak, indicating that only a small fraction of lipids is involved in 
the formation of this phase. The presence of a strong reﬂection at q = 1.16 nm-1 (ﬁrst 
order reﬂection of 5.42 nm phase) indeed conﬁrms that most lipids are present in 
another phase.  
Concerning the lateral arrangement of the lipids, the results show a crystalline 
packing for the CHOL:[CER1:CER3(C24)]:FFA mixture. Since WAXD only provides 
information on the bulk of the lipids, however, no discrimination can be made between 
the lateral packing of the different phases. Furthermore, the peaks of the orthorhombic 
phase overlap the peak of the 0.406 nm hexagonal phase. Therefore, the presence of 
lipids forming a hexagonal phase cannot be excluded. Previous fourier transformed 
infrared spectroscopy measurements performed with several synthetic ceramide 
mixtures [18, 19, 22] revealed that the lipids form phase-separated crystalline 
domains with an orthorhombic chain packing. This is in agreement with the results of 
the present study, in which the mixture lacking CER1 also revealed the coexistence of 
several phases (SAXD) and a crystalline lateral packing (WAXD).
In conclusion, from the results it is evident that the LPP, characteristic for stratum 
corneum lipid phase behaviour, is not formed in mixtures prepared with bovine brain 
ceramides (ΣCERIII or ΣCERIV). Even in the presence of CER1, only a lamellar phase 
with a short periodicity is present. Mixtures composed of cholesterol, ΣCERIII and 
palmitic acid, which are the subject of several phase behaviour studies, therefore cannot 
be considered as representative for the stratum corneum lipid phase behaviour. 
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It is possible to mimic the lipid organisation in native stratum corneum to a certain 
extent with a synthetic ceramide mixture, consisting of CER1 and CER3(C24). However, 
the periodicity of 11.6 nm differs from that obtained with ceramides isolated from 
native stratum corneum. Moreover, the intensities of the diffraction peaks attributed 
to the 11.6 nm phase are considerably weaker than observed for isolated ceramides. 
To increase the repeat distance and the fraction of lipids forming the LPP one may 
consider to optimise the preparation method of the lipid mixtures as well as the lipid 
composition of the mixture. For the preparation of the synthetic lipid mixtures the 
same method was used as for mixtures based on isolated ceramides. Due to differences 
between synthetic and isolated ceramides, however, the equilibration temperature 
used might not be optimal for appropriate mixing of individual synthetic lipids and for 
the formation of the LPP. The inﬂuence of equilibration temperature modulation and 
ceramide composition will therefore be the subject of future studies.
Acknowledgements 
This work was supported by a grant from the Technology Foundation STW (LGN.4654). 
The Netherlands Organisation for Scientiﬁc Research (NWO) is acknowledged for the 
provision of the beamtime. We would like to thank the companies Cosmoferm and 
Beiersdorf for the provision of the synthetic ceramides.
REFERENCES
1. Elias, P.M. Epidermal lipids, barrier function, 
and desquamation. J. Invest. Dermatol. 80 (1983) 
44s-49s.
2. Boddé, H.E., van den Brink, I., Koerten, 
H.K., de Haan, F.H.N. Visualization of in vitro 
percutaneous penetration of mercuric chloride 
transport through intercellular space versus cellular 
uptake through desmosomes. J. Control. Release 
15 (1991) 227-236.
3. Meuwissen, M.E.M.J., Janssen, J., Cullander, 
C., Junginger, H.E., Bouwstra, J.A. A cross-section 
device to improve visualization of ﬂuorescent probe 
penetration into the skin by confocal laser scanning 
microscopy. Pharm. Res. 15 (1998) 352-356.
4. Talreja, P.S., Kasting, G.B., Kleene N.K., 
Pickens W.L., Wang T.F. Visualization of the lipid 
barrier and measurement of lipid pathlength in 
human stratum corneum. AAPS Pharm. Sci. 3 
(2001) E13.
5. Wertz, P.W., Miethke, M.C., Long, S.A., 
Strauss, J.S., Downing, D.T. The composition of the 
ceramides from human stratum corneum and from 
comedones. J. Invest. Dermatol. 84 (1985) 410-
412.
6. Robson, K.J., Stewart, M.E., Michelsen, S., 
Lazo, N.D., Downing, D.T. 6-Hydroxy-4-sphingenine 
in human epidermal ceramides. J. Lipid Res. 35 
(1994) 2060-2068.
56 Chapter 2
7. Stewart, M.E., Downing, D.T. A new 6-
hydroxy-4-sphingenine-containing ceramide in 
human skin. J. Lipid Res. 4 (1999) 1434-1439.
8. Ponec, M., Weerheim, A., Lankhorst, P., Wertz, 
P. New acylceramide in native and reconstructed 
epidermis, J. Invest. Dermatol. 120 (2003) 581-
588.
9. Bouwstra, J.A., Gooris, G.S., van der Spek, 
J.A., Bras, W. The structure of human stratum 
corneum as determined by small angle X-ray 
scattering. J. Invest. Dermatol. 96 (1991) 1006-
1014.
10. Bouwstra, J.A., Gooris, G.S., van der Spek, 
J.A., Bras, W. Structural investigations of human 
stratum corneum by small angle X-ray scattering. 
J. Invest. Dermatol. 97 (1991) 1005-1012.
11. Bouwstra, J.A., Gooris, G.S., Bras, W., 
Downing, D.T. Lipid organization in pig stratum 
corneum. J. Lipid Res. 36 (1995) 685-695.
12. McIntosh, T.J., Stewart, M.E., Downing, 
D.T. X-ray diffraction analysis of isolated skin 
lipids: reconstitution of intercellular lipid domains. 
Biochemistry 35 (1996) 3649-3653.
13. Bouwstra, J.A., Gooris, G.S., Cheng, 
K., Weerheim, A., Bras, W., Ponec, M. Phase 
behavior of isolated skin lipids. J. Lipid Res. 37 
(1996) 999-1011.
14. Bouwstra, J.A., Gooris, G.S., Dubbelaar, 
F.E.R., Ponec, M. Phase behavior of stratum 
corneum lipid mixtures based on human 
ceramides: the role of natural and synthetic 
ceramide 1. J. Invest. Dermatol. 118 
(2002) 606-617.
15. Bouwstra, J.A., Gooris, G.S., Dubbelaar, 
F.E.R., Weerheim, A.M., Ponec, M. pH, cholesterol 
sulfate, and fatty acids affect the stratum corneum 
lipid organization. J. Invest. Dermatol. 3 (1998) 
69-73.
16. Fenske, D.B., Thewalt, J.L., Bloom, M., 
Kitson, N. Models of stratum corneum intercellular 
membranes: 2H NMR of microscopically 
oriented multilayers. Biophys. J. 67 (1994) 
1562-1573.
17. Kitson, N., Thewalt, J., Laﬂeur, M., Bloom, 
M. A model membrane approach to the epidermal 
permeability barrier. Biochemistry 33 (1994) 6707-
6715.
18. Moore, D.J., Rerek, M.E., Mendelsohn, R. 
Lipid domains and FTIR spectroscopy studies of 
the conformational order and phase behavior of 
ceramides. J. Phys. Chem. B 101 (1997) 8933-
8940.
19. Moore, D.J., Rerek, M.E., Mendelsohn, 
R. Lipid domains and orthorhombic phases in 
model stratum corneum: evidence from fourier 
transform infrared spectroscopy studies. Biochem. 
Biophys. Res. Commun. 231 (1997) 797
-801. 
20. Laﬂeur, M. Phase behaviour of model stratum 
corneum lipid mixtures: an infrared spectroscopy 
investigation. Can. J. Chem. 76 (1998) 1500-
1511.
21. Percot, A., Laﬂeur, M. Direct observations of 
domains in model stratum corneum lipid mixtures 
by Raman microspectroscopy. Biophys. J. 81 
(2001) 2144-2153.
22. Moore, D.J., Rerek, M.E. Insights 
into the molecular organisation of lipids in 
the skin barrier from infrared spectroscopy 
studies of stratum corneum lipid models. 
Acta Derm. Venereol. Suppl. (Stockh.) 208 
(2000) 16-22.
23. Wertz, P.W., Downing, D.T., 1991. 
Epidermal lipids. In: Physiology, Biochemistry 
and Molecular Biology of the Skin, L.A. Goldsmith 
(ed), Oxford University Press, Oxford, pp. 
205-235.
57Phase behaviour of skin lipid mixtures
24. Bouwstra, J.A., Thewalt, J., Gooris, G.S., 
Kitson, N. A model membrane approach to the 
epidermal permeability barrier: an X-ray diffraction 
study. Biochemistry 36 (1997) 7717-7725.
25. Parrott, D.T., Turner, J.E. Mesophase 
formation by ceramides and cholesterol: a model 
for stratum corneum lipid packing? Biochim. 
Biophys. Acta 1147 (1993) 273-276.
26. Bras, W. A SAXS/WAXS beamline at the 
ESRF and future experiments. J. Macromol. Sci. 
Phys. B 37 (1998) 557-566.
27. Dolbnya, I.P., Alberda, H., Hartjes, 
F.G., Udo, F., Bakker, R.E., Konijnenburg, M., 
Homan, E., Cerjak, I., Goedtkindt, P., Bras, W. 
A fast position sensitive MSGC detector at high 
count rate operation. Rev. Sci. Instrum. 73 
(2002) 3754-3758.
28. Dahlen, B., Pascher, I. Molecular 
arrangements in sphingolipids. Thermotropic 
phase behaviour of tetracosanoylphytosphingosin
e. Chem. Phys. Lipids 24 (1979) 119-133.
29. Sparr, E., Eriksson, L., Bouwstra, J.A., 
Ekelund, K. AFM Study of lipid monolayers: 
III. Phase behavior of ceramides, cholesterol 
and fatty acids. Langmuir 17 (2001) 
164-172.
30. Bouwstra, J.A., Gooris, G.S., Dubbelaar, 
F.E.R., Weerheim, A.M., Ijzerman, A.P., Ponec, M. 
Role of ceramide 1 in the molecular organization 
of the stratum corneum lipids. J. Lipid Res. 
39 (1998) 186-196.

59
Chapter 3
Novel lipid mixtures based on synthetic ceramides 
reproduce the unique stratum corneum lipid 
organisation
M.W. de Jager,* G.S. Gooris,* I.P. Dolbnya,# W. Bras,# M. Ponec,§ and J.A. Bouwstra*
*Leiden/Amsterdam Center for Drug Research, Department of Drug Delivery Technology, 
University of Leiden, P.O. Box 9502, 2300 RA Leiden, The Netherlands.
#Netherlands Organisation for Scientiﬁc Research, DUBBLE CRG/ESRF, Grenoble, France.
§Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
 (adapted from J. Lipid Res. 45 (2004) 923-932)
ABSTRACT
Lipid lamellae present in the outermost layer of the skin protect the body from 
uncontrolled water loss. In human stratum corneum two crystalline lamellar phases are 
present, which contain mostly cholesterol, free fatty acids and 9 types of free ceramides. 
Previous studies have demonstrated that the stratum corneum lipid organisation can 
be mimicked with model mixtures based on isolated stratum corneum lipids. However, 
those studies are hampered by low availability and high inter-individual variability of the 
native tissue. To elucidate the role of each lipid class in the formation of a competent skin 
barrier, the use of synthetic lipids would offer an alternative. The small-angle and wide-
angle X-ray diffraction results of the present study show for the ﬁrst time that synthetic 
lipid mixtures, containing only three synthetic ceramides, reﬂect to a high extent the 
stratum corneum lipid organisation. Both an appropriately chosen preparation method 
and lipid composition promote the formation of two characteristic lamellar phases with 
repeat distances similar to those found in native stratum corneum. From all synthetic 
lipid mixtures examined, equimolar  mixtures of  cholesterol,  ceramides,  and  free 
fatty acids equilibrated at 80°C resemble to the highest extent the lamellar and lateral 
stratum corneum lipid organisation, both at room and elevated temperatures.
60 Chapter 3
1. INTRODUCTION
One of the most important functions of the skin is to serve as a barrier to protect 
the body against uncontrolled water loss and to prevent the penetration of harmful 
agents. The protective function of the skin is provided primarily by the stratum 
corneum, the outermost layer of the skin. Stratum corneum has a unique morphology, 
where keratin-ﬁlled corneocytes are surrounded by multi-lamellar lipid regions [1]. 
The highly ordered intercellular lipid matrix is considered to play a crucial role in the 
maintenance of the barrier properties of the skin. Knowledge of the composition and 
the organisation of the stratum corneum lipids is therefore essential to increase our 
insight in the skin barrier function. 
The composition of the stratum corneum lipids differs from that of biological 
membranes, since phospholipids are nearly absent. Ceramides (CER) belong to the 
major lipid species of the stratum corneum. Together with cholesterol (CHOL) and long-
chain free fatty acids (FFA) they form the highly ordered intercellular lipid lamellae. 
At least 9 different types of free ceramides have been identiﬁed in human stratum 
corneum [2-5], which are classiﬁed as CER1 to CER9. The ceramides are composed 
of a sphingosine (S), a phytosphingosine (P) or a 6-hydroxysphingosine (H) base, to 
which a nonhydroxy (N) or α-hydroxy (A) fatty acid is chemically linked. CER1, CER4 
and CER9 have a unique molecular structure as they contain linoleic acid bound to an 
ω-hydroxy fatty acid (EO) with a chain length of approximately 30 to 32 carbon atoms. 
The molecular structures of the ceramides are illustrated in Figure 1.
The lipids in stratum corneum are organised in two coexisting crystalline lamellar 
phases: the short periodicity phase (SPP) with a repeat distance of approximately 6 
nm and the long periodicity phase (LPP) with a periodicity of around 13 nm [6-8]. Both 
the molecular organisation of the LPP and the predominantly crystalline nature of the 
lipid packing in the presence of substantial amounts of cholesterol are unique and are 
therefore suggested to be crucial for the barrier function of the skin.
In order to elucidate the role of each lipid class in the formation of a competent skin 
barrier, the phase behaviour of the stratum corneum lipids has been studied extensively. 
Using small-angle and wide-angle X-ray diffraction it has been demonstrated that 
mixtures of cholesterol, free fatty acids and ceramides isolated from either pig or 
human stratum corneum (natCER), closely mimic the lipid organisation in stratum 
corneum. The results further reveal that in particular cholesterol and ceramides play a 
key role in the formation of the LPP, whereas free fatty acids are required to induce the 
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orthorhombic packing of the lipids [9-11]. 
Figure 1 - (A) The molecular structures of the ceramides present in human stratum corneum, indicated 
according to the numbering system (based on chromatographic migration) and according to the structure. 
(B) The molecular structures of the synthetic ceramides used in the study. The acyl chain lengths of 
CER1(C30) and CER3(C24) are well-deﬁned, whereas bovine brain ceramide type IV (ΣCERIV) shows a 
distribution in chain lengths, with C18 and C24 as the most abundantly present.
Extensive studies with lipids isolated from stratum corneum are hampered by the 
low availability and high inter-individual variability of the native tissue. In addition, the 
isolation and separation of the ceramides from the stratum corneum is very labour-
intensive and expensive. The use of synthetic ceramides (synthCER) may therefore 
offer an attractive alternative. Moreover, each subclass of natCER shows a variation 
in acyl chain length [2], whereas synthCER have a well-deﬁned acyl chain length. 
Therefore, synthCER also enable studying in detail the inﬂuence of the acyl chain 
length on the SC lipid phase behaviour.
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In recent years, several studies have been performed with model mixtures based 
on synthCER. The most frequently studied mixtures contain cholesterol and/or palmitic 
acid and the commercially available bovine brain ceramide type III or type IV [12-17]. 
Other studies focused on mixtures prepared with for instance synthetic CER2, CER3 or 
CER5 [18-22]. Using a variety of techniques, it has been elucidated that the packing 
of the lipids is mainly orthorhombic. However, the results demonstrate that the lipids 
are not properly mixed in one lattice, but coexist in various phases, enriched in one 
of the components of the lipid mixture. Moreover, small-angle X-ray diffraction studies 
reveal that the characteristic LPP is not present in mixtures consisting of bovine brain 
ceramide type III, cholesterol and palmitic acid [23, 24]. 
In a recent study we have demonstrated that lamellar phases are formed in mixtures 
prepared with bovine brain ceramide type III or type IV. However, no LPP could be 
detected [25]. Moreover, the phase behaviour of mixtures prepared with synthetic 
CER3, having an acyl chain length of 24 or 16 carbon atoms, was studied. Mixtures 
prepared with CER3 revealed the presence of several coexisting phases, among others 
crystalline V-shaped CER3 structures. These V-shaped structures are not observed in 
stratum corneum and can therefore not be considered as representative for the stratum 
corneum lipid phase behaviour. The effect of synthetic CER1 on the phase behaviour 
of synthetic skin lipid mixtures was also studied. From all mixtures examined, only 
one mixture containing synthetic CER1, CER3, cholesterol and free fatty acids showed 
similar phase behaviour to that of stratum corneum. However, the repeat distance of 
the LPP was shorter than that observed in stratum corneum. The LPP was not formed 
in the absence of CER1, which is similar to previous observations made with mixtures 
containing natCER [11, 24, 26].
The objective of the present study is to generate a lipid mixture with synthCER, 
which closely mimics the natural stratum corneum lipid phase behaviour. In a previous 
study performed with natCER, it became evident that a certain degree of ﬂuidity of 
the lipid mixture is required for the formation of the LPP [11]. As synthCER have 
uniform chain lengths and form highly crystalline phases, it is reasonable to assume 
that increased lipid mobility and thus a possible enhancement of the formation of 
the LPP can be achieved by introducing variations in either acyl chain length or head 
group architecture. Therefore, in the present study bovine brain ceramide type IV was 
included in the lipid mixture. Bovine brain ceramide type IV consists of a sphingosine 
base linked to an α-hydroxy fatty acid with varying acyl chain lengths (see Fig. 1B), 
in which C18 and C24 are the most abundantly present [chapter 4]. In addition, the 
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preparation method was optimised to increase the degree of ﬂuidity of the lipids in 
order to accomplish LPP formation.
The present study shows that both a proper choice of the lipid composition as well 
as an optimal equilibration temperature during sample preparation are crucial for the 
formation of the LPP in mixtures based on synthCER.
 
2. MATERIALS AND METHODS
2.1 Materials 
Palmitic acid, stearic acid, arachidic acid, behenic acid, tricosanoic acid, lignoceric 
acid, cerotic acid, cholesterol and bovine brain ceramide type IV were purchased 
from Sigma-Aldrich Chemie GmbH (Schnelldorf, Germany). N-(30-Linoleoyloxy-
triacontanoyl)-sphingosine (synthetic ceramide 1(C30)-linoleate) was a gift from 
Beiersdorf AG (Hamburg, Germany). N-Tetracosanoyl-phytosphingosine (synthetic 
ceramide 3(C24)) was generously provided by Cosmoferm B.V. (Delft, the Netherlands). 
Figure 1B shows the ceramides used in this study. All organic solvents used were of 
analytical grade and manufactured by Labscan Ltd (Dublin, Ireland).
2.2 Preparation of the lipid mixtures
All samples were prepared with a synthCER mixture, consisting of CER1, CER3 
and bovine brain ceramide type IV (further referred to as ΣCERIV) at a molar ratio of 
1:7:2. The synthCER mixture was mixed with cholesterol an in equimolar ratio. For 
the preparation of the CHOL:synthCER:FFA mixtures, the fatty acids C16:0, C18:0, 
C20:0, C22:0, C23:0, C24:0 and C26:0 were mixed at molar ratios of respectively 
1.3, 3.3, 6.7, 41.7, 5.4, 36.8 and 4.7. This ratio is similar to that found in the native 
SC. Appropriate amounts of individual lipids dissolved in chloroform:methanol (2:1) 
were combined to yield mixtures of approximately 1.5 mg total dry weight at the 
desired composition at a total lipid concentration of 7 mg/ml. A Camag Linomat IV 
was used to apply the lipid mixtures onto mica. This was done at a rate of 4.3 µl/min 
under a continuous nitrogen stream. The samples were equilibrated for 10 minutes 
at the appropriate temperature that varied between 60 and 100°C and subsequently 
hydrated with an acetate buffer of pH 5.0. Finally, the samples were homogenised by 
10 successive freeze-thawing cycles between –20°C and room temperature, during 
which the samples were stored under gaseous argon. 
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2.3 Small-angle X-ray diffraction (SAXD)
All measurements were performed at the European Synchrotron Radiation Facility 
(ESRF, Grenoble), using station BM26B [27]. The X-ray wavelength and the sample-to-
detector distance were 1.24Å and 1.7m, respectively. Diffraction data were collected 
on a two-dimensional multiwire gas-ﬁlled area detector. The spatial calibration of 
this detector was performed using silver behenate. The samples were mounted in a 
temperature-controlled sample holder with mica windows. Static diffraction patterns 
of the lipid mixtures were obtained at room temperature for a period of 10 minutes. 
The temperature-induced phase changes were investigated by collecting diffraction 
patterns, while raising the temperature of the sample from 25 to 95°C at a rate of 
2°C/min. Each successive diffraction curve was collected for a period of one minute. All 
measurements were performed at least in duplicate.
SAXD provides information about the larger structural units in the sample, such as 
the repeat distance of a lamellar phase. The scattering intensity I (in arbitrary units) 
was measured as a function of the scattering vector q (in reciprocal nm). The latter 
is deﬁned as q=(4�sinθ)/λ, in which θ is the scattering angle and λ is the wavelength. 
From the positions of a series of equidistant peaks (qn), the periodicity, or d-spacing, 
of a lamellar phase was calculated using the equation qn=2n�/d, n being the order 
number of the diffraction peak. 
2.4 Wide-angle X-ray diffraction (WAXD)
Wide-angle X-ray diffraction provides information about the lateral packing of 
the lipids within the lamellae. Wide-angle X-ray diffraction data were collected on 
a microstrip gas chamber detector with an opening angle of 60° [28]. The sample-
to-detector distance was 36 cm and the X-ray wavelength was 1.24Å. The spatial 
calibration of the detector was performed with a mixture of silicium and cholesterol. 
The SAXD and WAXD data were collected simultaneously. 
3. RESULTS
3.1 Effect of the equilibration temperature during the sample preparation 
Mixtures consisting of CHOL:[CER1:CER3:ΣCERIV] at a molar ratio of 1:[0.1:0.7:0.2] 
were equilibrated at different temperatures ranging from 60°C to 100°C. The effect of 
the equilibration temperature on the lipid phase behaviour is summarised in Table 1. 
The corresponding diffraction patterns are described below. 
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Table 1 - The effect of the equilibration temperature on the formation of the phases in equimolar CHOL:
synthCER mixtures
Temp (°C) LPP SPP CER3 CHOL
60 -- 5.7 (1, 2) 3.7 (1, 2) 3.35 (1, 2)
70 12.8 (2) 5.7 (1) 3.7 (1, 2) 3.35 (1, 2)
80 12.5 (1, 2, 3) # 5.7 (1) 3.7 (1, 2) 4.3 (1) 3.35 (1, 2)
90 12.6 (1, 2, 3*) 5.5 (1*, 3*) 3.7 (1, 2) 4.3 (1, 2) 3.35 (1, 2)
95 12.3 (1, 2, 3*, 4, 7) 5.3 (1, 2) 3.7 (1, 2) 4.3 (1, 2) 3.35 (1, 2)
100 12.2 (1, 2, 3*, 4, 6, 7) 5.3 (1, 3) 4.3 (1, 2) 3.35 (1, 2)
# 12.5 (1, 2, 3) means the periodicity of the phase is 12.5 nm, and interpretation is based on the ﬁrst, 
second and third order reﬂections. An asterisk (*) indicates that the peak is present as a shoulder.
Figure 2A shows the diffraction pattern of a lipid mixture equilibrated at 100°C. A 
lamellar structure with a repeat distance of 12.2 nm (LPP) is indicated by the presence 
of 6 diffraction peaks (q = 0.52, 1.03, 1.54, 2.06, 3.08 and 3.58 nm-1). The reﬂections 
at q = 1.17 and 3.51 nm-1 correspond to the ﬁrst and third order maxima of a lamellar 
phase with a periodicity of 5.3 nm (SPP). The two sharp peaks at 1.46 and 2.91 nm-1 
indicate the presence of a 4.3 nm phase, ascribed to crystalline CER3 in a V-shaped 
structure [19, 22, 25]. The presence of crystalline cholesterol in separate domains can 
be deduced from the reﬂections at 1.87 and 3.74 nm-1.
A reduction in equilibration temperature from 100 to 95°C does not affect the 
formation of the LPP and SPP (data not shown). However, X-ray diffraction patterns of 
lipid mixtures equilibrated at 95°C reveal the presence of a new structure with a repeat 
distance of 3.7 nm, suggested by two reﬂections at respectively 1.69 and 3.40 nm-1. 
This phase can be assigned to another crystalline V-shaped structure of CER3 [19, 22, 
25]. The intensities of the peaks attributed to the 4.3 nm phase are slightly reduced 
compared to those observed in the samples that were equilibrated at 100°C. 
The repeat distance of the LPP increases to 12.6 nm when an equilibration 
temperature of 90°C is used during sample preparation (see Fig. 2A). However, only 
three reﬂections can be observed that attribute to this phase. The periodicity of 
the SPP has slightly increased to 5.5 nm, as deduced from the ﬁrst and third order 
reﬂections. Both reﬂections show partial overlap with other peaks in the diffraction 
pattern. Crystalline cholesterol and the two coexisting crystalline CER3 phases are also 
present in the lipid mixture.
The diffraction pattern of the lipid mixture prepared using an equilibration 
temperature of 80°C is illustrated in Figure 2B. It is evident that lowering the equilibration 
temperature reduces the intensities of the three equidistant LPP reﬂections compared to 
66 Chapter 3
the intensities of the peaks attributed to the SPP (and crystalline CER3 and cholesterol). 
The repeat distance of the SPP has slightly increased to 5.7 nm. Additionally, crystalline 
cholesterol and crystalline CER3 are present in the lipid mixture. The latter forms 
predominantly a 3.7 nm phase, although a weak reﬂection at q = 1.46 nm-1 indicates 
that a small fraction of CER3 might still be present as a 4.3 nm phase. A further 
reduction in the equilibration temperature to 70°C (see Fig. 2B) results in a diffraction 
pattern in which the diffraction peaks attributed to the LPP have almost disappeared. 
Only a weak reﬂection at q = 0.99 nm-1 (second order) reveals that a small fraction of 
lipids might form a LPP with a periodicity of about 12.8 nm. Compared to the diffraction 
pattern of the lipid mixture equilibrated at 80°C, no signiﬁcant shift is observed in the 
positions of the reﬂections attributed to the SPP and crystalline cholesterol. All phase-
separated CER3 forms a 3.7 nm phase, as the only two additional reﬂections observed 
in the diffraction pattern are located at 1.69 and 3.40 nm-1. Equilibration of the lipid 
mixture at 60°C (data not shown) does not result in the formation of the LPP. Instead, 
Figure 2 - The effect of the equilibration temperature on the phase behaviour of equimolar CHOL:
synthCER mixtures. The inset is a magniﬁcation of the reﬂections in the q-range between 2 and 4 nm-1. 
The Arabic and Roman numbers indicate the diffraction orders of the LPP and SPP, respectively. The letter 
C refers to the two crystalline phases of CER3. The asterisk (*) indicates the reﬂections of crystalline 
cholesterol located at 1.87 and 3.74 nm-1. (A) Diffraction patterns of mixtures equilibrated at 100°C and 
90°C. The various orders of the LPP are located at q = 0.52 nm-1 (1) , 1.03 nm-1 (2), 1.54 nm-1 (3) , 2.06 
nm-1 (4) , 3.08 nm-1 (6) and 3.58 nm-1 (7). The various orders of the SPP are located at q = 1.17 nm-1 
(I) and 3.51 nm-1 (III). The reﬂections at 1.46 and 2.91 nm-1 are attributed to crystalline CER3 (4.3 nm 
phase). (B) Diffraction patterns of mixtures equilibrated at 80°C and 70°C. The various orders of the LPP 
are located at q = 0.49 nm-1 (1) , 0.99 nm-1 (2) and 1.48 nm-1 (3). The only reﬂection attributed to the 
SPP is located at q = 1.09 nm-1 (I). The reﬂection at 1.46 nm-1 is attributed to crystalline CER3 (4.3 nm 
phase) and the reﬂections at 1.71 and 3.41 nm-1 are attributed to crystalline CER3 (3.7 nm phase).
67Organisation in synthetic lipid mixtures
broad reﬂections indicate the presence of a SPP with a repeat distance of 5.7 nm. In 
addition, crystalline cholesterol and crystalline CER3 (3.7 nm phase) can be detected.
3.2 The effect of addition of free fatty acids 
To investigate the inﬂuence of free fatty acids on the formation of the lamellar 
phases, free fatty acids were added to the above-mentioned CHOL:[CER1:CER3:ΣCERIV] 
mixture prepared at a molar ratio of 1:[0.1:0.7:0.2]. Based on the results obtained 
with the CHOL:synthCER mixtures, the initially chosen equilibration temperature was 
95°C. However, equilibration of an equimolar CHOL:synthCER:FFA mixture at 95°C did 
not result in the formation of the LPP, but in melting of the lipids (data not shown). 
Therefore, the equilibration temperature was reduced to 80°C. The effect of free fatty 
acids on the phase behaviour was examined with CHOL:synthCER:FFA mixtures, in 
which the amount of free fatty acids was gradually increased to achieve molar ratios 
ranging from 1:1:0 to 1:1:1.8. The results are summarised in Table 2.
The corresponding diffraction patterns are described below. Firstly, the diffraction 
curve of the CHOL:synthCER:FFA mixture at a molar ratio of 1:1:1 will be described 
(see Fig. 3A). Subsequently, the effect of decreased and increased free fatty acids 
levels on the lipid phase behaviour will be presented. The equimolar CHOL:synthCER:
FFA mixture shows the presence of a LPP with a repeat distance of 12.2 nm, of which 
the ﬁrst ﬁve reﬂections can be detected. The SPP with a periodicity of 5.5 nm is 
characterised by the presence of the ﬁrst three diffraction peaks. Crystalline cholesterol 
and the two coexisting crystalline phases of CER3 with periodicities of 3.7 and 4.3 nm 
can also be detected in the lipid mixture. 
 
Table 2 - The effect of free fatty acids on the formation of the phases in the lipid mixtures 
CHOL:CER:FFA LPP SPP CER3(C24) CHOL
1:1:0 12.5 (1*, 2, 3) 5.5 (1*) 3.7 (1, 2) 3.35 (1, 2)
1:1:0.25 12.5 (1*, 2, 3) 5.5 (1*) 3.7 (1, 2) 3.35 (1, 2)
1:1:0.5 12.5 (1, 2, 4) # 5.5 (1*, 2) 3.7 (1, 2) 4.3 (1, 2) 3.35 (1, 2)
1:1:0.75 12.3 (1, 2 , 3*, 4) 5.5 (1, 2, 3) 3.7 (1, 2) 4.3 (1, 2) 3.35 (1, 2)
1:1:1 12.2 (1, 2, 3*, 4, 5) 5.5 (1, 2, 3) 3.7 (1, 2) 4.3 (1, 2) 3.35 (1, 2)
1:1:1.4 12.0 (1, 2, 3*, 4) 5.4 (1, 2) 3.7 (1, 2) 4.3 (1, 2) 3.35 (1, 2)
1:1:1.8 12.0 (1*, 2, 4) 5.6 (1, 2) 3.7 (1, 2) 4.3 (1, 2) 3.35 (1, 2)
# 12.5 (1, 2, 4) means the periodicity of the phase is 12.5 nm, and interpretation is based on the ﬁrst, 
second and fourth order reﬂections. An asterisk (*) indicates that the peak is present as a shoulder. 
The diffraction pattern of the 1:1:0.75 CHOL:synthCER:FFA mixture is depicted in 
Figure 3A. Compared to the equimolar lipid mixture, a slight decrease in the intensities 
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of the reﬂections attributed to the LPP compared to the intensities of the peaks 
attributed to the SPP is observed. Furthermore, the peak intensities of the 3.7 nm 
phase are markedly increased compared to the reﬂections attributed to the 4.3 nm 
phase. Additionally, crystalline cholesterol can be detected.
A further decrease in free fatty acids content to a molar ratio of 1:1:0.5 resulted 
in the diffraction pattern illustrated in Figure 3B. Compared to the diffraction patterns 
obtained at higher free fatty acids content (1:1:0.75 and 1:1:1), the peak intensities 
of both LPP and SPP are considerably reduced. Only three orders of the LPP can be 
detected. Although a small fraction of CER3 forms the 4.3 nm phase, the ﬁrst order 
reﬂection of the 3.7 nm phase is the most prominent peak in the diffraction pattern (q 
= 1.69 nm-1). 
At a CHOL:synthCER:FFA molar ratio of 1:1:0.25 (data not shown) the intensities 
of the three reﬂections attributed to the LPP further decreases at the expense of the 
peak intensities of the 3.7 nm phase. Of the SPP only the ﬁrst order reﬂection can be 
detected, which partially overlaps with the second order of the LPP. At this molar ratio, 
a very small fraction of crystalline CER3 is present as a 4.3 nm phase, since the two 
reﬂections attributed to this phase are only weakly present. Crystalline cholesterol is 
again present, derived from the presence of its two reﬂections. The diffraction pattern 
of the CHOL:synthCER:FFA mixture at a molar ratio of 1:1:0 (Fig. 3B) closely resembles 
that of the 1:1:0.25 mixture: a small fraction of lipids forms the LPP and SPP, whereas 
the peaks of the 3.7 nm phase dominate the diffraction pattern. 
Figure 3C illustrates the effect of increasing the free fatty acids content to levels 
above equimolar ones. At a molar ratio of 1:1:1.4, four diffraction peaks are attributed 
to the LLP with a periodicity of 12.0 nm. Furthermore, the SPP (repeat distance 5.3 
nm) is present in the lipid mixture. Compared to Figure 3A, in which the diffraction 
pattern of the equimolar lipid mixture is plotted, a slight decrease in the intensities 
of the reﬂections attributed to the LPP compared to those attributed to the SPP is 
observed, similarly as observed for the 1:1:0.75 mixture. Both the 3.7 nm and 4.3 nm 
phases are present. However, the peak intensities of the 4.3 nm phase are markedly 
decreased compared to the equimolar mixture. Additionally, crystalline cholesterol can 
be detected.
The diffraction pattern of the 1:1:1.8 mixture is plotted in Figure 3C. A very broad 
peak is observed at 1.12 nm-1, caused by an overlap of the second order reﬂection of 
the LPP and the ﬁrst order peak of the SPP. A further reduction in the intensities of 
the LPP reﬂections compared to the SPP reﬂections is observed. A weak reﬂection at 
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Figure 3 - The effect of the free fatty acids content on the phase behaviour of CHOL:synthCER:FFA 
mixtures. The inset shows a magniﬁcation of the reﬂections in the q-range between 2 and 4 nm-1. The 
Arabic and Roman numbers indicate the diffraction orders of the LPP and SPP, respectively. The letter 
C refers to the two crystalline phases of CER3. The reﬂections at 1.46 and 2.91 nm-1 are attributed to 
crystalline CER3 (4.3 nm phase) and the reﬂections at 1.71 and 3.41 nm-1 are attributed to crystalline 
CER3 (3.7 nm phase). The asterisk (*) indicates the reﬂections of crystalline cholesterol located at 1.87 
and 3.74 nm-1. (A) Diffraction patterns of mixtures at a molar ratio of 1:1:1 and 1:1:0.75. The various 
orders of the LPP are located at q = 0.51 nm-1 (1) , 1.02 nm-1 (2), 1.53 nm-1 (3) , 2.04 nm-1 (4) and 2.56 
nm-1 (5). The various orders of the SPP are located at q = 1.14 nm-1 (I), 2.31 nm-1 (II) and 3.47 nm-1 
(III). (B) Diffraction patterns of mixtures at a molar ratio of 1:1:0.5 and 1:1:0. The various orders of the 
LPP are located at q = 0.50 nm-1 (1) , 1.00 nm-1 (2) and 2.00 nm-1 (4). The various orders of the SPP are 
located at q = 1.12 nm-1 (I) and 2.23 nm-1 (II). (C) Diffraction patterns of mixtures at a molar ratio of 
1:1:1.4 and 1:1:1.8. The various orders of the LPP are located at q = 0.52 nm-1 (1) , 1.05 nm-1 (2) and 
2.07 nm-1 (4). The various orders of the SPP are located at q = 1.12 nm-1 (I) and 2.24 nm-1 (II).
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1.46 nm-1 reveals that only a very small amount CER3 phase separates into a 4.3 nm 
phase. Furthermore, crystalline cholesterol and the 3.7 nm phase are present in the 
lipid mixture. 
3.3 The phase transitions as a function of temperature
The lipid phase behaviour of the equimolar CHOL:synthCER and CHOL:synthCER:
FFA mixtures (equilibrated at 95 and 80°C, respectively) has been examined in the 
temperature range from 25 to 95°C. In Figure 4A and B sequential diffraction curves as 
a function of temperature are presented. Each curve represents the lipid organisation 
during a temperature shift of 2°C. The diffraction pattern of the equimolar CHOL:
synthCER mixture at 25°C (see Fig. 4A) reveals a number of diffraction peaks that can 
be assigned to the presence of a LPP and SPP with periodicities of respectively 12.6 
and 5.4 nm, similarly as described for Figure 2A. The reﬂections attributed to the SPP 
disappear at around 43°C. In the same temperature region the reﬂections (ﬁrst and 
second order) of the LPP start to reduce in intensity and disappear at 55°C. Striking 
is the appearance of a new phase with a repeat distance of around 9.9 nm between 
59°C and 73°C. This phase might be formed by CER1 that crystallises into separate 
domains. In the same temperature region the reﬂections of the 3.7 and 4.3 nm phases, 
both attributed to crystalline CER3 slightly shift to lower q-values, corresponding to 
spacings of 4.0 and 4.5 nm, respectively. The intensities of the peaks attributed to 
the latter phase markedly increase with increasing temperature, whereas the intensity 
of the former hardly increases. Both phases are still present at 95°C. The cholesterol 
reﬂections disappear at a temperature of approximately 57°C.
The equimolar CHOL:synthCER:FFA mixture shows the presence of two lamellar 
phases with periodicities of 12.0 and 5.4 nm (see Fig. 4B). The intensities of the 
diffraction peaks attributed to the LPP and SPP hardly change between 25°C and 49°C. 
A further increase in temperature gradually decreases the intensities of the reﬂections 
of the SPP, resulting in a disappearance of this phase at around 59°C. The reﬂections 
of the LPP start to decrease in intensity at approximately 59°C and disappear at 65°C. 
Similarly as observed for the CHOL:synthCER mixture, the peaks attributed to the 
3.7 and 4.3 nm phase formed by CER3 shift to lower q-values. However, the shift of 
the reﬂections of the 3.7 nm phase is abrupt at 43°C, whereas the reﬂection of the 
4.3 nm phase gradually shifts over a wide temperature range to a spacing of 4.6 nm 
at 63°C.  At around 45°C a new phase is formed, of which only one reﬂection can be 
detected (q = 1.37 nm-1). The reﬂection considerably increases in intensity, being the 
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most prominent peak in the diffraction pattern at elevated temperatures. A maximal 
intensity is reached at around 71°C. A further increase in temperature reduces the 
peak intensity. The reﬂections at 1.37 and 1.57 nm-1 both disappear between 81°C and 
85°C. In this temperature range a broad peak at q = 1.90 nm-1 is formed, which is still 
present at 95°C.
3.4 Lateral packing of the lipids
A hexagonal lateral packing is characterised by a strong 0.41 nm reﬂection in 
the WAXD pattern, whereas the diffraction pattern of an orthorhombic packing is 
characterised by two strong 0.41 and 0.37 nm reﬂections. All lipid mixtures measured 
during this study are characterised by a large number of strong and weak reﬂections in 
the WAXD pattern. In the CHOL:synthCER mixtures a reﬂection at 0.41 nm is present, 
although its intensity is rather weak compared to the various strong neighbouring 
reﬂections attributed to either crystalline cholesterol or CER3 (data not shown). 
Therefore, it cannot be deduced with certainty whether a hexagonal lateral packing is 
present in the CHOL:synthCER mixtures. 
In the equimolar CHOL:synthCER:FFA mixture two strong 0.408 and 0.367 nm 
reﬂections indicate an orthorhombic lateral packing (data not shown). This is already 
observed at low free fatty acids content, such as in the mixture at a molar ratio of 
CHOL:CER:FFA 1:1:0.25. A further increase in free fatty acids content in the CHOL:
CER:FFA mixture to 1:1:1.8 does not affect the lateral packing, but drastically changes 
the diffraction pattern by weakening the intensities of the numerous cholesterol and 
CER3 reﬂections. Both SAXD and WAXD data obviously show that an increased free 
fatty acids content results in reduced intensities of the cholesterol and CER3 reﬂections, 
indicating an increased solubility of both components in the lamellar phases. 
The diffraction patterns of the equimolar CHOL:synthCER:FFA mixture monitored 
as a function of temperature are plotted in Figure 4C. The 0.408 and 0.367 nm peaks 
indicate an orthorhombic lateral packing. Between 35 and 37°C, the 0.367 nm reﬂection 
disappears, indicating an orthorhombic-hexagonal phase transition. The intensity of the 
0.408 nm reﬂection initially decreases. However, a further temperature rise increases 
the intensity of the 0.408 nm reﬂection slightly, indicating a metastable to stable phase 
change. Similar results were obtained with stratum corneum [Bouwstra J.A., Gooris 
G.S., unpublished results]. A disappearance of this peak is observed at 65°C, which is 
at the same temperature at which the LPP disappears in the SAXD pattern. 
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Figure 4 - Changes in the lipid phase behaviour as a function of temperature. (A) The lamellar organisation 
of equimolar CHOL:synthCER mixtures. (B) The lamellar organisation of equimolar CHOL:synthCER:FFA 
mixtures. (C) The lateral packing of CHOL:synthCER:FFA mixtures. The Arabic and Roman numbers 
indicate the diffraction orders of the LPP and SPP, respectively. The letter C refers to the two crystalline 
phases of CER3. The asterisk (*) indicates the reﬂections of crystalline cholesterol. The dashed line 
represents the diffraction curves at 25, 35, 45, 55, 65, 75 and 85°C.
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4. DISCUSSION
For detailed studies on the effect of molecular structure of individual ceramides 
on the stratum corneum lipid organisation the use of synthCER offers an attractive 
approach, as both the head group and acyl chain composition can be systematically 
modiﬁed. One should, however, be aware that the prerequisite to replace natCER by 
synthCER is that their phase behaviour reﬂects that of the stratum corneum. The 
major difference between natCER and synthCER is great variation in acyl chain length 
in natCER versus well-deﬁned acyl chain length in synthCER. Previous studies with 
mixtures prepared with ceramides isolated from native stratum corneum revealed 
that the stratum corneum phase behaviour can be mimicked with simpliﬁed mixtures, 
provided that CER1 is present [29]. In the present study a synthCER mixture was 
studied consisting of CER1, CER3 and bovine brain CER type IV mixed in a 1:7:2 ratio. 
The results clearly demonstrate that the lipid composition as well as the temperature at 
which the samples are equilibrated play an important role in the formation of the LPP.
4.1 Inﬂuence of equilibration temperature on phase behaviour
The formation of the LPP in equimolar CHOL:synthCER mixtures is enhanced when 
an increased equilibration temperature is used during the sample preparation. The 
mechanism behind this phenomenon is, however, not yet known, but will be subject of 
future studies. It is likely to assume that at elevated temperatures the formation of the 
LPP is promoted up to a certain optimal ﬂuidity or mobility of the hydrocarbon chains. 
For example, for CHOL:synthCER mixtures equilibrated at 95°C or 100°C, the diffraction 
patterns are very similar and show a dominant formation of the LPP, indicating that the 
optimum has most likely been achieved. A further increase to 105°C or 110°C results 
in melting of the lipids and in a decreased formation of the LPP.
4.2 Inﬂuence of free fatty acids on phase behaviour
Addition of free fatty acids to the equimolar CHOL:synthCER mixture obviously 
increases the ﬂuidity of the lipids at elevated temperatures, as equilibration at 95°C 
resulted in melting of the lipids. This can most likely be ascribed to the chain length 
variation in free fatty acids, ranging from 16 to 26 carbon atoms. It further becomes 
evident that for the formation of the LPP, an optimal amount of free fatty acids is 
required. Systematic increase in free fatty acids content to achieve an equimolar CHOL:
synthCER:FFA mixture promotes the formation of the LPP. However, when the relative 
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amount of free fatty acids further increases, the formation of the LPP is reduced and 
the SPP dominates. A lower equilibration temperature would probably shift the optimal 
amount of free fatty acids for the formation of the LPP to higher values, whereas the 
opposite is true for a higher equilibration temperature. From these observations we 
can conclude that for each lipid composition an optimal equilibration temperature is 
required.
Free fatty acids seem to play an important role in the lipid phase behaviour. This 
conclusion is drawn from the following observations made with CHOL:synthCER:FFA 
mixtures: (i) cholesterol is better incorporated (dissolved), as reﬂected by weaker 
intensities of the cholesterol reﬂections than seen in the absence of free fatty acids. 
The same trend is observed with natCER [9, 11]. (ii) The intensities of the peaks 
attributed to crystalline CER3 are also weaker than those observed in the CHOL:
synthCER mixtures, indicating better incorporation of CER3 in the presence of free fatty 
acids. (iii) A better ordering of the lamellar structures, because in the presence of free 
fatty acids, more higher order diffraction peaks can be observed for both LPP and SPP 
than in the absence of free fatty acids. (iv) Free fatty acids have a profound effect on 
the lateral packing, since only in their presence the packing is orthorhombic, similarly 
as observed for lipid mixtures based on isolated pig or human ceramides [10, 11] and 
in human stratum corneum [30]. 
 
4.3 Comparison between synthCER and natCER
The potential use of synthCER instead of natCER to study the stratum corneum 
lipid organisation is supported by the observations made at elevated temperatures. 
Many similarities can be observed in the lipid phase behaviour between CHOL:CER:FFA 
mixtures containing synthCER or natCER. Firstly, the LPP disappears at approximately 
65°C. This temperature is close to 63°C and 67°C found for mixtures prepared with 
pig natCER and human natCER, respectively [9, 31]. Furthermore, the SPP and the 
reﬂections of phase-separated cholesterol disappear in the same temperature range 
as observed for mixtures prepared with natCER. Moreover, a new phase with a repeat 
distance of 4.6 nm is formed at elevated temperatures. The formation of a similar 
phase is observed in lipid mixture containing natCER, although the periodicity of 4.3 
nm slightly differs from the 4.6 nm found in the mixtures based on synthCER.
Concerning the changes in lateral packing at elevated temperatures, at around 
35°C there is a phase transition from an orthorhombic to a hexagonal lateral packing 
in the CHOL:synthCER:FFA mixture. As described above, no changes in lamellar 
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organisation have been noticed at this temperature, suggesting that the transition does 
not affect the lamellar lipid phase behaviour. The hexagonal lateral packing disappears 
at around 65°C, which is the same temperature at which the LPP disappears. This 
suggests that either an orthorhombic or a hexagonal lateral packing is a prerequisite 
for LPP formation. This conﬁrms the ﬁndings with natCER, which revealed that when 
the fraction of lipids in a liquid phase is too high the formation of the SPP is increased 
at the expense of the LPP [11]. 
In spite of many similarities, also some differences are observed between mixtures 
prepared with synthetic and natural lipids. The main difference is that in mixtures 
prepared with synthCER two additional phases are present with repeat distances of 
3.7 and 4.3 nm, respectively. These phases, which are attributed to crystalline CER3, 
have never been observed in the mixtures containing ceramides isolated from pig 
or human stratum corneum. From the present study it is evident that an increase in 
equilibration temperature from 60°C to 100°C or an increase in free fatty acids content 
in CHOL:synthCER:FFA mixtures from 1:1:0 to 1:1:1 increases the intensities of the 
peaks attributed to 4.3 nm phase at the expense of the 3.7 nm phase. A further rise 
in the free fatty acids content leads to a marked reduction of the peak intensities of 
the 4.3 nm phase. However, under these conditions the fraction of lipids forming the 
characteristic LPP is also diminished. 
Another difference between the phase behaviour of CHOL:CER:FFA mixtures 
prepared with synthCER or natCER is the repeat distance of the LPP. In the absence of 
free fatty acids, the periodicity of the LPP in CHOL:synthCER mixtures equilibrated at 
95°C or 100°C is about 12.3 nm. The periodicity of the LPP in mixtures prepared with 
isolated human or pig ceramides is very similar, being 12.8 and 12.2 nm, respectively. 
When free fatty acids are included to reach an equimolar CHOL:natCER:FFA mixture, 
the repeat distance of the LPP slightly increases to 13.0 nm (human) and 13.3 nm 
(pig). These values are similar to that reported for native stratum corneum. However, 
this behaviour is not observed for mixtures prepared with synthCER. There, a rise in 
the free fatty acid level or equilibration temperature led to a slight decrease in the LPP 
repeat distance to approximately 12.2 nm (see Table 1 and Table 2).
The relative intensities of the various diffraction orders provide information on the 
relative electron density distribution in the LPP. Therefore, we determined the relative 
intensities of the various reﬂections of the LPP in six equimolar CHOL:synthCER:FFA 
mixtures, measured during four different X-ray diffraction sessions, and compared the 
values with those obtained with equimolar CHOL:pigCER:FFA mixtures. The results 
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given in Table 3 show that the relative intensities of the peaks attributed to the LPP 
show the same trend in all samples. However, in the synthCER mixtures the relative 
intensities of some LPP reﬂections differ from those found in the CHOL:pigCER:FFA 
mixtures. This indicates that the localisation of the lipids within the LPP in mixtures 
prepared with synthCER might differ slightly. 
Table 3 - Relative intensities of the diffraction peaks of the LPP in equimolar CHOL:synthCER:FFA mixtures 
and equimolar CHOL:pigCER mixtures
order 12 nm phase CHOL:synthCER:FFA 13 nm phase CHOL:pigCER:FFA *
1 1.0 1.0
2 2.94 ± 0.36 2.55 ± 0.28
3 0.37 ± 0.06 0.81 ± 0.10
4 0.15 ± 0.02 0.09 ± 0.01
7 0.04 ± 0.03 0.08 ± 0.03
For scaling, the intensity of the ﬁrst order diffraction peak of the LPP was set equal to 1. The values are 
presented as the average (n=6) ± the standard deviation. * de Jager et al., unpublished results
In conclusion, the results of the present study demonstrate for the ﬁrst time that 
one can generate lipid mixtures, containing synthCER, which closely mimic the phase 
behaviour observed in native stratum corneum. Prerequisite is that the experimental 
conditions are appropriately chosen, as the composition of the lipid mixtures and the 
temperature at which the lipid mixtures are equilibrated play a crucial role for the 
formation of the characteristic LPP. From all lipid mixtures tested, the phase behaviour 
of the equimolar CHOL:[CER1:CER3:ΣCERIV]:FFA mixtures resemble to the highest 
extent the lamellar and lateral stratum corneum lipid organisation, both at room and 
elevated temperatures. 
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ABSTRACT
Cholesterol, free fatty acids and 9 classes of ceramides (CER1-CER9) form the 
main components of the intercellular lipid lamellae in stratum corneum, which are 
responsible for the skin barrier function. Both the presence of a unique 13 nm lamellar 
phase, of which the formation depends on the presence of CER1, and the dense lateral 
lipid packing are characteristic for the stratum corneum lipid organisation. The present 
study focuses on the organisation in mixtures prepared with cholesterol, free fatty 
acids and a limited number of synthetic ceramides, namely CER1, CER3 and bovine 
brain ceramide type IV (ΣCERIV). The main objective is to determine the optimal molar 
ratio between CER3 and ΣCERIV for the formation of the 13 nm lamellar phase. CER3 
contains a uniform acyl chain length, whereas ΣCERIV contains fatty acids with varying 
chain lengths. Using small-angle X-ray diffraction, it is demonstrated that the CER3:
ΣCERIV molar ratio affects the formation of the 13 nm lamellar phase and that the 
optimal ratio depends on the presence of free fatty acids. Furthermore, the formation 
of the 13 nm lamellar phase is not very sensitive to variations in the total ceramide 
level, which is similar to the in vivo situation. 
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1. INTRODUCTION
The barrier properties of mammalian skin can be ascribed to the unique composition 
and structure of its most apical layer, the stratum corneum. The stratum corneum 
consists of ﬂat corneocytes, embedded in an intercellular matrix of lipids. Since these 
lipid domains form the only continuous structure in the stratum corneum, they are 
considered to play a crucial role in the maintenance of the skin barrier. Therefore, 
detailed information on the structure and organisation of the stratum corneum lipids is 
essential for a better understanding of the skin barrier function.
The main constituents of the intercellular lipid matrix are ceramides (CER), 
cholesterol (CHOL) and long-chain free fatty acids (FFA). Nine different extractable 
ceramides have been detected in human stratum corneum [1-4], which are classiﬁed 
as CER1 to CER9. The ceramides can be subdivided into three main groups, based on 
the nature of their head group architecture (sphingosine (S), phytosphingosine (P) or 
6-hydroxysphingosine (H)). Through an amide bonding, long-chain nonhydroxy (N) or 
α-hydroxy (A) fatty acids with varying acyl chain lengths are chemically linked to the 
sphingosine bases. CER1 (EOS), CER4 (EOH) and CER9 (EOP) are unique in structure 
as they contain linoleic acid linked to an ω-hydroxy fatty acid (EO) with a chain length 
of 30 to 32 carbon atoms. The molecular structures of the ceramides are illustrated in 
Figure 1A.
X-ray diffraction studies on native stratum corneum have demonstrated that the 
stratum corneum lipids are organised in two coexisting crystalline lamellar phases: the 
short periodicity phase (SPP) with a periodicity of approximately 6 nm and the long 
periodicity phase (LPP) with a periodicity of approximately 13 nm [5-7]. The 13 nm 
lamellar phase and the predominantly orthorhombic lipid packing are considered to be 
crucial for the skin barrier function. X-ray diffraction studies on lipid mixtures prepared 
with isolated pig or human ceramides, cholesterol and free fatty acids revealed that 
the lipid organisation in these mixtures is similar to that observed in native stratum 
corneum. The main advantage of these stratum corneum lipid models is the possibility 
to selectively exclude particular lipid classes from the mixtures, which is not possible 
with stratum corneum. Therefore, these studies greatly contributed to our present 
knowledge on the role of individual lipid classes in the lipid organisation. Interestingly, 
the formation of the characteristic LPP depends on the presence of cholesterol and 
speciﬁc ceramides, in particular CER1, whereas free fatty acids are required for the 
crystalline (orthorhombic) character of the lateral lipid packing [8-11]. 
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Figure 1 – (A) The molecular structures of the ceramides present in human SC. (B) The molecular 
structures of the synthetic CER used in the study. The acyl chain lengths of CER1(C30) and CER3(C24) 
are well-deﬁned, whereas bovine brain CER type IV (ΣCERIV) shows a distribution in chain lengths with 
C18 and C24 as the most abundantly present. 
 The use of synthetic lipids can overcome problems related to isolated stratum 
corneum lipids, such as variability of the native tissue and the laborious isolation and 
separation of the stratum corneum lipids. In a previous study it was shown for the ﬁrst 
time that the stratum corneum lipid phase behaviour can already be reproduced to a 
high extent with a synthetic lipid mixture consisting of only three synthetic ceramides 
[12]. In that study a ﬁxed ceramide composition was used, namely CER1, CER3 and 
bovine brain ceramide type IV (referred to as ΣCERIV) at a molar ratio of 1:7:2. In 
synthetic CER1 and CER3 a fatty acid with a well-deﬁned acyl chain length is bound 
to the sphingoid backbone, whereas in ΣCERIV fatty acids with varying acyl chain 
lengths are present (see Fig. 1 and Table 1). Both an appropriately chosen equilibration 
temperature during the sample preparation and the presence of free fatty acids in the 
mixture are crucial to achieve a similar lipid organisation as found in native stratum 
corneum [12]. In spite of great similarities in lipid phase behaviour between mixtures 
prepared with natural ceramides (natCER) and synthetic ceramides (synthCER), some 
differences have also been disclosed. The main difference is the presence of either one 
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or two additional phases in mixtures prepared with synthetic lipids. These additional 
phases, with repeat distances of respectively 3.7 and 4.3 nm, can be ascribed to 
crystalline CER3 in a V-shaped structure [13-15].
In the study presented in this paper, we further optimised the composition of the 
synthetic lipid mixtures to accomplish higher resemblance to the stratum corneum lipid 
organisation. To diminish the formation of the additional crystalline phases, which are 
not present in native stratum corneum, the amount of CER3 in the mixture was gradually 
reduced in favour of ΣCERIV. The main objective of the present study was to establish 
the optimal molar ratio of CER3 to ΣCERIV for the formation of the characteristic LPP 
and to determine the sensitivity of the lipid organisation to this ratio. In addition, the 
sensitivity of the lipid organisation to changes in the total synthCER level was studied. 
This was performed by varying the composition of the CHOL:synthCER:FFA mixture 
over a wide range of molar ratios, thereby maintaining a constant CHOL:FFA ratio.
2. MATERIALS AND METHODS
2.1 Synthetic lipids used in the study 
Palmitic acid, stearic acid, arachidic acid, behenic acid, tricosanoic acid, lignoceric 
acid, cerotic acid, cholesterol and bovine brain ceramide type IV were purchased 
from Sigma-Aldrich Chemie GmbH (Schnelldorf, Germany). N-(30-Linoleoyloxy-
triacontanoyl)-sphingosine (synthetic ceramide 1(C30)-linoleate) was a gift from 
Beiersdorf AG (Hamburg, Germany). N-Tetracosanoyl-phytosphingosine (synthetic 
ceramide 3(C24)) was generously provided by Cosmoferm B.V. (Delft, the Netherlands). 
Figure 1B shows the ceramides used in this study. All organic solvents used were of 
analytical grade and manufactured by Labscan Ltd (Dublin, Ireland).
2.2 Preparation and analysis of fatty acid methyl esters (FAMEs) 
To establish the fatty acid proﬁle in ΣCERIV, the lipid was dissolved in 100 µl toluene 
and transmethylated in 1 ml boron trichloride in methanol (10%) using microwave 
irradiation, which was carried out at the lowest power setting (85W) for 4 hours. 
FAMEs dissolved in hexane and puriﬁed on a silica gel column were separated and 
analysed on a Vega GC 6000 gas chromatograph (Carlo Erba Instruments, Italy) using 
capillary column CP Wax 52 (Chrompack, The Netherlands). An initial temperature of 
80°C was increased to 160°C with a rate of 40°C/min followed by a 4°C/min increase 
to 250°C that was maintained until all peaks had eluted. The peaks were identiﬁed by 
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comparison with FAME standards (Sigma-Aldrich Chemie GmbH, Germany). Integration 
of peak areas and calculation of relative percentages were performed by Baseline 810 
integrator. Heptadecanoic acid was used as an internal standard.
2.3 Preparation of the lipid mixtures
For the preparation of all CHOL:synthCER and CHOL:synthCER:FFA mixtures, a 
synthetic ceramide mixture was used that consisted of CER1, CER3 and ΣCERIV at a 
molar ratio ranging from 1:1:8 to 1:8:1. For the preparation of the CHOL:synthCER:FFA 
mixtures, the following fatty acid mixture was used: C16:0, C18:0, C20:0, C22:0, C23:0, 
C24:0 and C26:0 at molar ratios of 1.3, 3.3, 6.7, 41.7, 5.4, 36.8 and 4.7, respectively. 
This ratio is similar to that found in native stratum corneum [16]. Appropriate amounts 
of individual lipids dissolved in chloroform:methanol (2:1) were combined to yield lipid 
mixtures of approximately 1.5 mg dry weight at the desired composition at a total lipid 
concentration of 7 mg/ml. A Camag Linomat IV was used to apply the lipid mixtures 
onto mica. This was done at a rate of 4.3 µl/min under a continuous nitrogen ﬂow. 
The samples were equilibrated for 10 minutes at the appropriate elevated temperature 
that varied from 70 to 90°C and subsequently hydrated with an acetate buffer of pH 
5.0.  Finally, the samples were homogenised by 10 successive freeze-thawing cycles 
between -20°C and room temperature, during which the samples were stored under 
gaseous argon. 
2.4 Small-angle X-ray diffraction (SAXD)
All measurements were performed at the European Synchrotron Radiation Facility 
(ESRF, Grenoble), using station BM26B. A more detailed description of this beamline 
has been given elsewhere [17]. The X-ray wavelength and the sample-to-detector 
distance were 1.24Å and 1.7m, respectively. Diffraction data were collected on a two-
dimensional multiwire gas-ﬁlled area detector. The spatial calibration of this detector 
was performed using silver behenate. The samples were mounted in a specially 
designed sample holder with mica windows. All measurements were recorded at room 
temperature for a period of 10 minutes. 
SAXD provides information about the larger structural units in the sample, such as 
the repeat distance of a lamellar phase. The scattering intensity I (in arbitrary units) 
was measured as a function of the scattering vector q (in reciprocal nm). The latter 
is deﬁned as q=(4�sinθ)/λ, in which θ is the scattering angle and λ is the wavelength. 
From the positions of a series of equidistant peaks (qn), the periodicity, or d-spacing, 
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of a lamellar phase was calculated using the equation qn=2n�/d, n being the order 
number of the diffraction peak.  
3. RESULTS
3.1 Fatty acid proﬁle in ΣCERIV
To assess the fatty acid proﬁle in ΣCERIV, two batches of ΣCERIV were subjected 
to transmethylation with boron trichloride in methanol followed by puriﬁcation of the 
FAME by column chromatography. In this way, fractions containing methyl esters of α-
hydroxy fatty acids were collected and subsequently analysed by gas chromatography. 
The results of the FAME analysis summarised in Table 1 show low batch-to-batch 
variation in the composition and the relative amounts of the various α-hydroxy fatty 
acids. All lipid mixtures used in our studies were prepared with batch 2. There, the 
most abundantly fatty acids were C18 (22%) and C24 (42%).
Table 1 - α-hydroxy acyl proﬁle in two batches of ΣCERIV given as percentages of total α-hydroxy acids
acyl chain length α-hydroxy fatty acid batch 1 (%) batch 2 (%)
C18 18.0 22.2
C20 1.7 0.5
C22 8.0 7.9
C23 11.1 10.6
C24 44.0 41.8
C25 11.3 11.5
C26 5.9 5.5
3.2 Mixtures prepared with equimolar ratios of cholesterol and synthetic 
ceramides
The main objective of these studies is to determine the optimal molar ratio between 
CER3 and ΣCERIV for the formation of the LPP. All synthetic ceramide mixtures contained 
the same relative amount of CER1 (10%mol/mol), as earlier studies revealed that this 
amount is sufﬁcient for the formation of the LPP. The relative content of CER3 and 
ΣCERIV in CER1:CER3:ΣCERIV mixtures was varied between a molar ratio of 1:1:8 
and 1:8:1. During preparation, the dry lipid mixtures were equilibrated at either 80°C 
or 90°C. These temperatures were chosen, as use of a higher temperature results in 
melting of the CER1:CER3:ΣCERIV mixture with molar ratio of 1:1:8, while use of a 
lower equilibration temperature results in reduced LPP formation [12]. As no clear 
differences in the formation of the lamellar phases were observed between the lipid 
mixtures prepared at 80°C or 90°C, only the results of the mixtures equilibrated at 
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90°C will be presented. 
The diffraction pattern of the equimolar CHOL:synthCER mixture in which the 
CER fraction was prepared by mixing CER1:CER3:ΣCERIV to achieve a molar ratio of 
1:1:8 is shown in Figure 2A. A lamellar phase with a repeat distance of 5.5 nm (SPP) 
is indicated by the presence of a strong reﬂection at q = 1.14 nm-1 and two weak 
reﬂections at 2.29 and 3.43 nm-1. The diffraction pattern further depicts three weak 
diffraction peaks at 0.48, 0.97 and 1.45 nm-1, respectively. Taking into account the 
diffraction patterns depicted in Figure 2 and 3 (see below), it is conceivable to ascribe 
these reﬂections to the 1st, 2nd and 3rd order maxima of the LPP with a repeat distance 
of approximately 13 nm. In addition, crystalline cholesterol in separate domains is 
present, deduced from the sharp peaks at 1.87 and 3.74 nm-1.
A rise in the CER3 content at the expense of ΣCERIV to reach a CER1:CER3:ΣCERIV 
molar ratio of 1:3:6 was accompanied by a slight increase in peak width (Fig. 2A). This 
results in a partial overlap of the peaks located at 0.98 and 1.16 nm-1. In addition, a 
new structure with a repeat distance of 3.7 nm is present in the mixture, suggested 
by two reﬂections at 1.69 and 3.40 nm-1, respectively. This phase can be ascribed to 
crystalline CER3 in a V-shaped structure [13-15]. 
Figure 2B shows the diffraction pattern of the CHOL:synthCER mixture prepared 
at a 1:5:4 ratio of CER1, CER3 and ΣCERIV. Compared to the diffraction patterns 
obtained at lower CER3 content (1:1:8 and 1:3:6), the peak intensities of the LPP are 
considerably increased compared to the reﬂections attributed to the SPP, indicating 
that the formation of the LPP is promoted at increased CER3 content. Similarly as in the 
1:3:6 mixture, only one reﬂection of the SPP can be detected. In addition, crystalline 
CER3 and crystalline cholesterol are present. A further rise in CER3 content to a CER1:
CER3:ΣCERIV ratio of 1:7:2 results in the diffraction pattern illustrated in Figure 2C. 
Obviously, the reﬂection at q = 1.71 nm-1 is the most prominent peak in the diffraction 
pattern. This suggests that a considerable amount of crystalline CER3 phase separates 
into a 3.7 nm phase. The LPP and SPP are still present in the mixture, but their peak 
intensities are weaker than the those of cholesterol and CER3.
At a CER1:CER3:ΣCERIV ratio of 1:8:1, a marked reduction of LPP formation 
is observed. Only a small lipid fraction forms a lamellar phase with a periodicity of 
12.4 nm, whereas substantial amounts of crystalline CER3 are present in separate 
domains. 
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Figure 2 - The effect of the CER3 to ΣCERIV molar ratio on the phase behaviour of equimolar CHOL:
synthCER mixtures. The inset shows a magniﬁcation of the reﬂections in the q-range between 2 and 4 
nm-1. The Arabic and Roman numbers indicate the diffraction orders of the LPP and SPP, respectively. 
The letter C refers to the reﬂections of crystalline phase of CER3 at 1.71 and 3.42 nm-1. The asterisk 
(*) indicates the reﬂections of crystalline CHOL located at 1.87 and 3.74 nm-1. (A) Diffraction patterns 
of CHOL:[CER1:CER3:ΣCERIV] mixtures at a molar ratio of 1:[0.1:0.1:0.8] and 1:[0.1:0.3:0.6]. The 
various orders of the LPP are located at q = 0.48 nm-1 (1), 0.97 nm-1 (2) and 1.45 nm-1 (3). The various 
orders of the SPP are located at q = 1.14 nm-1 (I), 2.29 nm-1 (II) and 3.43 nm-1 (III). (B) Diffraction 
pattern of 1:[0.1:0.5:0.4] mixture. The various orders of the LPP are located at q = 0.50 nm-1 (1), 1.01 
nm-1 (2) and 1.49 nm-1 (3). The only reﬂection attributed to the SPP is located at q = 1.16 nm-1 (1). (C) 
Diffraction patterns of 1:[0.1:0.7:0.2] and 1:[0.1:0.8:0.1] mixtures. The various orders of the LPP are 
located at q = 0.50 nm-1 (1), 1.01 nm-1 (2) and 1.49 nm-1 (3). The only reﬂection attributed to the SPP 
is located at q = 1.14 nm-1 (I). 
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3.3 Mixtures prepared with equimolar ratios of cholesterol, synthetic ceramides 
and free fatty acids
The lipid organisation of mixtures containing free fatty acids has also been examined, 
as free fatty acids represent the third major lipid species in the stratum corneum. In 
a previous study it was observed that CHOL:synthCER:FFA mixtures melted at a lower 
equilibration temperature than CHOL:synthCER mixtures [11]. The lipid mixtures in 
the present study were therefore equilibrated at slightly lower temperatures, namely 
at 70°C or 80°C. As no obvious differences could be observed in the formation of 
the lamellar phases between mixtures equilibrated at 70° or 80°C, only the results 
obtained at an equilibration temperature of 80°C will be reported. 
The phase behaviour of the CHOL:[CER1:CER3:ΣCERIV]:FFA mixture prepared at 
a molar ratio of 1:[0.1:0.1:0.8]:1 is depicted in Figure 3A. The diffraction pattern 
reveals the presence of a strong reﬂection at q = 1.05 nm-1 and two weak reﬂections 
at 2.09 and 3.15 nm-1. These peaks are located at positions at which the 2nd, 4th and 
6th order diffraction peaks of the LPP should be expected. However, as no 1st and 3rd 
order reﬂections of the LPP are present, the reﬂections may also be related to another 
phase with a periodicity of 6.0 nm. In addition, the SPP with a periodicity of 5.4 nm is 
present, deduced from the presence of a shoulder at the right-hand side of the strong 
peak (1st order) and a weak reﬂection at 3.50 nm-1 (3rd order). A small fraction of 
cholesterol phase separates into crystalline domains, indicated by one weak reﬂection 
at 1.87 nm-1. 
A rise in CER3 content to reach a CER1:CER3:ΣCERIV ratio of 1:3:6 results in a 
clear appearance of the reﬂections attributed to the LPP. At this increased CER3 level, 
crystalline CER3 is present in separate domains as indicated by the two peaks at 1.71 
and 3.43 nm-1. In addition, the SPP and small amounts of crystalline cholesterol are 
present in the lipid mixture.
The diffraction pattern of the mixture at a CER1:CER3:ΣCERIV molar ratio of 1:5:4 
is presented in Figure 3B. A rise in the CER3 level obviously increases the intensities of 
the peaks attributed to the LPP compared to those attributed to the SPP. Five diffraction 
peaks of the LPP with a periodicity of 12.0 are present and two reﬂections of a 5.4 nm 
phase (SPP) can be detected. Crystalline CER3 and crystalline cholesterol can also be 
detected in the mixture.
A further rise in the CER3 content to a molar ratio of 1:7.2 promotes the formation 
of the LPP even more. The presence of the LPP, with a slightly decreased repeat 
distance of 11.9 nm, is indicated by six reﬂections, whereas the SPP is indicated by 
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Figure 3 - The effect of the CER3 to ΣCERIV molar ratio on the phase behaviour of equimolar CHOL:
synthCER:FFA mixtures. The inset shows a magniﬁcation of the reﬂections in the q-range between 2 and 
4 nm-1. The Arabic and Roman numbers indicate the diffraction orders of the LPP and SPP, respectively. 
The letter C refers to the reﬂections of crystalline phase of CER3 at 1.71 and 3.42 nm-1. The asterisk (*) 
indicates the reﬂections of crystalline CHOL located at 1.87 and 3.74 nm-1. (A) Diffraction patterns of 
CHOL:[CER1:CER3:ΣCERIV]:FFA mixtures at a molar ratio of 1:[0.1:0.1:0.8]:1 and 1:[0.1:0.3:0.6]:1. 
The various orders of the LPP in the latter mixture are located at q = 0.52 nm-1 (1), 1.03 nm-1 (2), 1.52 
nm-1 (3), and 2.06 nm-1 (4). The various orders of the SPP are located at q = 1.16 nm-1 (I), 2.31 nm-1 
(II), and 3.48 nm-1 (III). (B) Diffraction pattern of 1:[0.1:0.5:0.4]:1 mixture. The various orders of the 
LPP are located at q = 0.52 nm-1 (1), 1.05 nm-1 (2), 1.56 nm-1 (3), 2.11 nm-1 (4), and 3.64 nm-1 (7). The 
various reﬂections attributed to the SPP are located at q = 1.16 nm-1 (I) and 2.33 nm-1 (II). (C) Diffraction 
patterns of 1:[0.1:0.7:0.2]:1 and 1:[0.1:0.8:0.1]:1 mixture. The various orders of the LPP are located at 
q = 0.52 nm-1 (1) , 1.05 nm-1 (2), 1.58 nm-1 (3) , 2.11 nm-1 (4) , 3.12 nm-1 (6), and 3.65 nm-1 (7).  The 
various orders of the SPP are located at q = 1.17 nm-1 (I) and 2.34 nm-1 (II).
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two reﬂections. Weak reﬂections designate small amounts of crystalline cholesterol, 
whereas strong reﬂections at 1.71 and 3.43 nm-1 indicate that a substantial amount of 
CER3 phase separates in a crystalline phase. 
The diffraction pattern of the lipid mixture prepared with a 1:8:1 composition of 
CER1:CER3:ΣCERIV is plotted in Figure 3C. Compared to the diffraction pattern of the 
1:7:2 mixture, the relative intensities of the reﬂections of both LPP and SPP have not 
changed signiﬁcantly. However, the number of higher order reﬂections, which can be 
detected for both LPP and SPP, are reduced.
3.4 CHOL:synthCER:FFA mixtures with a variation in synthetic ceramide 
content
To determine the sensitivity of the lipid organisation towards changes in the total 
content of synthetic ceramides, the composition of the CHOL:synthCER:FFA mixture 
was varied over a wide synthetic ceramide level, thereby maintaining an equimolar 
cholesterol to free fatty acids ratio.
Figure 4 - Effect of changing the ceramide molar ratio, thereby maintaining an equimolar cholesterol 
to free fatty acids ratio. The inset shows a magniﬁcation of the reﬂections in the q-range between 2 and 
4 nm-1. The Arabic and Roman numbers indicate the diffraction orders of the LPP and SPP, respectively. 
The letter C refers to the reﬂections of crystalline phase of CER3 at 1.71 and 3.42 nm-1. The asterisk (*) 
indicates the reﬂections of crystalline CHOL located at 1.87 and 3.74 nm-1. (A) Diffraction patterns of 
CHOL:synthCER:FFA mixtures at a molar ratio of 1:2:1 and 1:1.5:1. The various orders of the LPP are 
located at q = 0.52 nm-1 (1), 1.03 nm-1 (2), 1.56 nm-1 (3), 2.08 nm-1 (4) , 3.09 nm-1 (6) and 3.60 nm-1 (7). 
The various orders of the SPP are located at q = 1.16 nm-1 (I) and 2.32 nm-1 (II). (B) Diffraction patterns 
of 1:0.75:1 and 1:0.5:1 mixtures. The various orders of the LPP are located at q = 0.49 nm-1 (1), 0.99 
nm-1 (2), 1.48 nm-1 (3), 1.99 nm-1 (4) and 3.49 nm-1 (7). The various reﬂections attributed to the SPP are 
located at q = 1.17 nm-1 (I) and 2.34 nm-1 (II). 
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The synthetic ceramide fraction was prepared with a 1:7:2 molar ratio of CER1, 
CER3 and ΣCERIV, as this appeared to be optimal for the formation of the LPP in the 
presence of free fatty acids. At a CHOL:synthCER:FFA molar ratio of 1:2:1 and 1:1.5:1, 
the majority of the lipids forms the LPP with a repeat distance of 12.0 nm (Fig. 4A). 
Reducing the synthetic ceramide content to a CHOL:synthCER:FFA ratio of 1:0.75:1 
does not considerably affect the formation of the LPP or SPP. A further decrease in 
the synthetic ceramide content to 1:0.5:1 is accompanied by a slight reduction in the 
fraction of lipids forming the LPP (Fig. 4B). These ﬁndings indicate that the formation of 
the lamellar phases is not extremely sensitive towards changes in the relative synthetic 
ceramide content.
Concerning phase-separated cholesterol, we observe that an increased relative 
amount of cholesterol results in increased intensities of the reﬂections attributed to 
phase-separated cholesterol, whereas almost no phase-separated choleseterol is 
present at a CHOL:synthCER:FFA ratio of 1:2:1. This is in agreement with the ﬁndings 
of McIntosh et al. [11, 18], who do not observe phase separation of cholesterol at a 
CHOL:CER:FFA ratio of 1:2:1.
4. DISCUSSION
Previous studies revealed that mixtures prepared with cholesterol, free fatty acids 
and ceramides isolated from pig or human stratum corneum closely mimic the stratum 
corneum lipid phase behaviour [8-10]. These observations offered an attractive 
opportunity to study the role of these lipids in the stratum corneum lipid organisation. 
Furthermore, due to its lipophilic nature, CER1 could be separated from the remaining 
ceramides and isolated in sufﬁcient large quantities. This offered the possibility to 
examine in detail the role CER1 plays in stratum corneum lipid organisation. As each 
subclass of natural ceramides consists of ceramides with varying acyl chain lengths [4], 
the study on the effect of the variation in acyl chain length on the stratum corneum lipid 
phase behaviour is difﬁcult to perform with natural ceramides. Therefore, the use of 
synthetic ceramides with a well-deﬁned acyl chain length and head group architecture 
may overcome this problem. In a previous study, a ﬁrst step has been made to 
investigate this by selecting a synthetic ceramide mixture consisting of CER1 and either 
synthetic CER3 with a uniform acyl chain length of 24 carbon atoms or semi-synthetic 
ΣCERIV containing fatty acids with varying acyl chain lengths. We demonstrated that 
equimolar CHOL:synthCER mixtures prepared with CER1 and ΣCERIV do not form the 
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LPP, whereas in mixtures prepared with synthetic CER1 and CER3 a small lipid fraction 
forms a 11.6 nm lamellar phase [13].
In a very recent study, we studied the phase behaviour of CHOL:synthCER and 
CHOL:synthCER:FFA mixtures prepared with a 1:7:2 molar ratio of CER1, CER3 and 
ΣCERIV [12]. The results of that study reveal that the LPP is formed in the lipid mixtures, 
provided that an optimal equilibration temperature is used during the preparation 
procedure. The phase behaviour of equimolar CHOL:synthCER:FFA mixtures equilibrated 
at 80°C resembled to a high extent the lamellar and lateral lipid organisation found in 
native human or pig stratum corneum. However, the presence of one or two additional 
crystalline phases was noticed, which are not present in stratum corneum and can be 
ascribed to crystalline CER3. Furthermore, the relative intensities of the various LPP 
reﬂections slightly differed from those observed with mixtures prepared with isolated 
ceramides.
In the present study, the CER3 to ΣCERIV ratio was varied to enhance the formation 
of the LPP and to reduce the formation of additional crystalline phases. The results 
clearly demonstrate that in the absence of free fatty acids, a CER1:CER3:ΣCERIV molar 
ratio of 1:5:4 is optimal for the formation of the LPP. In the presence of free fatty acids, 
the optimal synthetic ceramide composition shifts to a CER1:CER3:ΣCERIV molar ratio 
of 1:7:2. Furthermore, the peak width at half maximum of a number of reﬂections 
is much smaller in the diffraction patterns of the mixtures prepared with free fatty 
acids compared to those of the CHOL:synthCER mixtures. This indicates that free fatty 
acids increase the ordering of the lipid organisation. This has also been observed in 
our previous study [12]. Although the optimal synthetic ceramide compositions could 
be selected for the formation of the LPP, it is obvious from our data that the lipid 
organisation is not extremely sensitive towards variations in relative amounts of CER3 
and ΣCERIV in the lipid mixture. This is similar to the observations made with equimolar 
CHOL:natCER mixtures, which were remarkably insensitive towards changes in the 
natural ceramide composition [19]. Only a strong reduction in the level of natCER1 
decreased the formation of the LPP.  
In equimolar CHOL:synthCER:FFA mixtures, the intensities of the reﬂections 
attributed to crystalline cholesterol are much weaker than in the CHOL:synthCER 
mixtures. This indicates that free fatty acids increase the solubility of cholesterol into 
the lamellar phases, which is consistent with observations made with mixtures based 
on natural ceramides [8-10, 18]. Furthermore, the diffraction patterns of the synthetic 
ceramides mixtures do not show reﬂections ascribed to free fatty acids in a separate 
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phase (Fig. 3 and 4). This suggests that free fatty acids are completely intercalated in 
the lamellar phases and their presence is required for the formation of an orthorhombic 
sublattice within the lipid lamellae [8, 10, 12].
The synthetic lipid mixtures also contain an additional 3.7 nm phase, which is not 
present in native stratum corneum and can be ascribed to crystalline CER3. A rise in 
ΣCERIV content at the expense of CER3 increases the acyl chain length variation in the 
synthCER mixture (Table 1) and reduces the formation of phase-separated crystalline 
CER3. For a complete elimination of the 3.7 nm phase, the relative CER3 level should 
be below 3 (CER1:CER3:ΣCERIV molar ratio of 1:3:6). However, this increased ΣCERIV 
level is accompanied by a reduction in LPP formation, as is clearly demonstrated by 
the results of the present study. Partial replacement of CER3 by CER4 with known acyl 
chain lengths (e.g. C18 and C24 at a ratio of 1:2, mimicking the distribution in the 
ΣCERIV batch used in the present study) might offer a possibility to reduce the amount 
of phase-separated CER3. 
The present study further demonstrates that a reduction in LPP formation 
is only observed when the total synthetic ceramide content is reduced to a CHOL:
synthCER:FFA molar ratio of 1:0.5:1. This low sensitivity towards changes in the 
CHOL:synthCER:FFA molar ratio is in agreement with previous studies performed with 
mixtures prepared with natural ceramides [8, 10]. When extrapolating these ﬁndings 
to the in vivo situation, one can state that small variations in the molar ratios of the 
stratum corneum lipids will not lead to a substantial change in lipid organisation. Most 
phase behaviour studies performed with either isolated or synthetic lipids have been 
carried out with equimolar lipid mixtures. A recent study on tape-stripped stratum 
corneum shows that cholesterol, ceramides and free fatty acids are present at a molar 
ratio of approximately 1:1.5:1 [20], rather than the generally assumed equimolar 
ratio. However, inspection of literature data shows that there is a high inter-individual 
variability in stratum corneum lipid composition. This high variability together with 
the ﬁnding that the LPP has been detected in all stratum corneum samples studied so 
far can be ascribed to the fact that the LPP is formed in CHOL:CER:FFA mixtures even 
when the composition varies over a wide molar range. 
In conclusion, the results of the present study and previous studies demonstrate 
that one can generate lipid mixtures with limited number of synthetic ceramides that 
mimic closely the lipid phase behaviour of native stratum corneum. The presence of 
free fatty acids, the temperature used for equilibrating the mixtures and the CER3 to 
ΣCERIV ratio are important parameters for proper lipid organisation. 
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ABSTRACT
The lipid organisation in the upper layer of the skin, the stratum corneum, is 
important for the skin barrier function. This lipid organisation, including the characteristic 
13 nm lamellar phase, can be reproduced in vitro with mixtures based on cholesterol, 
free fatty acids and natural as well as synthetic ceramides. In human stratum corneum, 
nine ceramide classes have been identiﬁed (CER1-CER9). Detailed studies on the 
effect of molecular structure of individual ceramides on the stratum corneum lipid 
organisation are only possible with synthetic lipid mixtures, as their composition can 
be accurately chosen and systematically modiﬁed. In the present study, small-angle 
X-ray diffraction was used to examine the organisation in synthetic lipid mixtures of 
which the synthetic ceramide fraction was prepared with sphingosine based CER1 or 
phytosphingosine based CER9. The latter acylceramide contains an additional hydroxyl 
group at the sphingoid backbone. The results show that a gradual increase in CER1 
level consistently promotes the formation of the 13 nm lamellar phase and that partial 
replacement of CER1 by CER9 does not affect the phase behaviour. Interestingly, 
complete substitution of CER1 with CER9 reduces the formation of the long periodicity 
phase and results in phase separation of CER9.
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1. INTRODUCTION
Ceramides (CER), cholesterol (CHOL) and long-chain free fatty acids (FFA) are 
the most abundant lipid species present in the stratum corneum and are responsible 
for proper function of the skin barrier. Human stratum corneum contains at least 9 
extractable ceramide types [1-4], classiﬁed as CER1 to CER9. The ceramides can be 
subdivided into three main groups, based on the nature of their backbone (sphingosine 
(S), phytosphingosine (P) and 6-hydroxysphingosine (H)). Through an amide bonding, 
long-chain nonhydroxy (N) or α-hydroxy (A) fatty acids with varying acyl chain lengths 
are chemically linked to the sphingosine bases. The acylceramides CER1 (EOS), CER4 
(EOH) and the recently identiﬁed CER9 (EOP) are unique in structure as they contain 
linoleic acid linked to an ω-hydroxy fatty acid (EO) with a chain length of 30 to 32 
carbon atoms.
X-ray diffraction studies demonstrated the presence of two coexisting lamellar phases 
in human stratum corneum: the short periodicity phase (SPP) with a repeat distance 
of approximately 6 nm and the long periodicity phase (LPP) with a repeat distance of 
approximately 13 nm [5-7]. The molecular organisation of the LPP together with the 
predominantly orthorhombic lipid packing in the presence of substantial amounts of 
cholesterol are exceptional and are therefore considered to play an important role in 
the skin barrier function [8].
X-ray diffraction studies on lipid mixtures prepared with cholesterol, free fatty 
acids and ceramides isolated from human or pig stratum corneum revealed that the 
lipid organisation in these mixtures closely mimics that observed in native stratum 
corneum. Those studies have markedly contributed to our present knowledge on 
the stratum corneum lipid organisation and the role the main lipid classes play in 
the stratum corneum lipid organisation [9-11]. However, the role of the head group 
architecture or acyl chain length on the lipid phase behaviour cannot be studied using 
natural ceramides, as it is impossible to isolate the individual ceramide subclasses in 
large quantities. For this reason, we decided to investigate the lipid organisation in 
mixtures prepared with synthetic ceramides (synthCER), which offers the possibility to 
substitute one single ceramide subclass for another one. However, a ﬁrst prerequisite 
for the possibility to use synthetic ceramides is that their phase behaviour reﬂects 
that observed in stratum corneum. In previous studies we have demonstrated that the 
stratum corneum lipid organisation can be reproduced to a high extent with equimolar 
mixtures of cholesterol, free fatty acids and a limited number of synthetic ceramides, 
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namely CER1, CER3 and bovine brain ceramide type IV (referred to as ΣCERIV) mixed 
in a 1:7:2 molar ratio [12, 13]. In synthetic CER1 and CER3 non-hydroxy fatty acids 
of a uniform acyl chain length are linked to the (phyto)sphingoid backbone, whereas 
the sphingosine based ΣCERIV contains α-hydoxy fatty acids with varying acyl chain 
lengths, with C18 (22%) and C24 (42%) as the most abundantly present [13]. For 
achievement of a similar lipid organisation as observed in the stratum corneum, the 
presence of free fatty acids and an optimal ratio of CER3 and ΣCERIV are crucial 
[13]. 
The present study focuses on the role the head group architecture of the 
acylceramides plays on the phase behaviour of synthetic lipid mixtures. In human 
stratum corneum, approximately 8.3% of the total ceramide fraction comprises CER1 
(sphingosine base), whereas CER9 (phytosphingosine base) accounts for 6.4% [4]. For 
this reason, we studied synthetic ceramide mixtures containing only one acylceramide 
(CER1 or CER9) as well as mixtures in which both acylceramides are present, by 
partially substituting CER1 with CER9. The use of CER9 with an ω-hydroxy fatty acid 
chain length of either 30 or 27 carbon atoms also allowed us to study the role of the 
acyl chain length on the lipid organisation. The major ﬁnding of the present study 
is that partial replacement of CER1 by CER9 does not affect the lipid organisation, 
whereas complete substitution of CER1 with CER9 inhibits the formation of the LPP and 
results in phase separation of CER9.
2. MATERIALS AND METHODS
2.1 Materials 
Palmitic acid, stearic acid, arachidic acid, behenic acid, tricosanoic acid, lignoceric 
acid, cerotic acid, cholesterol and bovine brain ceramide type IV were purchased 
from Sigma-Aldrich Chemie GmbH (Schnelldorf, Germany). N-(30-Linoleoyloxy-
triacontanoyl)-sphingosine (synthetic ceramide 1(C30)-linoleate), N-(30-Linoleoyloxy-
triacontanoyl)-phytosphingosine (synthetic ceramide 9(C30)-linoleate), N-(27-
Linoleyl-heptacosanoyl)-phytosphingosine (synthetic ceramide 9(C27)-linoleate) and 
N-Tetracosanoyl-phytosphingosine (synthetic ceramide 3(C24)) were generously 
provided by Cosmoferm B.V. (Delft, the Netherlands). All organic solvents used were 
of analytical grade and manufactured by Labscan Ltd (Dublin, Ireland).
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2.2 Preparation of the lipid mixtures
For the preparation of the CHOL:synthCER:FFA mixtures, the following fatty 
acid mixture was used: C16:0, C18:0, C20:0, C22:0, C23:0, C24:0 and C26:0 at 
molar ratios of 1.3, 3.3, 6.7, 41.7, 5.4, 36.8 and 4.7, respectively. This is similar 
to the free fatty acids ratio found in stratum corneum [14]. Appropriate amounts 
of individual lipids dissolved in chloroform:methanol (2:1) were combined to yield 
mixtures of approximately 1.5 mg dry weight at the desired composition at a total lipid 
concentration of 7 mg/ml. A Camag Linomat IV was used to spray the lipid mixtures 
onto mica. This was done at a rate of 4.3 µl/min under a continuous nitrogen stream. 
The samples were equilibrated for 10 minutes at 80°C (CHOL:synthCER:FFA) or 95°C 
(CHOL:synthCER) and subsequently hydrated with an acetate buffer of pH 5.0.  Finally, 
the samples were homogenised by 10 successive freeze-thawing cycles between –20°C 
and room temperature, during which the samples were stored under gaseous argon. 
2.3 Small-angle X-ray diffraction (SAXD)
All measurements were performed at the European Synchrotron Radiation Facility 
(ESRF, Grenoble), using station BM26B [15]. The X-ray wavelength and the sample-to-
detector distance were 1.24Å and 1.7m, respectively. Diffraction data were collected 
on a two-dimensional multiwire gas-ﬁlled area detector. The spatial calibration of this 
detector was performed using silver behenate. The samples were mounted in a sample 
holder with mica windows. Diffraction patterns of the lipid mixtures were obtained at 
room temperature for a period of 5 minutes. All measurements were performed at 
least in duplicate during two different sessions.
SAXD provides information about the larger structural units in the sample, such as 
the repeat distance of a lamellar phase. The scattering intensity I (in arbitrary units) 
was measured as a function of the scattering vector q (in reciprocal nm). The latter 
is deﬁned as q=(4�sinθ)/λ, in which θ is the scattering angle and λ is the wavelength. 
From the positions of a series of equidistant peaks (qn), the periodicity, or d-spacing, 
of a lamellar phase was calculated using the equation qn=2n�/d, n being the order 
number of the diffraction peak. 
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3. RESULTS
3.1 LPP is formed in equimolar CHOL:synthCER:FFA mixtures prepared with 
CER1 or CER9
The diffraction pattern of a CHOL:[CER1:CER3:ΣCERIV]:FFA mixture prepared at a 
molar ratio of 1:[0.1:0.7:0.2] is shown in Figure 1A. The LPP with a repeat distance of 
12.2 nm is indicated by the presence of six reﬂections (q = 0.52, 1.03, 1.54, 2.06, 3.08 
and 3.59 nm-1). The reﬂections at q = 1.16 and 2.33 nm-1 correspond to the ﬁrst and 
second order diffraction peaks of a lamellar phase with a periodicity of 5.4 nm (SPP). 
The two strong reﬂections at 1.71 and 3.43 nm-1 reveal the presence of a phase with 
a periodicity of 3.7 nm, ascribed to crystalline CER3 in a V-shaped structure [16-18]. 
The presence of crystalline cholesterol in separate domains can be deduced from the 
peaks at 1.87 and 3.74 nm-1. 
Figure 1 - FFA promote LPP formation in mixtures containing 10% CER1 or 10% CER9. The inset shows 
a magniﬁcation of the reﬂections in the q-range between 2 and 4 nm-1. The Arabic and Roman numbers 
indicate the diffraction orders of the LPP and SPP, respectively. C3 refers to the reﬂections of crystalline 
CER3 located at 1.71 and 3.42 nm-1, whereas C9 refers to the reﬂections of crystalline CER9 located at 
0.70, 1.41, 2.10 and 2.79 nm-1. The asterisk (*) indicates the reﬂections of crystalline cholesterol located 
at 1.87 and 3.74 nm-1. (A) Diffraction patterns of CHOL:synthCER:FFA mixtures prepared with CER1 or 
CER9. The various orders of the LPP are located at q = 0.52 nm-1 (1), 1.03 nm-1 (2), 1.56 nm-1 (3), 2.08 
nm-1 (4), 3.09 nm-1 (6) and 3.56 nm-1 (7). The various orders of the SPP are located at q = 1.17 nm-1 (I) 
and 2.34 nm-1 (II). (B) Diffraction patterns of CHOL:synthCER mixtures prepared with CER1 or CER9. The 
various orders of the LPP are located at q = 0.52 nm-1 (1), 1.03 nm-1 (2), 1.56 nm-1 (3), 2.08 nm-1 (4) and 
3.09 nm-1 (6). The various orders of the SPP are located at q = 1.17 nm-1 (I) and 3.51 nm-1 (III).
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Complete substitution of CER1 with CER9(C30) results in the diffraction pattern 
depicted in Figure 1A. Obviously, the LPP with a repeat distance of 12.1 nm is also 
formed in the presence of CER9(C30), although the intensities of its reﬂections in 
comparison to the SPP reﬂections are weaker than observed for the CER1 containing 
mixture. A weak reﬂection at 0.70 nm-1 suggests that a small fraction of CER9(C30) 
phase separates (see next section for a more detailed description of this phase). In 
addition, crystalline cholesterol and CER3 in a V-shaped formation are present in the 
lipid mixture.
Replacement of CER9(C30) with CER9(C27) in the mixture results in a marked 
reduction of LPP formation (data not shown). In addition, the repeat distance of this 
phase shifts to 11.7 nm. The formation of the other above-mentioned phases is not 
affected by the reduced ω-hydroxy fatty acid chain length of CER9(C27).
3.2 LPP is not formed in mixtures prepared with CER9 in the absence of free 
fatty acids
Figure 1B shows the diffraction pattern of the equimolar CHOL:synthCER mixture, 
prepared at a 1:7:2 ratio of CER1, CER3 and ΣCERIV. Five equidistant peaks suggest the 
presence of the LPP (12.2 nm), whereas the SPP (5.3 nm) is indicated by two reﬂections. 
In addition, phase-separated CER3 and cholesterol can be detected. Compared to the 
diffraction curve of the equimolar CHOL:synthCER:FFA mixture prepared with CER1, 
the intensities of the reﬂections attributed to the LPP and SPP decreased as compared 
to those of crystalline CER3 and cholesterol. 
Complete substitution of CER1 with CER9(C30) results in the diffraction pattern 
depicted in Figure 1B. Three major changes are observed in the presence of CER9(C30): 
(i) No reﬂections can be detected that might be ascribed to the LPP, indicating that 
no LPP is formed. (ii) Four reﬂections at 0.70, 1.41, 2.10 and 2.79 nm-1 indicate the 
presence of a phase with a repeat distance of 9.0 nm. This periodicity well corresponds 
to the length of two opposing CER9(C30) molecules in a hairpin formation and is 
similar to the repeat distance found for hydrated pig CER1 [9]. Taking into account the 
diffraction patterns depicted in Figure 2B (see below), it is conceivable to assign this 
phase to crystalline CER9(C30) in separate domains. (iii) The 3.7 nm phase, attributed 
to crystalline CER3, is not present. Instead, a shoulder at 1.57 nm-1 might designate 
the presence of a new phase with a periodicity of 4.0 nm. However, no higher order 
reﬂections can be detected. The exact composition and nature of this phase is not 
known. 
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The diffraction pattern of the mixture containing CER9(C27) is almost identical to 
the one obtained with CER9(C30) (data not shown). No LPP is present in the mixture 
and several reﬂections indicate the presence of a phase with a repeat distance of 8.7 
nm, ascribed to phase-separated CER9. The slightly shorter periodicity of this phase 
can be explained by the shorter ω-hydroxy fatty acid chain length of CER9(C27). 
3.3 LPP formation in equimolar CHOL:synthCER:FFA mixtures depends on 
acylceramide content
To assess the effect of the relative acylceramide content on the lipid organisation in 
equimolar mixtures of cholesterol, synthetic ceramides and free fatty acids, the amount 
of CER1 or CER9 in the synthetic ceramide fraction was gradually increased from 0 to 
20% mol/mol, thereby maintaining the ratio between CER3 and ΣCERIV constant. As 
CER9(C27) is less effective in promoting the formation of the LPP, these experiments 
were only performed with CER1 and CER9(C30). Below, the changes in lipid organisation 
as a function of acylceramide type and relative amount are presented. 
In the absence of CER1 and CER9, the characteristic LPP is not present (data not 
shown). Instead, three strong reﬂections indicate the presence of a 5.4 nm lamellar 
phase (SPP). In addition, crystalline CER3 and cholesterol are present in the mixture, 
both indicated by two reﬂections. 
In the equimolar CHOL:synthCER:FFA mixture in which the synthetic ceramide 
fraction contains 5% CER1, only a small fraction of lipids forms the LPP, as deduced 
from the presence of four weak reﬂections in the diffraction pattern (see Fig. 2A). The 
diffraction curve of the mixture prepared with 10% CER1 is illustrated in Figure 1A (see 
previous section for a more detailed description of the phases present). Evidently, the 
fraction of lipids that forms the LPP increased. A rise in CER1 content to 15 or 20% 
results in diffraction patterns in which the intensities of the LPP reﬂections further 
increase as compared to the peak intensities of the SPP, CER3 and cholesterol. Even 
in the presence of 20% CER1 (see Fig. 2A), no peaks can be detected that might be 
ascribed to crystalline CER1 in separate domains. 
The diffraction pattern of the equimolar CHOL:synthCER:FFA mixture of which 
the synthetic ceramide fraction contains 5% CER9 (see Fig. 2B) is similar to the one 
obtained with 5% CER1. The majority of lipids forms the SPP, although weak reﬂections 
indicate that a minute fraction of lipids forms a phase with a periodicity of 12.0 nm. In 
addition, crystalline CER3 and cholesterol are present in the mixture. The diffraction 
curve of the mixture prepared with 10% CER9 (see Fig. 1A) has already been explained 
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in the previous section. At this relative amount, the LPP is clearly present and a small 
fraction of CER9 phase separates. When the amount of CER9 in the synthetic ceramide 
fraction is further raised to 15 or 20% (see Fig. 2B), some striking changes in the lipid 
organisation are observed: (i) The reﬂections attributed to the LPP markedly reduce 
in intensity as compared to the peak intensities of the other phases. Moreover, only 
the ﬁrst three order diffraction peaks of the LPP can be detected. This indicates that at 
increased CER9 content, the formation of the LPP is inhibited. (ii) An increased amount 
of CER9 phase separates into separate domains, indicated by strong reﬂections at q = 
0.70, 1.40, 2.10 and 2.80 nm-1, which reveal the presence of a 9.0 nm phase. (iii) The 
reﬂections ascribed to phase-separated CER3, which is present at a CER9 level of 5 and 
10%, completely disappear when the amount of CER9 in the mixture is increased. 
Figure 2 - LPP formation in equimolar CHOL:synthCER:FFA mixtures  depends on acylceramide content. 
The inset shows a magniﬁcation of the reﬂections in the q-range between 2 and 4 nm-1. The Arabic 
and Roman numbers indicate the diffraction orders of the LPP and SPP, respectively. C3 refers to the 
reﬂections of crystalline CER3 located at 1.71 and 3.42 nm-1, whereas C9 refers to the reﬂections of 
crystalline CER9 located at 0.70, 1.40, 2.10 and 2.80 nm-1. The asterisk (*) indicates the reﬂections of 
crystalline cholesterol located at 1.87 and 3.74 nm-1. (A) Diffraction patterns of CHOL:synthCER:FFA 
mixtures prepared with 5 and 20% CER1. The various orders of the LPP are located at q = 0.52 nm-1 (1), 
1.03 nm-1 (2), 1.56 nm-1 (3) , 2.08 nm-1 (4), 3.09 nm-1 (6) and 3.56 nm-1 (7). The various orders of the 
SPP are located at q = 1.17 nm-1 (I) and 2.34 nm-1 (II). (B) Diffraction patterns of CHOL:synthCER:FFA 
mixtures prepared with 5 and 20% CER9. The various orders of the LPP are located at q = 0.52 nm-1 (1), 
1.03 nm-1 (2) and 1.56 nm-1 (3). The various orders of the SPP are located at q = 1.17 nm-1 (I), 2.34 nm-1 
(II) and 3.51 nm-1 (III).
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3.4 No change in LPP formation upon partial substitution of CER1 with CER9 
in equimolar CHOL:synthCER:FFA mixtures.
As native stratum corneum contains both CER1 (8.3%) and CER9 (6.4%), we also 
prepared lipid mixtures in which both acylceramides were present in ratios similar to 
that found in human stratum corneum. The mixtures were prepared with a synthetic 
ceramide fraction that contained 5% CER1 and 10% CER9 and vice versa, thereby 
maintaining the ratio between CER3 and ΣCERIV constant. In both mixtures, six 
diffraction peaks clearly indicate the presence of the LPP, whereas the SPP is identiﬁed 
by two diffraction peaks (see Fig. 3). In addition, crystalline CER3 and cholesterol are 
present. The relative intensities of the reﬂections attributed to the various phases in 
both diffraction patterns are similar. Moreover, the diffraction patterns resemble closely 
the one obtained with the mixture prepared with 15% CER1.
4. DISCUSSION
In human stratum corneum, approximately 8.3% of the total ceramide fraction 
comprises CER1, whereas CER4 and CER9 account for 5.0 and 6.4%, respectively 
[4]. From studies performed with mixtures based on natural ceramides, we know that 
CER1 plays a prominent role in the formation of the LPP, characteristic for the stratum 
corneum lipid phase behaviour. After exclusion of CER1 from mixtures prepared with 
ceramides isolated from human stratum corneum, still a small fraction of lipids forms 
the LPP [11]. This indicates that CER4 or CER9 or both contribute to a certain extent to 
Figure 3 - No substantial change in lipid 
organisation in CHOL:synthCER:FFA mixtures in 
which CER1 is partially substituted with CER9. 
The inset shows a magniﬁcation of the reﬂections 
in the q-range between 2 and 4 nm-1. The Arabic 
and Roman numbers indicate the diffraction 
orders of the LPP and SPP, respectively. C3 refers 
to the reﬂections of crystalline CER3 located at 
1.71 and 3.42 nm-1. The asterisk (*) indicates 
the reﬂections of crystalline cholesterol located at 
1.87 and 3.74 nm-1. The various orders of the LPP 
are located at q = 0.52 nm-1 (1), 1.03 nm-1 (2), 
1.56 nm-1 (3) , 2.08 nm-1 (4), 3.09 nm-1 (6) and 
3.56 nm-1 (7).  The various orders of the SPP are 
located at q = 1.17 nm-1 (I) and 2.34 nm-1 (II).
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the formation of the LPP. However, until now the role CER4 and CER9 play in the lipid 
organisation could not be studied, as it is impossible to isolate these acylceramides in 
sufﬁcient quantities from human stratum corneum. As we now have available synthetic 
CER9, this is the ﬁrst study in which the role of CER9 and CER9 in combination with 
CER1 on the lipid organisation could be systematically studied. Several important 
features were noticed: 
(i) CER1 promotes the formation of the LPP to a higher extent than CER9. 
(ii) The maximum solubility of CER9 in the lipid lamellar phases is lower than that of CER1. 
(iii) CER1 promotes incorporation of CER9 into the lamellar phases.
What can we learn from these observations?
The presence of an additional hydroxyl group and simultaneous loss of a double 
bond at the sphingoid base of acylceramides impedes the formation of the LPP. This is 
specially observed in equimolar CHOL:synthCER mixtures in which CER9 is not able to 
induce the formation of the LPP. Instead, strong reﬂections in the diffraction pattern 
reveal the presence of crystalline CER9 in separate domains. A possible explanation 
for this ﬁnding is that the larger and more hydrophilic head group of CER9 inhibits the 
formation of the LPP. The situation changes when free fatty acids were added to the 
CHOL:synthCER mixtures: phase separation of CER9 is reduced and the LPP is formed. 
Unlike the synthetic ceramides, the free fatty acids fraction shows a high variation 
in acyl chain lengths. This may suggest that incorporation of CER9 into the lamellar 
phases in synthetic lipid mixtures requires the presence of acyl chains with varying 
lengths. However, additional studies with mixtures prepared with free fatty acids of a 
uniform chain length should be performed to elucidate this. Furthermore, it needs to 
be emphasised that, due to limited variability in head group architecture and acyl chain 
length in the synthetic ceramide fraction, the simpliﬁed synthetic lipid mixtures used 
might be more sensitive to phase separation than natural ceramides in native stratum 
corneum.
Interestingly, the chain length of the ω-hydroxy acid in CER9 seems to have a 
major inﬂuence on the lamellar ordering of the lipids, as CER9(C27) is less effective in 
promoting the formation of the LPP than CER9(C30). Possibly, the shorter ω-hydroxy 
acid in CER9(C27) less efﬁciently spans the two broad lipid layers within the suggested 
tri-layer unit of the LPP [19]. This may result in a reduced stability of the LPP and a 
shift of the repeat distance to lower values (11.7 nm).
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Another difference observed between CER1 and CER9 is the dependence of the 
formation of the LPP on the acylceramide level. Whereas a rise in CER1 content from 0 
to 20% leads to a consistent enhancement of the LPP formation, a more complex phase 
behaviour is observed in mixtures prepared with CER9. There, a rise in CER9 content 
up to 10% promotes the formation of the LPP. A further rise in the CER9 content 
reduces the formation of the LPP and results in the formation of crystalline CER9 in 
separate domains. Phase separation of CER9 is already observed in mixtures in which 
the synthetic ceramide fraction is prepared with 10% CER9. This means that even in 
the presence of free fatty acids, the amount of CER9 that can be incorporated into the 
LPP is limited. 
The ﬁndings that only a minute fraction of lipids organises into the LPP when 
the synthetic ceramide fraction contains 5% CER9 and that no LPP is present in the 
absence of CER1 and CER9 conﬁrm and extend previous results obtained with mixtures 
prepared with natural ceramides [11]. Based on the results of the present study, we 
may speculate that CER9 is indeed able to promote the formation the LPP in natural 
ceramide mixtures, which are excluded from CER1. However, from our results we 
cannot deduce whether the relative amount of CER9 present in the stratum corneum is 
insufﬁcient to effectively promote the formation of the LPP or that its larger and more 
hydrophilic head group hampers the formation of the LPP. Although the differences in 
phase behaviour between CER1 and CER9 in synthetic ceramide mixtures are much 
more pronounced at increased acylceramide levels, CER1 always more effectively 
promotes the formation of the LPP than CER9, even at a relative amount of 5%. The 
question whether CER4, which contains a 6-hydroxysphingosine head group that is 
even larger than the phytosphingosine head group of CER9, is also able to promote the 
formation of the LPP remains unanswered.
In spite of the ﬁnding that CER9 is less efﬁcient in enhancing the formation of the 
LPP than CER1, partial substitution of CER1 with CER9 does not signiﬁcantly affect 
the lipid organisation. When extrapolating these ﬁndings to the in vivo situation, it 
is expected that small variations in the relative content of individual acylceramides 
will not substantially change the stratum corneum lipid organisation. However, in vivo 
the situation is usually more complex. In lamellar ichthyosis and atopic dermatitis, a 
marked reduction in CER1 in the lesion parts of the stratum corneum is observed [20-
23]. In addition, in various skin disorders simultaneous changes in composition and 
content of various lipid classes are observed [24]. All these changes may explain the 
reduced LPP formation in these skin disorders.
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 In conclusion, lipid mixtures prepared with synthetic ceramides offer an attractive 
tool to unravel the importance of molecular structure of individual ceramides on the 
stratum corneum lipid organisation. The primary ﬁnding of the present study is that the 
head group architecture of acylceramides considerably affects the lipid organisation. 
Compared to CER1, containing a sphingosine base, CER9 with its phytosphingosine 
base is less efﬁcient in promoting the formation of the characteristic LPP and the level 
CER9 in the LPP is limited. 
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ABSTRACT
Lipid lamellae present in the outermost layer of the skin, the stratum corneum, 
form the main barrier for diffusion of molecules through the skin. The presence of a 
unique 13 nm lamellar phase and the high crystallinity are characteristic for the stratum 
corneum lipid phase behaviour. In the present study, small-angle and wide-angle X-
ray diffraction were used to examine the organisation in lipid mixtures prepared with 
a unique set of well-deﬁned synthetic ceramides, varying from each other in head 
group architecture and acyl chain length. The results show that equimolar mixtures of 
cholesterol, free fatty acids and synthetic ceramides (resembling the composition of pig 
ceramides) closely resemble the lamellar and lateral stratum corneum lipid organisation, 
both at room and elevated temperatures. Exclusion of several ceramide classes from 
the mixture does not affect the lipid organisation. However, complete substitution of 
ceramide 1 (acylceramide with a sphingosine base) with ceramide 9 (acylceramide 
with a phytosphingosine base) reduces the formation of the long periodicity lamellar 
phase. This indicates that the head group architecture of acylceramides affects the 
lipid organisation. In conclusion, lipid mixtures prepared with well-deﬁned synthetic 
ceramides offer an attractive tool to unravel the importance of molecular structure of 
individual ceramides for proper lipid organisation. 
110 Chapter 6
1. INTRODUCTION
The barrier function of the skin is predominantly attributed to its outermost 
layer, the stratum corneum, which efﬁciently protects the body from desiccation and 
percutaneous penetration of compounds. The stratum corneum consists of several 
layers of overlapping corneocytes, embedded in a matrix of lipids. It has generally 
been accepted that the intercorneocyte lipids, with a very speciﬁc composition and 
organisation, play an important role in the skin barrier function. Unlike biological 
membranes, phospholipids are nearly absent in the stratum corneum and the major 
constituents are ceramides (CER), cholesterol (CHOL) and long-chain free fatty acids 
(FFA). Ceramides are structurally heterogeneous and together with cholesterol and 
free fatty acids they exhibit quite different phase behaviour than phospholipids and 
other more widely studied biological membrane lipids. 
Ceramides are composed of a long-chain sphingosine (S), phytosphingosine (P) 
or 6-hydroxysphingosine (H) base with variations in position and number of hydroxyl 
groups and double bonds [1-4]. Through an amide bonding, long-chain nonhydroxy 
(N) or α-hydroxy fatty acids (A) with varying acyl chain lengths (predominantly 24 
and 26 carbon atoms) are linked to the sphingoid bases. In pig stratum corneum, the 
exceptions are CER1 (EOS) and CER5 (AS). The former contains an ω-hydroxy fatty 
acid with a chain length of 30 to 32 carbon atoms to which linoleic acid is linked (EO), 
whereas CER5 (AS) contains a fatty acid with a chain length of only 16 to 18 carbon 
atoms. In human stratum corneum, three ceramides (CER1 (EOS), CER4 (EOH) and 
CER9 (EOP)) have an exceptional long molecular structure, whereas CER5 (AS) has a 
fatty acid chain length of approximately 24 carbon atoms.
Several studies have been performed to provide insight into the complex lipid 
architecture underlying the skin barrier function. Electron microscopy studies 
demonstrated that the intercellular lipids in the stratum corneum have a lamellar 
organisation with a repeating pattern of approximately 13 nm, consisting of a broad-
narrow-broad sequence of electron lucent bands [5, 6]. X-ray diffraction studies 
demonstrated the presence of two coexisting lamellar phases in human stratum 
corneum: the short periodicity phase (SPP) with a repeat distance of around 6 nm and 
the long periodicity phase (LPP) with a repeat distance of approximately 13 nm [7-9]. 
The molecular organisation of the LPP together with the predominantly orthorhombic 
lipid packing in the presence of substantial amounts of cholesterol are exceptional and 
are therefore considered to play an important role for the maintenance of a competent 
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skin barrier. 
Mixtures prepared with cholesterol, free fatty acids and ceramides isolated from 
human or pig stratum corneum closely mimic the lipid organisation found in the SC 
[10-12]. It has been demonstrated that in particular cholesterol and ceramides are 
important for the formation of the LPP, whereas free fatty acids are required for the 
crystalline (orthorhombic) character of the lateral lipid packing. As natural ceramides 
contain various subclasses of ceramides with varying acyl chain lengths, it is practically 
impossible to selectively remove individual ceramides in quantities. Detailed studies on 
the effect of molecular structure of individual ceramides on the stratum corneum lipid 
organisation are therefore only possible with mixtures based on synthetic ceramides, 
as their composition can be accurately chosen and systematically modiﬁed. The 
prerequisite to replace natural ceramides (natCER) by synthetic ones (synthCER) is 
that their phase behaviour reﬂects that of the stratum corneum. In previous studies we 
have demonstrated that equimolar mixtures of cholesterol, free fatty acids and a limited 
number of synthetic ceramides, namely CER1, CER3 and bovine brain ceramide type 
IV (referred to as ΣCERIV) mixed in a 1:7:2 ratio, closely resemble the lamellar and 
lateral stratum corneum lipid organisation, both at room and elevated temperatures 
[13, 14]. CER1 (EOS) and CER3 (NP) contain fatty acids of a uniform acyl chain length, 
whereas ΣCERIV (AS) contains fatty acids with varying acyl chain lengths, with C18 
and C24 as the most abundantly present [14]. Mixtures prepared with CER1, CER3 and 
ΣCERIV are denoted as synthCER I mixtures. It has been demonstrated that proper 
lipid organisation in synthCER I mixtures can only be achieved with an optimal CER3:
ΣCERIV ratio in the presence of CER1 [14, 15].
In spite of many similarities, also some differences are observed between mixtures 
prepared with natCER or synthCER I. The main difference is the presence of one or 
two additional phases with repeat distances of 3.7 and 4.3 nm, respectively. These 
phases have never been observed in mixtures containing natCER and can be ascribed 
to crystalline CER3, present in separate domains. Another difference is the repeat 
distance of the LPP, which is slightly shorter in synthCER mixtures (~12 nm) than 
in natCER mixtures (~13 nm). In addition, the relative intensities of the reﬂections 
attributed to the LPP in mixtures prepared with synthCER slightly differ from those 
observed in mixtures prepared with natCER [13]. This indicates that the localisation of 
the lipids within the LPP in mixtures prepared with synthCER might differ slightly. 
Currently, we have at our disposal a unique set of synthesised ceramides, which 
closely mimic the ceramides composition of pig stratum corneum (see Fig. 1). In 
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addition, we have synthetic CER9 (EOP), which is present in human stratum corneum, 
but not in pig stratum corneum. CER9 is structurally similar to CER1, but contains an 
additional hydroxyl group at the sphingoid backbone. Each of the synthetic ceramides 
has a well-deﬁned head group architecture and acyl chain length. Mixtures prepared with 
the well-deﬁned synthetic ceramides are referred to as synthCER II. As the synthetic 
counterpart of CER5 (AS) (acyl chain length 16 carbon atoms) is not available, all 
synthCER II mixtures were prepared with CER3 (NP) with an acyl chain of 16 carbon 
atoms (CER3(C16)). 
Figure 1 - The molecular structures of the synthetic ceramides used in the present study.
The aim of the present study is three-fold and can be summarised in the following 
questions:
(i) Is it possible to mimic the stratum corneum lipid phase behaviour with 
mixtures prepared with well-deﬁned synthetic ceramides at room and elevated 
temperatures? We will particularly focus on the role of free fatty acids, the 
presence of additional phases and the intensity distribution of the diffraction 
peaks of the LPP.
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(ii) Is the formation of the LPP also enhanced when CER1 is gradually substituted 
with CER9?
(iii) Is it possible to reduce the number of synthetic ceramides classes in the mixture, 
without affecting the formation of the lamellar phases?
In order to answer the aforementioned questions, the phase behaviour of various 
equimolar CHOL:synthCER II:FFA mixtures was studied. Firstly, a mixture was studied 
that closely mimics the composition of the ceramides in pig stratum corneum [10, 16]. 
Subsequently, the synthCER II composition was gradually changed (see Table 1) to 
elucidate the role various synthetic ceramides play in the formation of the LPP. 
Table 1 - The composition of the synthetic ceramides fractions used in this study (in molar ratios).
mixture CER1 CER2 CER3(C24) CER4 CER3(C16) CER6 CER9
synthCER II1 0.15 0.51 0.16 0.04 0.09 0.05 -
synthCER II2 0.10 0.51 0.16 0.04 0.09 0.05 0.05
synthCER II3 0.05 0.51 0.16 0.04 0.09 0.05 0.10
synthCER II4 - 0.51 0.16 0.04 0.09 0.05 0.15
synthCER II5 - 0.60 0.19 0.04 0.11 0.06 -
synthCER II6 0.15 0.53 0.17 - 0.10 0.05 -
synthCER II7 0.15 0.54 0.17 0.04 0.10 - -
synthCER II8 0.15 0.57 0.18 - 0.10 - -
synthCER II9 0.15 0.25 0.29 0.06 0.16 0.09 -
2. MATERIALS AND METHODS
2.1 Materials 
Palmitic acid, stearic acid, arachidic acid, behenic acid, tricosanoic acid, lignoceric 
acid, cerotic acid and cholesterol were purchased from Sigma-Aldrich Chemie GmbH 
(Schnelldorf, Germany). CER1(C30)-linoleate, CER2(C24), CER3(C24), CER3(C16), 
CER4(C24), CER6(C24) and CER9(C30)-linoleate were generously provided by 
Cosmoferm B.V. (Delft, the Netherlands). All organic solvents used were of analytical 
grade and manufactured by Labscan Ltd (Dublin, Ireland).
2.2 Preparation of the lipid mixtures 
For the preparation of the CHOL:synthCER:FFA mixtures, the following free fatty 
acid mixture was used: C16:0, C18:0, C20:0, C22:0, C23:0, C24:0 and C26:0 at 
molar ratios of 1.3, 3.3, 6.7, 41.7, 5.4, 36.8 and 4.7, respectively. This is similar to 
the composition of the free fatty acids in native stratum corneum [17]. Appropriate 
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amounts of individual lipids dissolved in chloroform:methanol (2:1) were combined 
to yield mixtures of approximately 1.5 mg dry weight at the desired composition at 
a total lipid concentration of 7 mg/ml. A Camag Linomat IV was used to spray the 
lipid mixtures onto mica. This was done at a rate of 4.3 µl/min under a continuous 
nitrogen stream. Subsequently, the samples were equilibrated for 10 minutes at the 
optimal temperature, being 70°C for equimolar CHOL:synthCER:FFA mixtures and 
85°C for equimolar CHOL:synthCER mixtures and hydrated with an acetate buffer of 
pH 5.0. Finally, the samples were homogenised by 10 successive freeze-thawing cycles 
between –20°C and room temperature, during which the samples were stored under 
gaseous argon. 
2.3 Small-angle X-ray diffraction
All measurements were performed at the European Synchrotron Radiation Facility 
(ESRF, Grenoble), using station BM26B [18]. The X-ray wavelength and the sample-to-
detector distance were 1.24Å and 1.7m, respectively. Diffraction data were collected 
on a two-dimensional multiwire gas-ﬁlled area detector. The spatial calibration of 
this detector was performed using silver behenate. The samples were mounted in a 
sample holder with mica windows. Static diffraction patterns of the lipid mixtures were 
obtained at room temperature for a period of 5 minutes. The temperature-induced 
phase changes were investigated by collecting diffraction patterns, during which the 
temperature of the sample was increased from 25 to 95°C at a rate of 2°C/min. Each 
successive diffraction curve was collected for a period of one minute. 
Small-angle X-ray diffraction provides information about the larger structural units 
in the sample, such as the repeat distance of a lamellar phase. The scattering intensity 
I (in arbitrary units) was measured as a function of the scattering vector q (in reciprocal 
nm). The latter is deﬁned as q=(4�sinθ)/λ, in which θ is the scattering angle and λ is 
the wavelength. From the positions of a series of equidistant peaks (qn), the periodicity, 
or d-spacing, of a lamellar phase was calculated using the equation qn=2n�/d, n being 
the order number of the diffraction peak. 
 
2.4 Wide-angle X-ray diffraction
Wide-angle X-ray diffraction provides information about the lateral packing of 
the lipids within the lamellae. Wide-angle X-ray diffraction data were collected on 
a microstrip gas chamber detector with an opening angle of 60° [19]. The sample-
to-detector distance was 36 cm and the X-ray wavelength was 1.24Å. The spatial 
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calibration of the detector was performed with a mixture of silicium and cholesterol. 
The small-angle and wide-angle X-ray diffraction data were collected 
simultaneously. 
3. RESULTS 
3.1 Importance of free fatty acids for proper lamellar organisation
The role of free fatty acids for the formation of the lamellar phases was investigated 
using a synthetic ceramide mixture that closely mimics the composition of the ceramides 
in pig stratum corneum (synthCER II1; see Table 1 for detailed composition). The 
corresponding diffraction patterns are illustrated in Figure 2. The diffraction pattern of 
the equimolar CHOL:synthCER II1:FFA mixture reveals the presence of ﬁve reﬂections 
(q = 0.52, 1.03, 1.56, 2.08 and 3.09 nm-1) that can be ascribed to a 12.2 nm phase 
(LPP). The reﬂections at q = 1.18 and 2.36 nm-1 correspond to the ﬁrst and second 
order diffraction peaks of a lamellar phase with a periodicity of 5.3 nm (SPP).  The 
two reﬂections at 1.87 and 3.74 nm-1 reveal the presence of crystalline cholesterol in 
separate domains. 
Figure 2 - Free fatty acids promote the formation 
of the LPP in CHOL:synthCER II1 mixtures. The inset 
shows a magniﬁcation of the reﬂections in the q-
range between 2 and 4 nm-1. The Arabic and Roman 
numbers indicate the diffraction orders of the LPP 
and SPP, respectively. The asterisk (*) indicates the 
reﬂections of crystalline cholesterol located at 1.87 
and 3.74 nm-1. The letter A refers to the reﬂections 
of the additional phase with a repeat distance of 
7.1 nm present in the absence of free fatty acids (q 
= 0.89, 1.77 and 3.57 nm-1). The various orders of 
the LPP are located at q = 0.52 nm-1 (1), 1.03 nm-1 
(2), 1.56 nm-1 (3), 2.08 nm-1 (4) and 3.09 nm-1 (6).  
The various orders of the SPP are located at q = 
1.18 nm-1 (I) and 2.36 (II).
In the absence of free fatty acids, three major changes are observed in the 
diffraction pattern: (i) The reﬂections attributed to the LPP markedly reduce in intensity. 
In addition, an increased peak width is observed, indicating a reduced ordering of the 
lipids within the LPP. (ii) Three reﬂections at 0.89, 1.77 and 3.57 nm-1 reveal the 
presence of a phase with a repeat distance of 7.1 nm. The exact composition and 
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nature of this phase is not known. (iii) The broad reﬂection at 1.30 nm-1 might be 
ascribed to the SPP with a reduced periodicity of 4.8 nm. However, no higher order 
reﬂections can be detected, which makes the interpretation uncertain.
3.2 Substitution of CER1 with CER9 in equimolar CHOL:synthCER II:FFA 
mixtures 
 To investigate whether an additional hydroxyl group at the sphingoid head group 
of CER1 inﬂuences the formation of the LPP, mixtures were prepared in which CER1 
was gradually substituted with CER9, thereby maintaining the molar ratio between the 
remaining synthetic ceramides constant. The lipid organisation in mixtures prepared 
with 10% CER1 and 5% CER9 (synthCER II2) and vice versa (synthCER II3) closely 
resembles that obtained with the mixture prepared with 15% CER1 only (synthCER II1). 
Five diffraction peaks indicate the presence of the LPP, whereas the SPP is identiﬁed 
by three equidistant peaks.
Figure 3 - Inﬂuence of acylceramide type on the lamellar lipid organisation. (A) Partial substitution 
of CER1 with CER9 does not affect the lipid organisation in equimolar CHOL:synthCER:FFA mixtures, 
whereas complete substitution inhibits the formation of the LPP. The arrow indicates the increased peak 
width at half maximum. (B) LPP is only present in acylceramide containing mixtures. The inset shows a 
magniﬁcation of the reﬂections in the q-range between 2 and 4 nm-1. The Arabic and Roman numbers 
indicate the diffraction orders of the LPP and SPP, respectively. The asterisk (*) indicates the reﬂections 
of crystalline cholesterol located at 1.87 and 3.74 nm-1. The various orders of the LPP are located at q = 
0.52 nm-1 (1), 1.03 nm-1 (2), 1.56 nm-1 (3) , 2.08 nm-1 (4) and  3.09 nm-1 (6).  The various orders of the 
SPP are located at q = 1.16 nm-1 (I), 2.36 (II) and 3.51 nm-1 (III). 
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In addition, two reﬂections indicate the presence of crystalline CHOL. The diffraction 
pattern of the mixture prepared with 5% CER1) and 10% CER9 (synthCER II3) is 
illustrated in Figure 3A. 
Complete substitution of CER1 with CER9 (synthCER II4) results in decreased 
relative intensities of the reﬂections attributed to the LPP as compared to those of 
the SPP (see Fig. 3A). In addition, a slightly increased peak width at half maximum 
of the LPP reﬂections is observed, which indicates a reduced ordering of the lipids. 
No reﬂections can be detected that might be ascribed to crystalline CER9 in separate 
domains [15]. As observed in previous studies [15, 20], the characteristic LPP is not 
present in mixtures prepared in the absence of any acylceramide (synthCER II5). 
Instead, three strong reﬂections indicate the presence of a 5.4 nm lamellar phase 
(SPP). In addition, crystalline cholesterol is present in the mixture (Fig. 3B). 
3.3 Effect of reducing the number of individual synthetic ceramides in 
equimolar CHOL:synthCER II:FFA mixtures
Mixtures prepared in the absence of CER4, CER6 or both (synthCER II6-8) were 
studied to elucidate the sensitivity of the lipid phase behaviour towards a reduction in 
the number of synthetic ceramide classes. The choice to exclude CER4 and CER6 from 
the mixture is based on the low relative amounts of these synthetic ceramides in the 
synthCER II mixture. In addition, one mixture was examined in which the amount of 
CER2 in the synthetic ceramide fraction was decreased to 50% of its original amount 
(synthCER II9).
Exclusion of CER4, CER6 or both from the synthetic ceramide mixtures does not 
affect the phase behaviour of the lipid mixtures (see Fig. 4; only the curve of the 
lipid mixture prepared with synthCER II8 is presented). Five equidistant peaks suggest 
the presence of the LPP (12.2 nm), whereas the SPP (5.4 nm) is indicated by three 
reﬂections. In addition, phase-separated cholesterol can be detected. The intensities 
of the reﬂections attributed to the LPP and SPP show high similarity to those observed 
in the equimolar CHOL:synthCER II1:FFA mixture. 
The diffraction pattern of the equimolar CHOL:synthCER II9:FFA mixture is also 
shown in Figure 4. A reduction in CER2 content to 25% does not affect the formation of 
the LPP and SPP. However, it results in the appearance of a weak reﬂection at q = 1.45 
nm-1. Although no higher order reﬂections can be detected, this reﬂection can most 
likely be attributed to a phase with a repeat distance of 4.3 nm, ascribed to crystalline 
CER3(C24) in separate domains [13, 20]. 
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3.4 Phase behaviour as a function of temperature
The lipid phase behaviour of the equimolar CHOL:synthCER II1:FFA mixture has 
been examined in the temperature range from 25 to 95°C (see Fig. 5A). Each curve 
represents the mean of the lipid phases, which are present during a temperature 
shift of 2°C. The diffraction pattern at 25°C reveals a number of reﬂections that can 
be ascribed to the presence of a LPP and SPP with periodicities of 12.2 and 5.4 nm, 
respectively (similarly as described in Fig. 2). Between 25 and 55°C, no signiﬁcant 
changes are observed in positions or intensities of the LPP and SPP reﬂections. However, 
a further rise in temperature gradually decreases the peak intensities of the SPP, which 
eventually disappear at around 61°C. The reﬂections of the LPP disappear at around 
65°C, whereas the two reﬂections attributed to crystalline cholesterol disappear at 
approximately 53°C. 
At around 45°C a new phase is formed, of which only one reﬂection can be detected 
that gradually shifts to q = 1.37 nm-1 (repeat distance 4.6 nm) at 63°C. As its intensity 
drastically increases, it is the most prominent reﬂection in the diffraction pattern at 
elevated temperatures. Between 91°C and 93°C, however, the reﬂection disappears. 
3.5 Lateral packing of the lipids
A hexagonal lateral packing is characterised by a strong 0.41 nm reﬂection in the 
wide-angle X-ray diffraction pattern, whereas the diffraction pattern of an orthorhombic 
packing is characterised by two strong 0.41 and 0.37 nm reﬂections, located at q = 
15.40 and 17.12 nm-1, respectively. The diffraction pattern of the equimolar CHOL:
Figure 4 - No substantial change in LPP formation 
in equimolar CHOL:synthCER II:FFA mixtures in 
which CER4 and CER6 are absent or the amount of 
CER2 is decreased. The inset shows a magniﬁcation 
of the reﬂections in the q-range between 2 and 4 
nm-1. The Arabic and Roman numbers indicate the 
diffraction orders of the LPP and SPP, respectively. 
The asterisk (*) indicates the reﬂections of 
crystalline cholesterol located at 1.87 and 3.74 
nm-1, whereas the arrow indicates the reﬂection 
attributed to phase-separated CER3(C24) (q = 1.45 
nm-1). The various orders of the LPP are located at q 
= 0.52 nm-1 (1) , 1.03 nm-1 (2), 1.56 nm-1 (3) , 2.08 
nm-1 (4) and 3.09 nm-1 (6).  The various orders of 
the SPP are located at q = 1.17 nm-1 (I), 2.34 nm-1 
(II) and 3.51 nm-1 (III).
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synthCER II1:FFA mixture monitored as a function of temperature is plotted in Figure 
5B. The 0.408 and 0.367 nm peaks indicate an orthorhombic lateral packing. Between 
33 and 35°C, the 0.367 nm reﬂection disappears, indicative for an orthorhombic to a 
hexagonal phase transition. The 0.408 nm reﬂection initially decreases in intensity. 
However, a further rise in temperature slightly increases the intensity of the 0.408 
nm reﬂection, indicating a metastable to stable phase change. Similar results were 
obtained with isolated stratum corneum [Bouwstra J.A. and Gooris G.S., unpublished 
results]. A disappearance of this peak is observed at 65°C, which is at the same 
temperature at which the LPP disappears in the small-angle X-ray diffraction pattern. 
In addition, two reﬂections of crystalline cholesterol can be detected (q = 10.98 and 
16.58 nm-1), which both disappear at around 53°C. 
Figure 5 - Changes in the lipid phase behaviour as a function of temperature. (A) The lamellar organisation 
of equimolar CHOL:synthCER II1:FFA. (B) The lateral packing of CHOL:synthCER II1:FFA mixtures. The 
Arabic numbers indicate the diffraction orders of the LPP, whereas the Roman numbers indicate the 
diffraction orders of the SPP. The asterisk (*) indicates the reﬂections of crystalline cholesterol. The 
dashed lines represent the diffraction curves at 25, 35, 45, 55, 65, 75 and 85°C.
3.6 Relative intensities of the LPP reﬂections
The relative intensities of the various LPP reﬂections in six equimolar CHOL:
synthCER II1:FFA mixtures were determined in order to obtain information on the 
relative electron density distribution in the characteristic 12 nm lamellar phase. The 
results provided in Table 2 show that the relative intensities of the peaks attributed 
to the LPP show the same trend in equimolar CHOL:CER:FFA mixtures prepared with 
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either synthCER I, synthCER II1 or pig ceramides (pigCER). The values obtained with 
synthCER II1 mixtures resemble more closely those of pig ceramide mixtures than the 
synthCER I mixture (CER1:CER3:ΣCERIV in a 1:7:2 molar ratio).
Table 2 - Relative intensities of the diffraction peaks of the LPP in equimolar CHOL:synthCER II1:FFA 
mixtures, equimolar CHOL:synthCER I:FFA mixtures [13] and equimolar CHOL:pigCER mixtures [13].
order LPP CHOL:synthCER II1:FFA LPP CHOL:synthCER I:FFA LPP CHOL:pigCER:FFA
1 1.0 1.0 1.0
2 2.53 ± 0.15 2.94 ± 0.36 2.55 ± 0.28
3 0.50 ± 0.03 0.37 ± 0.06 0.81 ± 0.10
4 0.13 ± 0.02 0.15 ± 0.02 0.09 ± 0.01
6 0.02 ± 0.01 - 0.03 ± 001
7 - 0.04 ± 0.03 0.08 ± 0.03
For scaling, the intensity of the ﬁrst order diffraction peak of all phases was set equal to 1. The values are 
presented as the average (n=6) ± the standard deviation. Due to (partial) overlap with more prominent 
peaks in the diffraction pattern, the 6th and 7th order of the LPP could not always be determined in the 
synthCER I and synthCER II mixture, respectively. 
 
4. DISCUSSION
4.1 Lipid organisation in mixtures prepared with well-deﬁned synthetic 
ceramides
The results of the present study convincingly show that the lipid organisation in 
mixtures prepared with cholesterol, synthCER II and free fatty acids closely resembles 
that of natCER mixtures, as both the LPP and SPP are present and a small fraction 
of cholesterol phase separates into crystalline domains [10-12, 21]. Also at elevated 
temperatures many similarities can be observed in lipid phase behaviour between 
equimolar CHOL:CER:FFA mixtures containing synthCER II1 or natCER [10, 11]: (i) 
Between 33 and 35°C a phase transition from an orthorhombic to a hexagonal lateral 
packing occurs. (ii) The LPP and SPP disappear at around 65 and 61°C, respectively. 
(iii) At elevated temperatures, an additional phase is formed with a repeat distance 
of 4.6 nm (synthCERII1) or 4.3 nm (natCER). (iv) The hexagonal lateral packing 
disappears at 65°C, which is the same temperature at which the LPP disappears. This 
suggests that either an orthorhombic or a hexagonal lateral packing is a prerequisite 
for LPP formation, which conﬁrms the ﬁndings with natCER: when the fraction of lipids 
in a liquid phase is too high, the formation of the SPP is increased at the expense of 
the LPP [21]. 
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4.2 Inﬂuence of gradual substitution of CER1 with CER9 on LPP formation
CER1 promotes the formation of the LPP more efﬁciently than CER9, indicating 
that the additional hydroxyl group of CER9 and simultaneous loss of the 4,5 double 
bond (see Fig. 1) inhibits the formation of the LPP. When the diffraction patterns of 
the lipid mixtures containing either synthCER II or synthCER I [15] are compared, 
two important differences are noticed, namely (i) CER9 promotes the formation of the 
LPP more efﬁciently in the synthCER II mixtures than in the synthCER I mixtures. (ii) 
In the synthCER II mixtures the maximum solubility of CER9 in the lamellar phases 
is increased as compared to the synthCER I mixtures, as in the latter mixture CER9 
partially phase separates. Both observations illustrate that the lipid organisation in 
synthCER II mixtures, in which the overall head group variability is increased, is less 
sensitive to variations in the acylceramide head group architecture. Interestingly, in 
both synthCER mixtures partial substitution of CER1 with CER9 does not signiﬁcantly 
affect the lipid organisation.
4.3 Effect of diminishing the number of synthetic ceramides on phase 
behaviour
Exclusion of CER4 and CER6 from the synthCER II mixture (synthCER II8) changes 
the relative amounts of CER1, CER2, CER3(C24) and CER3(C16) to a 15:57:18:10 
molar ratio. The composition of the synthCER I fraction prepared with 15% CER1 is 
CER1, CER3(C24) and ΣCERIV in a 15:66:19 molar ratio. The ratio between the two 
most abundantly present acyl chain lengths in ΣCERIV is C24:C18 2:1. Therefore, the 
molar ratios of the various synthetic ceramides in synthCER II8 and synthCER I are very 
similar, with CER2 or CER3(C24) as the most abundantly present. Whereas extensive 
phase separation of CER3(C24) is observed in mixtures prepared with synthCER I, 
no additional phases attributed to CER2 can be detected in mixtures prepared with 
synthCER II. The difference between CER2 and CER3 is the presence of an additional 
hydroxyl group in CER3 and the simultaneous loss of the 4,5 double bond (see Fig. 
1). The additional hydroxyl group enables strong intermolecular head group hydrogen 
bonding, which is most likely the driving force for molecular organisation of CER3 in 
separate domains [22]. Striking is that in the synthCER II9 mixture, prepared with a 
relative CER2 content of 25%, a small reﬂection indicates the presence of a additional 
4.3 nm phase. This phase can be ascribed to crystalline CER3(C24) in a V-shaped 
structure [20, 23, 24] and its formation is caused by the increased relative amount of 
CER3(C24) in synthCER II9. In a previous study, in which the optimal CER3 to ΣCERIV 
122 Chapter 6
ratio for the formation of the LPP was established, phase separation of CER3 was also 
observed when the relative amount of CER3 increased [14].
4.4 Phase behaviour of natCER mixtures versus synthCER II mixtures
In spite of many similarities, also two differences in phase behaviour are observed 
between natCER mixtures and synthCER II mixtures. The ﬁrst difference is the slightly 
reduced repeat distance of the LPP in mixtures prepared with synthCER II1 as compared 
to mixtures prepared with natCER. The periodicity of the LPP in equimolar CHOL:natCER 
mixtures prepared with isolated human or pig ceramides is very similar, being 12.8 and 
12.2 nm, respectively [10, 11]. Addition of free fatty acids to those mixtures slightly 
increases the LPP periodicity from 12.8 and 12.2 nm to 13.0 and 13.3 nm, respectively. 
However, the repeat distance of the LPP in synthCER II or synthCER I mixtures is always 
approximately 12 nm, irrespective from the presence of free fatty acids. Although we 
may speculate this is related to differences in crystallinity or acyl chain length of the 
ceramides, further studies are required to unravel this phenomenon. 
Secondly, the results of the present study reveal that free fatty acids are required for 
proper lipid organisation in synthCER II mixtures, as in the equimolar CHOL:synthCER 
II1 mixture a marked reduction in the formation of the LPP is observed and an additional 
phase with a repeat distance of 7.1 nm is formed. This strongly suggests that free fatty 
acids with varying acyl chain lengths facilitate incorporation of the synthetic ceramides 
into the lamellar phases. The major difference between natCER and synthCER II is great 
variation in acyl chain length in natCER versus well-deﬁned chain length in synthCER 
II. The importance of chain length variation for proper LPP formation was already 
demonstrated in synthCER I mixtures by systematically increasing the relative amount 
of free fatty acids or by increasing the amount of ΣCERIV (chain length variation) at 
the expense of CER3 (uniform chain length). An increased relative amount of free 
fatty acids or ΣCERIV initially enhances the formation of the LPP. However, when the 
amount exceeds a certain optimal amount, the formation of the LPP is reduced and 
the SPP dominates. This suggests that for proper lipid organisation a certain optimal 
chain length variation should be present in the mixture, present in either the free fatty 
acids  or the synthetic ceramides. However, additional studies should be performed to 
further elucidate this.
In conclusion, the results of the present study demonstrate that one can generate 
lipid mixtures with well-deﬁned synthetic ceramides that closely mimic the lamellar and 
lateral organisation in native stratum corneum. As their composition can be accurately 
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chosen and modiﬁed, synthetic ceramide mixtures provide insight in the importance 
of molecular structure of individual ceramides in relation to the lipid organisation. 
Skin disorders are frequently characterised by a defective permeability barrier and an 
aberrant lipid proﬁle as compared to healthy skin. Synthetic ceramide mixtures are 
therefore an attractive tool to study in detail the effects of altered lipid composition on 
the lamellar and lateral lipid organisation.
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ABSTRACT
The intercellular stratum corneum (SC) lipids form the main barrier for diffusion of 
substances through the skin. A porous substrate covered with synthetic SC lipids would 
be an attractive model to study percutaneous penetration, thereby replacing native 
human SC. Prerequisite is that this stratum corneum substitute (SCS) is prepared with 
a uniform lipid composition and layer thickness. Furthermore, the lipid organisation and 
orientation should resemble that in SC. The objective of this study was to investigate 
the utility of an airbrush spraying device to prepare a SCS composed of cholesterol, 
ceramides and free fatty acids on a polycarbonate ﬁlter. The results demonstrate that a 
proper choice of solvent mixture and lipid concentration is crucial to achieve a uniform 
distribution of the lipids over the ﬁlter surface. A smooth and tightly packed lipid layer 
is only obtained when the equilibration conditions are appropriately chosen. The SCS 
possesses two crystalline lamellar phases with periodicities similar to those present 
in native SC. The orientation of these lamellae is mainly parallel to the surface of the 
polycarbonate ﬁlter, which resembles the orientation of the intercellular SC lipids. In 
conclusion, the airbrush technique enables generation of a homogeneous SCS, which 
ultimately may function as a predictive in vitro percutaneous penetration model.
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1. INTRODUCTION
The nonviable outermost layer of the skin, the stratum corneum (SC), serves 
as a penetration, dehydration and protection barrier against various environmental 
hazards. The SC consists of several layers of overlapping corneocytes, embedded in a 
lipid matrix of ordered lamellae. Despite their overall small percentage, the lipids in the 
SC represent the main barrier to diffusion of substances. These barrier properties are 
based on the unique composition and organisation of the intercellular lipid lamellae. 
Ceramides (CER), cholesterol (CHOL) and long-chain free fatty acids (FFA) are the 
major constituents of the intercellular lamellae [1-4], which are oriented approximately 
parallel to the surface of the corneocytes [5, 6]. These lipids are organised in two 
coexisting lamellar phases with periodicities of 6 nm (short periodicity phase: SPP) 
and 13 nm (long periodicity phase: LPP) [7-9]. In particular the LPP and the crystalline 
lateral packing are considered to play a crucial role for the skin barrier function. 
Recently, there has been an increased interest in drug administration via the skin 
for both local treatment of the diseased state (dermal delivery) as well as for systemic 
delivery (transdermal delivery). For this reason, the choice of predictive in vitro test 
models is important. The use of isolated epidermis or SC sheets from human or animal 
origin has a number of disadvantages, like high intra- and inter-individual variations 
and scarcity of the tissue, in particular diseased skin for which numerous topical drug 
products are designed. In addition, after 2009 there will be an EU-wide ban on the use 
of animal skin in the testing of cosmetic products. Our ultimate goal is to develop a 
novel skin barrier model, which can substitute for SC in diffusion studies. The stratum 
corneum substitute (SCS) consists of a porous substrate covered with speciﬁc synthetic 
SC lipids of uniform composition and layer thickness, mimicking the lipid organisation 
and orientation in SC. Such SCS may function as a standardised and predictive 
percutaneous penetration model and will therefore circumvent problems related to 
SC sheets isolated from human or animal skin. Another major advantage of the SCS 
is that the composition of the synthetic SC lipid mixtures can easily be modiﬁed. This 
allows studying the relation between lipid composition, lipid organisation and barrier 
function in one single model. As a result, important insights may be provided into the 
defective barrier function and altered SC lipid composition and organisation underlying 
various skin diseases [10-13]. Ultimately, a SCS may be prepared that mimics not 
only healthy, but also diseased and dry skin, for which there is currently no alternative 
screening system available.
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To mimic the SC barrier function, the SCS should meet the following requirements: 
(i) The lipids should spread homogeneously over the entire substrate surface. This is 
important for the formation of the characteristic LPP and the crystalline lateral packing 
[14-16]. (ii) The lipid layer should have a uniform thickness. Furthermore, cracks or 
holes should be absent, as these defects will disrupt the barrier properties. (iii) The 
orientation of the lamellae should be parallel to the substrate surface, which mimics 
the situation in native SC. (iv) The lipids should be organised in the LPP and SPP with 
an orthorhombic lateral packing, similarly as observed in SC.
In previous studies we have already demonstrated that the unique SC lipid 
organisation, including the 13 nm lamellar phase, can be reproduced in vitro with 
mixtures based on cholesterol, free fatty acids and synthetic ceramides (synthCER), 
provided that the lipid composition and equilibration temperature are appropriately 
chosen [17-19]. The objective of the present study was to explore the possibility of 
preparing a SCS with an airbrush. This was performed by spraying equimolar mixtures 
of cholesterol, synthetic ceramides and free fatty acids onto a polycarbonate ﬁlter. The 
SCS was subsequently characterised in terms of distribution of the lipid classes over 
the substrate surface, homogeneity of the lipid layer and orientation and organisation 
of the lipid lamellae. For these purposes, high performance thin layer chromatography, 
cryo-scanning electron microscopy, small-angle and wide-angle X-ray diffraction were 
used.
2. MATERIALS AND METHODS
2.1 Materials 
CER1(C30)-linoleate, CER2(C24), CER3(C24), CER3(C16), CER4(C24) and 
CER6(C24) were generously provided by Cosmoferm B.V. (Delft, the Netherlands). 
Palmitic acid, stearic acid, arachidic acid, behenic acid, tricosanoic acid, lignoceric 
acid, cerotic acid and cholesterol were purchased from Sigma-Aldrich Chemie GmbH 
(Schnelldorf, Germany). Nuclepore polycarbonate ﬁlter disks (pore size 50 nm) were 
purchased from Whatman (Kent, UK). All organic solvents used were of analytical 
grade and manufactured by Labscan Ltd (Dublin, Ireland). All other chemicals were of 
analytical grade and the water used was of Millipore quality. 
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2.2. Preparation of the SCS
For the preparation of the synthCER mixture, CER1, CER2, CER3(C24), CER4, 
CER3(C16) and CER6 were mixed in a 15:51:16:4:9:5 molar ratio, which resembles 
the composition of the ceramides in pig SC [14, 20]. For the preparation of the free 
fatty acids mixtures, the following fatty acid mixture was used: C16:0, C18:0, C20:0, 
C22:0, C23:0, C24:0 and C26:0 at molar ratios of 1.3, 3.3, 6.7, 41.7, 5.4, 36.8 and 4.7, 
respectively. This is similar to the free fatty acids composition in SC [21]. Appropriate 
amounts of individual lipids dissolved in chloroform:methanol (2:1) were combined 
to yield lipid mixtures at the desired equimolar CHOL:synthCER:FFA composition. 
After evaporation of the organic solvent under a stream of nitrogen, the lipid mixtures 
were re-dissolved in either hexane:isopropanol (3:2), methanol:ethylacetate (2:1), or 
hexane:ethanol (2:1) at a total lipid concentration of  2 or 4.5 mg/ml.  
An evolution solo airbrush (Airbrush Service Almere, The Netherlands) connected 
to gaseous nitrogen was used to spray the lipid mixtures onto a polycarbonate ﬁlter 
disk with a pore size of 50 nm. A schematic representation of the application set-up is 
illustrated in Figure 1.
Figure 1 - A schematic representation of the airbrush. During the spraying period, the trigger of the 
airbrush is opened pneumatically by a bar (indicated with an arrow). After the spraying period, the air 
pressure drops, the bar goes down, the trigger is closed and the liquid supply immediately stops.
Brieﬂy, the porous substrate was mounted in a holder and ﬁxed under the airbrush, 
which was constructed vertically with the nozzle facing downwards. The reservoir of 
the airbrush was subsequently ﬁlled with the lipid solution. The device enables us to 
control: (i) The spraying period. During the spraying period, the trigger is opened 
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pneumatically for a certain adjustable time period, during which a small fraction of 
the lipid solution passes the nozzle. Due to this nitrogen pressure, the lipid solution 
is sprayed in very small droplets onto the porous substrate. The distance over which 
the trigger is opened can be adjusted accurately with a micrometer screw. (ii) The 
drying period, which follows the spraying period. During the drying stage, the trigger is 
closed, the organic solvent evaporates by the nitrogen ﬂow and the lipids attach to the 
substrate. To ensure proper spreading of the lipids, the nitrogen pressure during the 
spraying and the drying stage can be regulated independently. This has been achieved 
by making use of an air valve, which assures a high pressure during spraying and a low 
pressure during drying. (iii) Multiple application. The number of spraying and drying 
cycles is adjustable to obtain the required layer thickness. Prior to the spraying stage, 
the nitrogen pressure is increased to levels required for appropriate spraying. The 
used equipment settings are listed in Table 1. After preparation, the lipid-loaded ﬁlters 
were equilibrated at 70°C, for a period of 10 minutes. If required, hydration of the lipid 
membranes was performed by applying an excess of an acetate buffer of pH 5.0 after 
the equilibration step.
Table 1 - Equipment settings used for spraying of the SCS. 
parameter setting
pressure during spraying (above atmospheric pressure) 1.16 bar
time trigger open 1 sec
distance over which the trigger is opened 5.5 mm
pressure during drying (above atmospheric pressure) 160 mbar
time trigger closed 15 sec
distance between the nozzle and the ﬁlter 4.5 cm
2.3 Lipid distribution
One dimensional high performance thin layer chromatography was used to establish 
the distribution of the various lipid classes over the ﬁlter surface. Brieﬂy, the lipid-
loaded ﬁlters were cut into two circular parts: the centre (diameter 4 mm; area 12.6 
mm2) and the periphery (diameter 9 mm; area 51.0 mm2). The lipids were extracted 
in 0.5 ml chloroform:methanol (2:1) by extensive vortexing and were subsequently 
re-dissolved in ratios according to the surface area. Aliquots were applied on a silica 
plate (Merck, Darmstad, Germany) under a ﬂow of nitrogen using a Camag Linomat IV 
(CAMAG, Muttenz, Switzerland). After eluting with different organic solvent mixtures 
[22], the silica plate was sprayed with copper sulphate. After charring, the intensities 
of the lipid bands were determined using a photodensiometer with automatic peak 
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integration (Biorad GS 710, Hercules, USA). 
2.4 Homogeneity of lipid layer
Cryo-scanning electron microscopy was used to establish the compactness of 
the lipid layer of lipid membranes that were (i) equilibrated and hydrated, (ii) not 
equilibrated and not hydrated, (iii) equilibrated but not hydrated, or (iv) equilibrated 
and cooled to room temperature prior to hydration. Prior to processing the specimens 
for cryo-scanning electron microscopy, hydrated lipid membranes were all exposed to 
the buffer solution for at least 24 hours. Subsequently, the lipid-loaded ﬁlters were cut 
into sheets of 1.5 x 2 mm2, folded and ﬁxed in a small copper “shoe-nail” using Tissue-
Tek O.C.T. Compound (Miles Inc. Elkhart, IN USA). The samples were then quickly 
frozen by plunge-freezing (Reichert Jung-KF80, Vienna, Austria) into liquid propane at 
–180°C. The frozen specimens were kept in liquid nitrogen until they were mounted 
into a sample holder. The cryo-ﬁxed samples were planed in a cryo ultramicrotome 
(Leica Ultracut UCT/Leica EM FCS, Wetzlar, Germany), using a specimen temperature 
of –90°C and a knife temperature of –100°C [23]. Subsequently, the samples were 
vacuum dried for 3 min at –90°C at 0.1 Pa to obtain contrast and sputtered with a layer 
of platinum (CT 1500 HF, Oxford Instruments, UK). After transferring the specimens 
into the ﬁeld emission scanning electron microscope (Jeol 6400F, Tokyo, Japan), the 
samples were analysed at -190°C. At least 5 electron micrographs were taken from 
each lipid-loaded ﬁlter and at least 2 lipid-loaded ﬁlters were prepared and visualised 
per condition.
2.5 Correlation between the layer thickness and quantity of lipid material
To establish the correlation between the quantity of lipid material and the resulting 
layer thickness, ﬁlters were covered with approximately 0.5, 0.8, 1.2 and 1.5 mg/cm2 
of lipid material and were subsequently equilibrated. Three lipid-loaded ﬁlters were 
prepared and examined per experimental condition. Brieﬂy, circular lipid-loaded ﬁlter 
pieces (diameter 6 mm; area 12.6 mm2) were cut into two equally sized parts. One 
part was dissolved in 100 µl chloroform/methanol (2:1) and the lipids were extracted 
by extensive vortexing. After evaporation of the organic solvent, the amount of lipids 
was determined by weighing. The other part was used for cryo-scanning electron 
microscopy to establish the thickness and compactness of the lipid layer. At least 4 
microscopic images were taken from each lipid-loaded ﬁlter. At equal distances of 20 
µm along the cutting plane, the thickness of the cross section of each lipid layer was 
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determined by establishing the pixel position of the top and bottom of the lipid layer in 
proportion to that of the magniﬁcation bar that is present in each micrograph.
2.6 Orientation and organisation of lipid lamellae 
Small-angle X-ray diffraction was used to acquire information about the lamellar 
organisation (i.e. the repeat distance of a lamellar phase) and the orientation of the 
lamellae. The scattering intensity I (in arbitrary units) was measured as a function 
of the scattering vector q (in reciprocal nm). The latter is deﬁned as q=(4�sinθ)/λ, in 
which θ is the scattering angle and λ is the wavelength. From the positions of a series of 
equidistant peaks (qn), the periodicity, or d-spacing, of a lamellar phase was calculated 
using the equation qn=2n�/d, n being the order number of the diffraction peak. A 
preferred orientation of the lamellae parallel to the substrate surface is indicated by 
small arcs on the detection plane with a maximum intensity at the meridian, whereas 
disoriented lamellae result in full rings of equal intensity.
All measurements were performed at the European Synchrotron Radiation Facility 
(ESRF, Grenoble), using station BM26B [24]. The X-ray wavelength and the sample-to-
detector distance were 1.24Å and 1.7m, respectively. Diffraction data were collected 
on a two-dimensional multiwire gas-ﬁlled area detector. The spatial calibration of this 
detector was performed using silver behenate. A ﬁlter with lipid layers was mounted 
parallel to the primary beam in a temperature-controlled sample holder with mica 
windows. Static diffraction patterns were obtained at room temperature for a period 
of 5 minutes. The temperature-induced phase changes were investigated by collecting 
diffraction patterns, while the temperature of the sample was raised to 75°C at a rate 
of 2°/min. Each successive diffraction curve was collected for a period of one minute.
Wide-angle X-ray diffraction provides information about the lateral packing of the 
lipids within the lamellae. Data were collected on a microstrip gas chamber detector 
with an opening angle of 60° [25]. The sample-to-detector distance was 36 cm and 
the X-ray wavelength was 1.24Å. The spatial calibration of the detector was performed 
with a mixture of silicium and cholesterol. 
3. RESULTS
3.1 Lipid distribution 
Polycarbonate ﬁlters are not resistant towards chloroform. Therefore, three 
alternative organic solvent mixtures were selected to dissolve the lipids, namely 
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methanol:ethylacetate (M:EA), hexane:isopropanol (H:IPA) and hexane:ethanol (H:
Et). Filters were covered with approximately 0.25 mg/cm2 and 0.5 mg/cm2 of lipid 
material. Whereas the total amount of lipids applied on the ﬁlter does not have an effect 
on the distribution (data not shown), the solvent mixture and total lipid concentration 
markedly affect the lipid distribution, in particular that of cholesterol. Figure 2 shows 
the lipid distribution of the lipid subclasses between the ﬁlter centre and periphery, 
making use of the three organic solvent mixtures at a total lipid concentration of 4.5 
mg/ml. From the intensities of the bands it is obvious that an even distribution of 
cholesterol is only obtained when the lipids are dissolved in H:Et or M:EA. When H:
IPA is used as a solvent, the amount of cholesterol present at the ﬁlter periphery is 
nearly 6 to 8-fold higher than the amount present in the central part. With 2 mg/ml 
solutions an inhomogeneous distribution of the lipid classes is observed for all three 
solvent mixtures (data not shown), similarly as the distribution obtained with H:IPA at 
4.5 mg/ml solution. 
Although the distribution of the lipids from H:Et and M:EA solutions is comparable, 
a considerable improvement of the spraying process is obtained when the lipids are 
dissolved in H:Et. Moreover, the lipid loss during application is slightly lower, which can 
most likely be ascribed to the lower solubility of the lipids in M:EA in comparison to that 
in H:Et. For this reason, all further experiments were performed with lipid solutions in 
H:Et at a total lipid concentration of 4.5 mg/ml.
Figure 2 - Lipid distribution from three solvent mixtures at a total lipid concentration of 4.5 mg/ml. 1 = centre 
M/EA; 2 = periphery M/EA; 3 = centre H/IPA; 4 = periphery H/IPA; 5 = centre H/Et; 6 = periphery H/Et.
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3.2 Compactness of the lipid layer 
Figure 3A shows an electron micrograph of a cross-section of a lipid membrane and 
the underlying polycarbonate ﬁlter, equilibrated at 70°C and subsequently hydrated 
with an acetate buffer. It can be clearly observed that this procedure, which is routinely 
used to obtain proper lipid organisation in synthetic lipid mixtures for X-ray diffraction 
measurements, results in the formation of large holes in the lipid layer. To elucidate 
whether the holes are caused by the elevated temperature during equilibration or by 
the successive addition of the acetate buffer, ﬁlters were covered with approximately 
0.5 mg/cm2 of lipid material and the lipid membranes were either i) not equilibrated 
and not hydrated (Fig. 3B), ii) equilibrated but not hydrated (Fig. 3C), or iii) equilibrated 
and cooled to room temperature prior to hydration (Fig. 3D). 
Figure 3 - Cryo-scanning electron microscopy photographs of cross-sections of lipid membranes (LM) 
and underlying porous substrates (PS). (A) lipid membrane that was equilibrated and hydrated (large 
open structures (OS) can be observed in the lipid layer). (B) lipid membrane that was not equilibrated 
and not hydrated. (C) lipid membrane that was equilibrated, but not hydrated. The detachment of the 
lipid layer from the polycarbonate ﬁlter is most likely an artefact, which arose during the preparation 
of this specimen for electron microscopy. (D) lipid membrane that was equilibrated and cooled to room 
temperature prior to hydration (lower magniﬁcation).
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The results indicate that when the buffer is applied directly after the equilibration 
step, it is able to penetrate the lipid membrane, where it phase separates to form 
water-rich domains. Because the samples were vacuum dried for a short period prior 
to visualisation, the water-rich domains are consequently visible as holes in the lipid 
layer. 
No signiﬁcant differences can be observed between the lipid membranes presented 
in Figure 3B-3D. All preparation methods result in the formation of a tightly packed 
lipid layer in the absence of large open structures. In addition, no lipid material is 
present inside the pores or at the bottom side of the ﬁlter. From Figure 3D, in which 
a lower magniﬁcation of the lipid membrane and the underlying ﬁlter is presented, it 
can further be deduced that also over a larger surface area the lipid membranes have 
a uniform layer thickness. 
3.3 Correlation between layer thickness and quantity of lipid material
Figure 4A demonstrates that an almost linear relationship exists between the layer 
thickness and the quantity of lipid material of individual lipid membranes (correlation 
coefﬁcient = 0.98). The layer thickness of each individual lipid membrane as well as 
the quantity of lipid material applied per ﬁlter is highly reproducible and only slightly 
ﬂuctuates with steady relative standard deviations of 10% and 5%, respectively. 
From the slope of the line in Figure 4B, in which the average layer thickness is 
plotted against the number of sprays required to obtain that particular layer thickness, 
it can be observed that approximately 0.14 µm of lipid material is applied onto the 
ﬁlter per spray. 
Figure 4 - The correlation between the layer thickness and quantity of lipid material (A) and the correlation 
between the average layer thickness and the number of sprays (B).
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3.4 Orientation and organisation
Figure 5A shows a typical two-dimensional X-ray diffraction pattern of a non-hydrated 
lipid membrane. The arcs on the detection plane, having a maximum intensity at the 
meridian, indicate a preferred orientation of the lamellae parallel to the polycarbonate 
ﬁlter. Sector integration (angle 60°) resulted in Figure 5B, in which the intensity of the 
arcs is plotted versus the scattering vector q. The LPP with a repeat distance of 12.2 
nm is indicated by the presence of ﬁve reﬂections (q = 0.52, 1.03, 1.54, 2.06 and 
3.08 nm-1). The reﬂections at q = 1.18, 2.36 and 3.53 nm-1 correspond to the ﬁrst, 
second and third order diffraction peaks of a lamellar phase with a periodicity of 5.4 
nm (SPP). The presence of crystalline cholesterol in separate domains can be deduced 
from the peaks at 1.86 and 3.72 nm-1. No signiﬁcant differences in the orientation 
or lamellar organisation could be observed between hydrated and non-hydrated lipid 
membranes.
Figure 5 - The orientation (A) and lamellar organisation (A and B) of a non-hydrated lipid membrane. 
The inset shows a magniﬁcation of the reﬂections in the q-range between 2 and 4 nm-1. The Arabic and 
Roman numbers indicate the diffraction orders of the LPP and SPP, respectively. The asterisk (*) indicates 
the reﬂections of crystalline cholesterol located at 1.87 and 3.74 nm-1. The various orders of the LPP are 
located at q = 0.52 nm-1 (1) , 1.03 nm-1 (2), 1.54 nm-1 (3) , 2.06 nm-1 (4) and 3.08 nm-1 (6).  The various 
orders of the SPP are located at q = 1.18 nm-1 (I) and 2.36 nm-1 (II) and 3.53 nm-1 (III).
The lamellar and lateral lipid phase behaviour of the non-hydrated and hydrated 
lipid membranes was also studied as a function of temperature (Fig. 6A-D). Each curve 
represents the mean of the lipid phases present during a temperature shift of 2°C. The 
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diffraction patterns illustrated in Figure 6A (non-hydrated lipid membranes) and Figure 
6B (hydrated lipid membranes) reveal a number of reﬂections that can be ascribed to the 
presence of the LPP (12.2 nm) and SPP (5.4 nm), similarly as described in Figure 5. In 
addition, crystalline cholesterol is present in separate domains. No signiﬁcant changes 
are observed in the intensities or positions of the reﬂections of the phases between 25 
and 51°C. However, the reﬂections of the LPP disappear at around 65°C. Despite these 
similarities, two differences in the lamellar organisation are observed between non-
hydrated and hydrated lipid membranes. Firstly, in hydrated lipid membranes the two 
reﬂections attributed to crystalline cholesterol disappear at around 57°C, whereas in 
non-hydrated lipid membranes it is reproducibly observed that the cholesterol reﬂections 
disappear only at approximately 73°C. Secondly, in hydrated lipid membranes the 
reﬂections of the SPP disappear at around 51°C. In the same temperature range, a 
new phase is formed, of which only one reﬂection can be detected that gradually shifts 
to q = 1.37 nm-1 (repeat distance 4.6 nm). In non-hydrated lipid membranes, however, 
the reﬂections of the SPP do not disappear at elevated temperatures and in addition 
no additional phase with a repeat distance of 4.6 nm is formed. Previous studies 
performed with mixtures based on isolated ceramides have shown that the formation 
of the additional phase at elevated temperatures is strongly related to the amount of 
cholesterol that is available for the formation of this phase [26]. For hydrated lipid 
membranes it can be observed that the formation of the additional 4.6 nm phase is in 
the same temperature region in which the reﬂections of phase-separated cholesterol 
disappear. The cholesterol reﬂections in non-hydrated lipid mixtures disappear at a 
much higher temperature than in hydrated lipid membranes. Hence the amount of 
available cholesterol is most likely insufﬁcient for the formation of the 4.6 nm phase. 
In isolated human SC the formation of this additional phase at elevated temperatures 
is also hardly ever observed [26], which once again demonstrates the high similarity in 
lipid phase behaviour between SC and the SCS.
A hexagonal lateral packing is characterised by a strong 0.41 nm reﬂection in the 
wide-angle X-ray diffraction pattern, whereas the diffraction pattern of an orthorhombic 
packing is characterised by two strong 0.41 and 0.37 nm reﬂections. The diffraction 
patterns of non-hydrated and hydrated lipid membranes monitored as a function 
of temperature are plotted in Figure 6C and Figure 6D, respectively. Figure 6E, in 
which the diffraction pattern of isolated human SC as a function of temperature is 
illustrated, serves as a control. Both non-hydrated and hydrated lipid membranes show 
similar behaviour as isolated human SC. The 0.408 and 0.367 nm peaks indicate an 
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Figure 6 - Temperature-induced changes in (A) the lamellar lipid organisation of a non-hydrated 
lipid membrane, (B) the lamellar lipid organisation of a hydrated lipid membrane, (C) the lateral lipid 
organisation of a non-hydrated lipid membrane, (D) the lateral lipid organisation of a hydrated lipid 
membrane, and (E) the lateral lipid organisation of isolated human SC. The Arabic and Roman numbers 
indicate the diffraction orders of the LPP and SPP, respectively. The asterisk (*) indicates the reﬂections 
of crystalline cholesterol. The dashed lines represent the diffraction curves at 25, 35, 45, 55, 65, and 
75°C. 
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orthorhombic lateral packing. At around 33°C, the 0.367 nm reﬂection disappears, 
indicating an orthorhombic to a hexagonal phase transition. The 0.408 nm reﬂection 
initially decreases in intensity. However, a further rise in temperature slightly increases 
the intensity of the 0.408 nm reﬂection, indicating a metastable to stable phase change. 
This phenomenon is also observed in the diffraction patterns of SC (see Fig. 6E). A 
disappearance of this peak is observed at 65°C, which is in the same temperature 
range at which the LPP disappears in the small-angle X-ray diffraction patterns. 
4. DISCUSSION
The objective of the present study was to evaluate the possibility of preparing a 
SCS, which closely resembles the composition, organisation and orientation of the 
intercellular lipids in SC. As the resulting SCS may ultimately function as a percutaneous 
penetration model, it is further important that the lipids of the SCS are tightly packed 
and have a uniform layer thickness. These various aspects are discussed below.
4.1 Uniform lipid distribution
The results of the present study show that both the organic solvent mixture and 
the total lipid concentration are important determinants for successful preparation of a 
SCS of uniform lipid composition. It should be stressed, however, that the equipment 
settings used for the preparation of the SCS are at least as important as the two 
aforementioned factors. The most critical parameters in this respect are the distance 
between the nozzle of the airbrush and the ﬁlter, the nitrogen pressure during the 
spraying and drying stage and the quantity of lipid solution that passes the nozzle per 
spray. One can state that the evaporation rate during the drying stage should balance 
the quantity of lipid solution that reaches the polycarbonate ﬁlter during the preceding 
spraying stage. 
When the process conditions were not optimally chosen, the evaporation process 
of the organic solvent occurred from the inside to the periphery and sometimes the 
lipid solution itself was even blown to the ﬁlter periphery. The latter phenomenon was 
speciﬁcally observed when the nitrogen pressure during the drying stage was set too 
high or when the evaporation velocity was too slow for the supply of lipid solution (e.g. 
by preparing lipid solutions at a total lipid concentration of 2 mg/ml). In either case, 
cholesterol was mainly present at the periphery of the lipid membrane, whereas the 
central part hardly contained any cholesterol (see also Fig. 2). 
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The solubility of cholesterol in the organic solvent mixtures is higher than that of the 
synthetic ceramides and free fatty acids. During the evaporation process of the organic 
solvent, the concentration of the lipids increases and the lipids crystallise according to 
their solubility. Cholesterol therefore remains in solution up to the edges of the lipid 
membrane. Interestingly, this could sometimes even be visually observed by a small 
band of crystals. On the other hand, when the supply of lipid solution was set too low, 
most of the organic solvent already evaporated before the lipid solution reached the 
ﬁlter. Due to substantial lipid loss, only a small area of the ﬁlter could be covered with 
lipid material. 
4.2 Compactness of the lipid layer
The airbrush spraying technique results in the formation of smooth and tightly 
packed lipid membranes, provided that the hydration step, which immediately follows 
the equilibration step, is omitted. As demonstrated by the X-ray diffraction data, 
omission of the hydration step does not affect the lamellar or lateral lipid organisation. 
It has to be kept in mind, however, that during a diffusion experiment, non-hydrated 
lipid membranes will be exposed to a donor and an acceptor solution. In order to 
guarantee proper barrier function, it is necessary that the SCS remains intact under 
those conditions. Preliminary studies indicate that the SCS remains intact for several 
hours during diffusion experiments. 
The results of the present study demonstrate that lipid membranes that are ﬁrst 
cooled to room temperature prior to hydration do not possess large holes, indicating 
that no water pools are formed in the lipid membranes at room temperature. This 
ﬁnding is crucial, as these defects would disrupt the barrier properties of the SCS. 
For preparation of a homogeneous SCS it is further important that the lipid layer is 
only present on top of the ﬁlter and not inside the pores of the ﬁlter. Filled or partially 
ﬁlled pores are easily recognisable by the fact that pores are not at all visible over the 
entire length of the ﬁlter, up to a certain depth. However, electron microscopy studies 
on lipid membranes prepared at the optimal equipment settings evidently demonstrate 
that the lipids are able to span the pores of the supporting membrane, as no lipid 
material is present inside the pores or at the bottom side of the ﬁlter. The results further 
demonstrate that a uniform layer thickness and penetration pathway for substances 
can be obtained and established. This will considerably facilitate the interpretation of 
future diffusion results.
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4.3 Orientation of the lipid lamellae
The orientation of the lipid lamellae in the lipid membranes is parallel to the surface 
of the hydrophilic polycarbonate ﬁlter. From the width of the arcs, however, it cannot 
be excluded that some disorientation exists. Previous X-ray diffraction measurements 
on isolated human SC reveal that the orientation of the intercellular lamellae is also 
not exactly parallel to the skin surface [Bouwstra J.A., Gooris, G.S, unpublished data]. 
The width of the arcs of the SCS approximates that of SC rather closely, indicating that 
the synthetic lipids in the SCS resemble the orientation of the intercellular lipids in the 
SC. In vivo, the monolayer of covalently bound lipids surrounding each corneocyte is 
often suggested to serve as a template in the assembly of the multilamellar structures 
parallel to the corneocyte surface [27]. The SCS is solely composed of synthetic SC 
lipids and does not contain any corneocytes. Nonetheless, the orientation of the lipid 
lamellae is found to be mainly parallel to the ﬁlter surface, which suggests that one 
lipid layer forms a template for the next layer. Inspection of literature reveals that the 
airbrush has also been used successfully for the preparation of aligned samples of 
phospholipids [28, 29].
4.4 Lipid composition and organisation
Although the method of lipid analysis used in the present study did not allow the 
investigation of the lipid distribution as a function of depth, previous studies have 
shown that the lipid organisation is not extremely sensitive towards changes in the 
total CHOL:synthCER:FFA molar ratio [9, 30]. For this reason, small variations in the 
lipid composition will presumably not affect the lipid organisation to a high extent. 
The results of the present study reveal that the LPP (12.2 nm) and SPP (5.4 
nm) are both present in non-hydrated and hydrated lipid membranes. Moreover, 
an orthorhombic lateral packing of the lipids is observed in both non-hydrated and 
hydrated lipid membranes. This indicates that only the equilibration temperature and 
no hydration is important for proper lamellar and lateral lipid organisation. This ﬁnding 
is of crucial importance, as only in non-hydrated lipid membranes the lipid layer is 
tightly packed. The periodicities of the lamellar phases in hydrated and non-hydrated 
lipid membranes are exactly the same. This is in good agreement with previous X-
ray diffraction measurements on hydrated SC [7, 8] and lipid mixtures prepared with 
isolated ceramides [31] in which an increased hydration level did not result in signiﬁcant 
lamellar swelling. However, McIntosh et al. found that mixtures of isolated ceramides 
prepared in the absence of water are more sensitive to phase separation of cholesterol 
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than hydrated lipid mixtures of the same composition [31]. This may explain the 
small differences in the lamellar lipid organisation of non-hydrated and hydrated lipid 
membranes at elevated temperatures. Studies performed in our group revealed that 
only in the presence of a buffer the phase behaviour of mixtures prepared with isolated 
ceramides is similar to that in SC [de Jager, M.W., Gooris, G.S., Ponec, M. and Bouwstra 
J.A., unpublished data].
In conclusion, the present study has shown that the airbrush is an elegant 
apparatus to homogeneously spray reconstituted synthetic SC lipids onto a porous 
polycarbonate ﬁlter, provided that the experimental conditions used for spraying as 
well as for equilibration are appropriately chosen. As the SCS prepared in the present 
study has a uniform lipid layer thickness and further closely resemble the composition, 
organisation and orientation of the intercellular lipids in SC, they may have a great 
potential to ultimately serve as a novel skin barrier diffusion model. The barrier 
properties of the SCS will therefore be investigated in a future study.
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ABSTRACT
The objective of this study was to evaluate the utility of a stratum corneum substitute 
(SCS) as a novel in vitro percutaneous penetration model. The SCS consists of synthetic 
stratum corneum (SC) lipids (cholesterol, free fatty acids, and speciﬁc ceramides) 
applied onto a porous substrate. The composition, organisation and orientation of lipids 
in the SCS bear high resemblance to that of the intercellular barrier lipids in SC. The 
barrier integrity of the SCS was evaluated by means of passive diffusion studies, using 
three model compounds with different lipophilicities. The effects of lipid layer thickness, 
permeant lipophilicity and altered lipid composition on the barrier properties were 
investigated, using isolated human SC as a control. For all three model compounds 
the permeability characteristics of the SCS having a 12 µm thick lipid layer closely 
resemble those of human SC. Modiﬁcation of the lipid composition, generating a SCS 
that lacks the characteristic long periodicity phase as present in SC, was accompanied 
by a two-fold increased permeability. The SCS offers an attractive tool to predict solute 
permeation through human skin. Moreover, as its lipid composition can be modiﬁed, 
they may also serve as a suitable screening model for diseased skin. 
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1. INTRODUCTION
For many years, the delivery of drugs into and through the skin has been an 
important area for research. Due to the natural function of the skin, however, only a 
limited number of drugs are capable to cross the outer layer of the skin, the stratum 
corneum (SC). The SC consists of several layers of partially overlapping corneocytes, 
which are surrounded by a cell envelope and are embedded in a lipid matrix. Because of 
the highly impermeable character of the corniﬁed envelope, substances that penetrate 
the SC bypass the corneocytes and follow the tortuous intercellular pathway [1-3]. As 
a result, the SC lipids provide the actual barrier to the diffusion of substances through 
the skin. The lipid lamellae, which are oriented approximately parallel to the surface of 
the corneocytes [4, 5], are predominantly composed of ceramides, cholesterol and free 
fatty acids. It has been demonstrated that these stacks of crystalline lipid layers have 
repeating patterns of approximately 13 nm (long periodicity phase: LPP) and 6 nm 
(short periodicity phase: SPP), respectively [6-8]. In particular the LPP is considered 
to play a crucial role for proper skin barrier function. 
At present, the most common means to screen transdermal and dermal drug 
delivery systems is the use of epidermis or SC, isolated from excised human or animal 
skin. However, those studies are hampered by the scarcity of human tissue and high 
intra- and inter-individual variability of human and animal skin. Although animal skin 
is frequently used for permeation studies, its anatomical properties differ greatly from 
those of human skin. Due to the presence of numerous hair follicles and sebaceous 
glands, deviating composition and organisation of the intercellular SC lipids and SC 
thickness, skin permeability cannot always be predicted adequately when using animal 
skin [9-11]. Moreover, there will be an EU-wide ban on the use of animal skin in the 
testing of cosmetic products from 2009. 
The quest to circumvent these problems has prompted an extensive search for 
novel reliable in vitro penetration models. A few studies described the formation of 
model membranes by using lipids extracted from pig SC on a porous substrate [12, 
13]. However, such an approach does not obviate the variability of native tissue and the 
laborious and time-consuming isolation and separation of the SC lipids. Accordingly, 
membranes prepared with isolated ceramides cannot be used for large-scale screening 
studies. Model membranes have also been prepared with the commercially available 
bovine brain ceramide type III or IV [14-19]. Although the available information in 
literature about their use as a percutaneous penetration model is somewhat limited, 
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the transport of water and some permeants across those model membranes appear to 
be similar to that across SC [16-18]. However, it has been demonstrated that the lipid 
organisation in those lipid membranes does not resemble that of SC [19-21]. Moreover, 
no data on the orientation of the lamellae have been reported. 
Obviously, the skin lipid membranes reported in literature do not meet all 
requirements for a reliable in vitro screening system to substitute for SC in diffusion 
studies. In a previous study, we developed a method to reproducibly produce a stratum 
corneum substitute (SCS) composed of cholesterol, long-chain free fatty acids and 
speciﬁc synthetic ceramides on a porous substrate [22]. The SCS was characterised 
in terms of uniformity of the lipid layer, distribution of the various lipid classes over 
the substrate surface and the orientation and organisation of the lipid lamellae [22]. 
To the best of our knowledge, that was the ﬁrst study in which a SCS was prepared 
that resembles the composition, organisation and orientation of the intercellular lipid 
lamellae in SC.
The aim of the present study was to evaluate the barrier properties of this SCS and 
to explore the possibility of using it as a novel predictive in vitro skin barrier model. This 
was accomplished by means of passive diffusion studies, using ﬂow-through diffusion 
chambers, with p-aminobenzoic acid (PABA), ethyl-PABA and butyl-PABA as model 
compounds and isolated human SC as a control sample. PABA is the most hydrophilic 
compound and its lipophilicity increases with increasing ester chain length (see Table 1). 
We aimed to answer the following questions:
(i) What is the effect of layer thickness on the diffusion proﬁle?
(ii) What is the effect of permeant lipophilicity on the diffusion proﬁle?
(iii) Is the presence of the LPP crucial for a proper permeability barrier?
2. MATERIALS AND METHODS
2.1 Materials
CER(EOS)C30, CER(NS)C24, CER(NP)C24, CER(NP)C16, CER(AS)C24 and 
CER(AP)C24 were generously provided by Cosmoferm B.V. (Delft, the Netherlands). 
The ceramides are composed of a long-chain sphingosine (S) or phytosphingosine (P) 
base with variations in the position and number of hydroxyl groups and double bonds. 
Through amide bonding, long-chain nonhydroxy (N) or α-hydroxy fatty acids (A) with 
a uniform acyl chain length (24 or 16 hydrocarbon atoms) are linked to the sphingoid 
bases. The exception is CER(EOS), which contains an ω-hydroxy fatty acid with a chain 
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length of 30–32 carbon atoms to which linoleic acid is linked  (EO) [23].
Para-aminobenzoic acid (PABA), ethyl-PABA and butyl-PABA, trypsin (type III, 
from bovine pancreas) and trypsin inhibitor (Type II-S from soybean) were purchased 
from Sigma-Aldrich (Zwijndrecht, The Netherlands). Dialysis membrane disks (cut 
off value of 5000 Da) were purchased from Diachema (Munich, Germany). Nuclepore 
polycarbonate ﬁlter disks (pore size 50 nm) were purchased from Whatman (Kent, UK). 
All organic solvents used were of analytical grade and manufactured by Labscan Ltd 
(Dublin, Ireland). All other chemicals were of analytical grade. All aqueous solutions 
were prepared with Millipore water (Billerica, MA, USA).
2.2 Isolation of SC from human skin
SC was isolated from abdominal or mammary skin, which was obtained within 24 
hours after cosmetic surgery. After removal of the subcutaneous fat tissue, the skin 
was dermatomed to a thickness of approximately 250 µm using a Padgett Electro 
Dermatome Model B (Kansas City, KS, USA). The SC was separated from the epidermis 
by trypsin digestion (0.1% in phosphate buffered saline pH 7.4), after overnight 
incubation at 4°C and subsequently at 37°C for 1 h. The SC was then placed in a 0.1 
% solution of trypsin inhibitor and rinsed twice with Millipore water. Until use, the SC 
was stored in a silica containing box under gaseous nitrogen in the dark to prevent 
oxidation of the intercellular SC lipids.
2.3 Preparation of SCS
The components for the synthetic ceramide mixtures were CER(EOS), 
CER(NS)C24, CER(NP)C24, CER(AS)C24, CER(NP)C16 and CER(AP)C24 in a molar ratio 
15:51:16:4:9:5 [22, 24]. This lipid composition resembles the ceramide composition 
in pig SC [25]. For the preparation of the free fatty acids mixtures, the following fatty 
acids were used: C16:0, C18:0, C20:0, C22:0, C23:0, C24:0 and C26:0 at molar 
ratios of 1.3, 3.3, 6.7, 41.7, 5.4, 36.8 and 4.7, respectively. This is similar to the 
composition of the free fatty acids in SC [26]. Appropriate amounts of individual lipids 
dissolved in chloroform:methanol (2:1) were combined to yield lipid mixtures at the 
desired equimolar composition of cholesterol, synthetic ceramides and free fatty acids. 
After evaporation of the organic solvent under a stream of nitrogen, the lipid mixtures 
were re-dissolved in hexane:ethanol (2:1) at a total lipid concentration of 4.5 mg/ml. 
An evolution solo airbrush (Airbrush Service Almere, The Netherlands) was used to 
spray the lipid mixtures onto a polycarbonate ﬁlter disk with a pore size of 50 nm. 
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Brieﬂy, the substrate was mounted in a holder and ﬁxed under the airbrush, which was 
constructed vertically with the nozzle facing downwards. The reservoir of the airbrush 
was subsequently ﬁlled with lipid solution. During the spraying period, the trigger of the 
airbrush was opened pneumatically for a certain adjustable time period, during which a 
small fraction of the lipid solution passed the nozzle. Due to this nitrogen pressure, the 
lipid solution was sprayed in very small droplets onto the porous substrate. During the 
drying stage, the trigger was closed, the organic solvent evaporated by the nitrogen 
ﬂow and the lipids attached to the substrate. The number of spraying and drying cycles 
was adjustable to obtain the required layer thickness. The lipid-loaded ﬁlters were held 
at 70°C for 10 minutes and subsequently cooled to room temperature, after which the 
lipid organisation closely resembles that in human SC [22].
2.4 Diffusion studies
In vitro permeation studies were performed using Permegear in-line diffusion cells 
(Bethlehem, PA, USA) with a diffusion area of 0.28 cm2. SC on a dialysis supporting 
membrane (apical side facing the donor chamber) or the SCS was mounted in the 
diffusion cell and was hydrated for 1h in phosphate buffered saline pH 7.4 prior to 
the experiment. The donor compartment was ﬁlled with 1280 µl of the drug solution 
in acetate buffer pH 5.0 at saturated concentrations to obtain equal thermodynamic 
activities. The acceptor compartment consisted of phosphate buffered saline pH 7.4, 
which was perfused at a ﬂow rate of about 2 ml/h. The exact volume per collected 
fraction was determined by weighing. Each experiment was performed under occlusive 
conditions, by closing the opening of the donor compartment with adhesive tape. The 
temperature of the SC or SCS was maintained at 32°C during the total length of the 
experiment, using a thermostated water bath. Fractions were collected for 20 hours 
at a 1-hour interval. At the end of each experiment, the recovery was determined 
according to the following equation:
Table 1 - Compounds used in the present study
PABA ethyl-PABA butyl-PABA
MW (g/mol) 137.1 165.2 193.2
LogPoct/H2O 0.58 1.44 2.61
Cd (mg/ml) 6.16 0.65 0.05
(amount penetrated + amount remaining in donor compartment)
initial amount in donor compartment
Recovery = x100%
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2.4.1 Inﬂuence of compound lipophilicity on the diffusion proﬁle across SC
Transport studies were performed across isolated human SC from 4 different 
donors. PABA, ethyl-PABA and butyl-PABA were used as model compounds (see Table 
1). Each experiment was performed with SC originating from 1 donor, using 6 diffusion 
cells (i.e. 2 cells were used per test compound). 
2.4.2 Inﬂuence of layer thickness on the diffusion proﬁle across SC
To assess the effect of the SC thickness on the diffusion proﬁle of ethyl-PABA, 
the diffusion was measured across i) a single SC sheet, ii) two SC sheets laid on top 
of each other or iii) three SC sheets placed on top of each other. Each experiment 
was performed with SC originating from 1 donor, using 6 diffusion cells (i.e. 2 cells 
were used per layer thickness). SC derived from 4 different donors was used per 
experimental condition. 
2.4.3 Inﬂuence of lipid layer thickness on the diffusion proﬁle across the SCS
Diffusion proﬁles of ethyl-PABA were measured across the SCS, that was prepared 
with 160, 230, 350 and 420 µg of lipid material in the diffusion area. Six lipid-loaded 
ﬁlters were prepared and used per condition.
2.4.4 Inﬂuence of compound lipophilicity on the diffusion proﬁle across the 
SCS
Transport studies were performed across lipid-loaded ﬁlters, covered with 
approximately 350 µg of lipid in the diffusion area. PABA, ethyl-PABA and butyl-PABA 
were used as model compounds. Each experiment was performed with 6 diffusion cells 
(i.e. 2 cells were used per compound). The experiment was performed in triplicate.
2.4.5 Inﬂuence of altered lipid composition on the diffusion proﬁle across the 
SCS 
Diffusion proﬁles of ethyl-PABA were measured across the SCS, prepared with two 
ceramide mixtures, either containing or not containing CER(EOS). Each experiment 
was performed with 6 diffusion cells. In 3 diffusion cells, the SCS that was prepared 
with ceramide mixtures lacking CER(EOS) was mounted, whereas the other 3 cells 
served as a control and contained the SCS prepared with ceramide mixtures containing 
CER(EOS). The experiment was performed in duplicate.
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2.5 HPLC analysis
The samples were analysed using a reverse-phase HPLC assay. The HPLC system 
consisted of a SP8810 LC pump (Spectra-Physics, California, USA) equipped with a 
Gilson 234 auto injector and UV-detector (Spectra-Physics UV150). A microparticulated 
C-18 column (Varian, Chromosper C-18, 100 x 3.0 mm) was used as stationary phase. 
The mobile phase for ethyl-PABA and butyl-PABA consisted of acetonitrile and water 
in a ratio of 40:60. Acetonitrile, water and acetic acid in a ratio of 20:78:2 was used 
as a mobile phase for PABA. The ﬂow rate and the detection wavelength were set to 
1.0 ml/min and 286 nm, respectively. A series of standards was run with each series 
of samples.
2.6 Data analysis
The ﬂux and cumulative amount of the model compounds were plotted as a function 
of time. Steady state ﬂux values (Jss) were determined from the linear portions of the 
individual cumulative amount versus time plot. The lag time (tlag) was determined by 
extrapolation of this curve to the intercept with the time axis. Permeability coefﬁcients 
(P) were calculated according to the equation P = Jss / Cd, in which Cd is the concentration 
of the solute in the donor solution (mg/cm3). Diffusion coefﬁcients (D) were calculated 
from the slopes of the linear portions of the permeability coefﬁcients versus path 
length plots, according to the equation P = (K*D)/h, in which K represents the partition 
coefﬁcient of the permeant between the SC or SCS and the donor solution, D the 
diffusion coefﬁcient of the permeant in the SC or SCS (cm2/s) and h the length of the 
pathway through the SC or SCS (cm).
All results are expressed as mean values ± standard deviations. Statistical analyses 
were performed using one-way ANOVA at a signiﬁcance level set at p<0.05. When a 
statistical analysis was performed for only 2 groups, an unpaired two-tailed t-test was 
used.
2.7 Determination of the amount and thickness of the lipid layer on the ﬁlter
After each diffusion experiment, the quantity of lipid material that was present 
in the diffusion area was determined. Brieﬂy, the SCS was cut into two equally sized 
parts. One part was dissolved in 100 µl chloroform/methanol (2:1) and the lipids 
were extracted by extensive vortexing. After evaporation of the organic solvent, the 
amount of lipids was subsequently determined by weighing. The other part was used 
for cryo-scanning electron microscopy to establish the thickness of the lipid layer and 
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to establish whether the SCS remains intact under the aqueous solutions used in the 
transport studies [22]. Brieﬂy, the lipid-loaded ﬁlters were cut into sheets of 1.5 x 2 
mm2, folded and ﬁxed in a small copper “shoe-nail” using Tissue-Tek O.C.T. Compound 
(Miles Inc. Elkhart, IN USA). The samples were then quickly frozen by plunge-freezing 
(Reichert Jung-KF80, Vienna, Austria) into liquid propane at –180°C. The frozen 
specimens were kept in liquid nitrogen until they were mounted into a sample holder. 
The cryo-ﬁxed samples were planed in a cryo ultramicrotome (Leica Ultracut UCT/
Leica EM FCS, Wetzlar, Germany), using a specimen temperature of –90°C and a knife 
temperature of –100°C. Subsequently, the samples were vacuum dried for 3 min at 
–90°C at 0.1 Pa to obtain contrast and sputtered with a layer of platinum (CT 1500 
HF, Oxford Instruments, UK). After transferring the specimens into the ﬁeld emission 
scanning electron microscope (Jeol 6400F, Tokyo, Japan), the samples were analysed 
at -190°C. At least 4 microscopic images were taken from each SCS and 3 SCSs 
were examined per experimental condition. At equal distances of 20 µm along the 
cutting plane, the thickness of the cross section of each lipid layer was determined by 
establishing the pixel position of the top and bottom of the lipid layer in proportion to 
that of the magniﬁcation bar that is present in each micrograph.
3. RESULTS
3.1 The effect of layer thickness on the diffusion proﬁle
To assure that the polycarbonate ﬁlter used for the generation of the SCS does not 
form an additional diffusion barrier, experiments were ﬁrst carried out with lipid-free 
polycarbonate ﬁlters. The measured ﬂux values of ethyl-PABA were approximately 15-
fold higher (data not shown) than those measured across the SCS prepared with a 12 
µm thick lipid layer or isolated human SC, indicating that the polycarbonate ﬁlter does 
not act as an additional barrier. In addition, the ﬂux values of ethyl-PABA across the 
supporting dialysis membranes were investigated. These appeared to be approximately 
10-fold higher (data not shown) than those across SC.
Figure 1 shows the ﬂux proﬁles of ethyl-PABA across SC and the SCS as a function 
of time. The average steady-state ﬂux (Jss) and lag time (tlag) values obtained from 
the individual cumulative amount versus time plots, together with the calculated 
permeability coefﬁcient (P) are presented in Table 2. The tlag values obtained in these 
permeation experiments are quite variable, which is reﬂected by large standard 
deviations. An increase in the SC thickness by increasing the number of SC layers from 
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one to three is accompanied by an almost 3-fold decrease in the Jss and an almost 4-fold 
increase in the tlag. For the SCS it can also be observed that the ﬂux is highly affected 
by the layer thickness. Plots of P versus the reciprocal quantity of lipid material in the 
diffusion area (Fig. 2A) or P versus the reciprocal layer thickness of the SCS (Fig. 2B) 
both have positive linear slopes and a correlation coefﬁcient of 0.96, indicating that the 
steady state diffusion across the SCS is in accordance with Fick’s Law. 
Figure 1 - The effect of layer thickness on the ﬂux proﬁles of ethyl-PABA across isolated human SC (A) 
and the SCS (B). An increased layer thickness is accompanied by a decrease in the steady state ﬂux. Data 
are presented as average ± sd (n=8 for SC and n=6 for the SCS).
In contrast to the Jss, no relationship is found between the lipid layer thickness 
of the SCS and the tlag. Independent of the lipid layer thickness, an average tlag of 
approximately 1 h is observed. It should be stressed, however, that very short tlag 
values cannot be appropriately determined with the diffusion set up used in the present 
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Figure 2 - The relationship between the partition coefﬁcient and the reciprocal quantity of lipid material in 
the diffusion area (A), the relationship between the partition coefﬁcient and the reciprocal layer thickness 
of the SCS (B), and the relationship between the partition coefﬁcient and the reciprocal path length in 
SC (C). In accordance with Fick’s ﬁrst law of diffusion, the linear slope represents the diffusion coefﬁcient 
multiplied with the partition coefﬁcient. The reciprocal layer thickness values are presented as average ± 
sd. All lipid-loaded ﬁlters examined were still intact after the permeation studies and did not reveal the 
presence of any defects (open structures).
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study. At a ﬂow rate of 2 ml/hr it takes about 1 hour to replace the acceptor ﬂuid in 
the acceptor compartment and the connecting tubings to the fraction collector. As a 
result, the obtained tlag values of ethyl-PABA across the SCS may not reﬂect the real 
situation. 
The results of these experiments convincingly show that the diffusion proﬁle of 
ethyl-PABA across the SCS can be regulated by means of its layer thickness. Diffusion 
proﬁles of ethyl-PABA across a single SC sheet bear high resemblance to the SCS 
prepared with approximately 350 µg of lipid material in the diffusion area. This quantity 
corresponds to a lipid layer thickness of approximately 12 µm (see also Fig. 2B and 
5B).
Table 2 - Inﬂuence of the layer thickness on the diffusion characteristics of ethyl-PABA. The numbers 
provided with the SCS are the amount of lipid in the diffusion area and the lipid membrane thickness, 
respectively.
parameter
1 SC 
sheet
2 SC 
sheets
3 SC 
sheets
SCS 160 
µg/6 µm
SCS 230 
µg/9 µm
SCS 350 
µg/12 µm
SCS 420 
µg/15 µm
Jss (µg/cm²/h) 14.6 ± 2.4 9.2 ± 1.9 5.4 ± 1.2 42.6 ± 4.5 26.4 ± 3.3 12.9 ± 2.1 4.0 ± 0.6
tlag (h) 0.8 ± 0.4 1.3 ± 0.4 3.0 ± 1.4 0.8 ± 0.6 1.3 ± 1.0 1.4 ± 0.3 1.0 ± 0.3
P (cm/s)
6.3x10-6
± 1.0x10-6
4.0x10-6
± 8.3x10-7
2.3x10-6
± 5.2x10-7
1.8x10-5
± 1.9x10-6
1.1x10-5
± 1.4x10-6
5.5x10-6
± 8.9x10-7
1.7x10-6
± 2.5x10-6
recovery (%) 101.3 ± 7.0 100.7 ± 6.5 99.2 ± 7.4 95.6 ± 3.9 100.2 ± 8.1 97.6 ± 5.6 95.2 ± 3.1
3.2 The effect of permeant lipophilicity on the diffusion proﬁle
Figure 3A and 3B show the ﬂux versus time proﬁles of the three model compounds 
across a single layer of SC and across the SCS prepared with approximately 350 µg 
of lipid material, respectively. In case of the SCS, a slight decrease in the Jss of butyl-
PABA can be observed after approximately 10 hours, which is due to depletion of the 
compound from the donor phase (Fig. 3B). 
The average Jss and tlag values obtained from the individual cumulative amount 
versus time plots, together with P are presented in Table 3. The diffusion proﬁles of 
the three compounds across the SCS and SC are very similar. For both SCS and SC it 
can be observed that the tlag of PABA is signiﬁcantly longer than for the more lipophilic 
compounds ethyl-PABA and butyl-PABA. Furthermore, the tlag of PABA across the SCS 
was found to be longer than that across SC. With respect to the tlag of other two model 
compounds, however, no signiﬁcant differences are observed between the SCS and 
SC. 
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Figure 3 - The effect of permeant lipophilicity on the diffusion proﬁle. Flux versus time proﬁles of PABA 
(-♦-), ethyl-PABA (-▲-) and butyl-PABA (-□-) across SC (A) and the SCS prepared with approximately 
350 µg lipid material in the diffusion area (B). 
The results further reveal that the highest ﬂuxes are obtained with the intermediate 
lipophilic ethyl-PABA. Increasing (butyl-PABA) or decreasing (PABA) the compound 
lipophilicity results in a signiﬁcant decrease in the Jss. The calculated P values indicate that 
the permeability of both SC and SCS increases with increasing compound lipophilicity. 
For PABA and ethyl-PABA no signiﬁcant differences in P (or Jss) are observed between 
the SCS and SC. Compared to SC, however, the SCS appears to be slightly more 
permeable to butyl-PABA, as can be derived from the nearly 2-fold higher P (and Jss).
159Barrier integrity of stratum corneum substitute
Table 3 - Inﬂuence of the permeant lipophilicity on the diffusion characteristics across SC and the SCS
parameter
PABA
SC
Ethyl-PABA 
SC
Butyl-PABA 
SC
PABA
SCS
Ethyl-PABA 
SCS
Butyl-PABA 
SCS
Jss (µg/cm²/h) 2.7 ± 1.0 12.5 ± 2.0 1.2 ± 0.3 2.0 ± 0.3 12.9 ± 2.1 2.2 ± 0.5
tlag (h) 4.7 ± 1.7 0.7 ± 0.3 0.8 ± 0.6 7.4 ± 0.8 1.4 ± 0.3 0.7 ± 0.4
P (cm/s)
1.2x10-7
±  4.5x10-8
5.4x10-6
±  8.5x10-7
7.2x10-6
±  2.0x10-6
8.8x10-8
±  1.2x10-8
5.5x10-6
±  8.9x10-7
1.3x10-5
±  2.6x10-6
recovery (%) n.d. n.d. n.d. 101.0 ± 1.1 97.6 ± 5.6 98.9 ± 3.4
3.3 Effect of altered lipid composition on the diffusion proﬁle across the SCS 
To investigate the effect of altered lipid composition on the permeability barrier, the 
SCS was also prepared with ceramide mixtures lacking CER(EOS). From previous X-ray 
diffraction studies it became evident that synthetic SC lipid mixtures prepared lacking 
CER(EOS) do not form the characteristic LPP [24, 27]. Figure 4 and Table 4 show that 
the SCS prepared with mixtures lacking CER(EOS) show almost two-fold higher Jss 
values (p<0.01) than the SCS prepared with CER(EOS). This indicates that the 13 nm 
lamellar phase, at least partially, contributes to the barrier integrity of the SCS.
Figure 4 - The effect of altered lipid composition on the ﬂux proﬁles of ethyl-PABA across the SCS, 
prepared with approximately 440 µg of lipid material in the diffusion area. The SCS prepared in the 
absence of CER(EOS) (-▲-) do not reveal the long periodicity phase. The reduced barrier efﬁcacy of this 
SCS is reﬂected by a 2-fold increase in the steady state ﬂux as compared to the SCS prepared in the 
presence of CER(EOS) (-□-). Data are presented as average ± sd (n=6). 
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Table 4 - Inﬂuence altered lipid composition of SCS on diffusion characteristics of ethyl-PABA
parameter
SCS prepared in the 
presence of CER(EOS)
SCS prepared in the 
absence of CER(EOS)
Jss (µg/cm²/h) 2.7 ± 0.4 5.2 ± 0.7
tlag (h) 0.6 ± 0.4 0.8 ± 0.6
P (cm/s) 1.2x10-6 ± 1.8x10-7 2.2x10-6 ± 3.2x10-7
recovery (%) 97.8 ± 9.1 94.9 ± 3.0
4. DISCUSSION
Our overall goal is to develop a skin barrier model (consisting of a porous substrate 
covered with synthetic SC lipids), which mimics the lipid composition, lipid organisation, 
lipid orientation and permeability barrier of human SC. This SCS may ultimately 
function as an in vitro screening system pertaining transdermal drug delivery. The 
main advantages of such a percutaneous penetration model are that i) it is a well-
deﬁned system, ii) it circumvents problems related to human or animal skin, iii) it is 
easy to handle and can be mounted in a commercially available Permegear diffusion 
cell, and iv) the composition of the synthetic SC lipids can be manipulated, which offers 
the opportunity to mimic the lipid organisation in healthy as well as diseased skin. 
In a previous study, we have already demonstrated that an airbrush is an elegant 
apparatus to apply smooth and tightly packed lipid membranes of uniform thickness 
onto a polycarbonate ﬁlter [22]. Lipid analysis revealed that all lipids within the SCS 
are homogeneously distributed over the ﬁlter surface. The SCS further possesses two 
crystalline lamellar phases with periodicities of 12.2 and 5.4 nm, which are oriented 
parallel to the ﬁlter surface. Those results indicate that it is possible to prepare a 
SCS that closely resemble the lipid composition, organisation and orientation of the 
intercellular lipids in SC.
The present study investigated the permeability barrier of this SCS. The results 
convincingly show that the barrier properties of the SCS prepared with a 12 µm thick 
lipid layer are very similar to those of isolated human SC. However, some items need to 
be discussed to evaluate the full potential of the SCS as a novel in vitro percutaneous 
penetration model, namely i) differences in the penetration route between the SCS and 
SC, ii) the effect of permeant lipophilicity on the penetration proﬁle, and iii) the effect 
of altered membrane composition on the permeability barrier of lipid membranes. Each 
of these items is discussed below.
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4.1 Differences in penetration route between SCS and SC
Diffusion proﬁles of ethyl-PABA across the SCS prepared with a 12 µm thick lipid 
layer show high similarity to those obtained with isolated human SC. An increased 
layer thickness is accompanied by an increased barrier efﬁcacy, which is reﬂected by a 
decrease in Jss. However, an increased layer thickness does not result in an increased 
tlag, which is different from the observations made with SC. It is therefore of interest to 
compare the organisation of the synthetic lipids in the SCS with the intercellular lipids 
in SC.
4.1.1 Difference in number of lipid lamellae
SC consists of approximately 15 layers of partially overlapping corneocytes (28). 
When the assumptions are made that (i) 6 lamellae are present between two adjacent 
corneocytes and (ii) the repeat distance of these lamellae is 13 nm, it can be calculated 
that the total thickness of the intercellular lipid lamellae in SC is approximately 1.2 
µm [3]. This is 10-fold smaller than the thickness of the lipid layer in the SCS, being 
approximately 12 µm. When the quantity of lipid material present per unit area in SC 
and the SCS is compared, again a nearly 10-fold difference is observed. Whereas the 
SCS is composed of approximately 350 µg lipid material in the diffusion area, SC only 
contains approximately 30 µg lipids. This latter calculation is based on the assumptions 
that (i) ceramides, cholesterol and free fatty acids account for 10% of the SC dry 
weight (3), (ii) the density of SC is 1 g/cm3, and (iii) the thickness of dry SC is 10 µm 
[29]. 
4.1.2 Difference in penetration path length
Another difference between SC and the SCS is the penetration path length, h. 
Figure 5A shows a cryo-scanning electron microscopy picture of isolated human 
SC, hydrated in phosphate buffered saline. SC contains corneocytes, which are all 
surrounded by a very impermeable corniﬁed envelope. As a result, compounds that 
penetrate the SC do not traverse the interior of the corneocytes, but follow the tortuous 
path along the corneocytes [1-3]. Based on this principle, Talreja et al. [29] calculated 
the tortuous lipid path length in alkali-expanded human SC from arbitrary points on the 
SC surface to the viable epidermis. Based on their results, average path lengths of 180 
and 130 µm are reported for alkali-expanded and dry SC, respectively. As the alkaline 
expansion technique produces swelling of the SC comparable to that obtained with full 
hydration [29], 150 µm has been advocated as a realistic penetration path length in 
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PBS hydrated SC, used in the present study.
In contrast to SC, the SCS is solely composed of synthetic lipids and does not 
contain corneocytes. We hypothesise that the path length in the SCS is perpendicular 
to the lipid membrane surface, rather than tortuous, and therefore equal to the 
thickness of the lipid layer, being approximately 12 µm. As compounds may not only 
diffuse perpendicularly to the lipid lamellae, but also parallel to the lipid lamellae, 
the actual path length in both the SCS and SC might be considerably longer than the 
proposed 150 and 12 µm. In fact, to bypass the corneocytes in the SC, a compound 
already needs to diffuse laterally to some extent. For instance, through mathematical 
modeling, Johnson et al. [3] calculated that the effective tortuosity in SC (i.e. taking 
into account parallel diffusion) is approximately 3.6 cm.
4.1.3 Difference in diffusion coefﬁcient
Figure 2C shows the relationship between the calculated permeability coefﬁcient 
in SC and the reciprocal penetration path length, assuming an intercellular path length 
of 150, 300 and 450 µm in 1, 2 and 3 SC sheets, respectively. From the slope of 
the linear portions of Figure 2B and 2C, the diffusion coefﬁcient D was calculated. 
For these calculations, the partition coefﬁcient of ethyl-PABA between the SC or lipid 
membranes and the donor solution is assumed to be equal to the octanol to water 
partition coefﬁcient of ethyl-PABA. The diffusion coefﬁcient in the SCS (D = 4.7 x10-10 
cm2/s) is nearly 6-fold smaller than in SC (D = 2.7 x 10-9 cm2/s). This indicates that, 
despite the shorter path length in the SCS, the mobility of ethyl-PABA is lower than in 
SC, assuming that the estimated penetration path lengths in SC and SCS are correct. 
A possible explanation for the lower diffusion coefﬁcient in the SCS is that ethyl-PABA 
has to cross 10-fold more lamellae, as the total thickness of the SCS is 10-fold larger 
than in SC. Moreover, the corneocytes and adjacent lamellae in SC are not exactly 
running parallel to the skin surface. As a result, the penetration into the SC is not only 
affected by diffusion perpendicular to the lipid lamellae but also by diffusion parallel 
to the lipid lamellae (illustrated in Fig. 5C). We would like to stress that the diffusion 
rate parallel to the lipid lamellae may be higher than the diffusion rate perpendicular 
to the lipid lamellae, as in the latter a compound has to pass alternately lipophilic and 
hydrophilic domains. 
In contrast to the SCS, native SC contains appendages, such as sweat glands 
and hair follicles with their associated sebaceous glands. As the appendages only 
represent approximately 0.1% of the total skin area [30], for passive diffusion 
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Figure 5 - Cryo-scanning electron microscopy photos of isolated human SC, hydrated in phosphate 
buffered saline (A). and the SCS after a permeation experiment (B). Schematic representation of SC and 
parallel diffusion (C). The wall-like structure represents the partially overlapping corneocytes (bricks) and 
the surrounding lipids (mortar). The thick line illustrates a possible penetration route, which a substance 
may take to travel from the SC surface to the viable epidermis. However, as parallel diffusion of molecules 
within the stacks of lamellae is possible (see magniﬁcation), the actual path length may be considerably 
increased. The black vertical arrow indicates the concentration gradient.
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the transappendageal route is frequently considered to be less important than the 
transepidermal route. The results of the present study reveal that pores as remnants 
of the transappendageal route, which may be present in the diffusion area of the 
isolated SC pieces, do not contribute signiﬁcantly to the transport of ethyl-PABA. Pores 
that might be present in the SC pieces are blocked when two or more SC sheets are 
placed on top of each other. When pores would play a signiﬁcant role in the diffusion of 
ethyl-PABA across SC, a non-linear decrease in the permeability coefﬁcient is expected 
[31]. However, as a linear relationship is obtained between the permeability coefﬁcient 
and the reciprocal path length (see Fig. 2C), pores are not considered to contribute 
signiﬁcantly to the transport of ethyl-PABA through SC. Moreover, constant relative 
standard deviations are found for Jss and tlag of ethyl-PABA across one, two or three SC 
sheets.
4.2 The effect of permeant lipophilicity on the permeability coefﬁcient in SCS 
is similar to that in SC
The results of the present study show that the permeability coefﬁcients of 
PABA, ethyl-PABA and butyl-PABA in the SCS prepared with a 12 µm thick lipid layer 
closely resemble those in SC. This means that the SCS has very similar permeability 
characteristics as human SC. It has further been demonstrated that the permeability 
coefﬁcient increases in the order PABA<ethyl-PABA<butyl-PABA (see Table 3). This is 
consistent with literature data obtained with human or hairless mouse skin, in which 
a linear relationship between the permeability and the lipophilicity of homologous n-
alkanols or hydrocortisone-21 esters is reported until a plateau is reached [32, 33]. 
The SCS appears to be slightly more permeable to the most lipophilic compound 
butyl-PABA. However, the observed differences in P and Jss are maximal 2-fold, which 
are much smaller than reported for other compounds when using animal or in vitro 
reconstructed skin to replace human SC [10, 11, 34-36]. Differences in the permeability 
between SC and the SCS may be explained by differences in the lipid composition. 
The SCS is composed solely of synthetic ceramides, cholesterol and free fatty acids, 
whereas SC also contains more hydrophilic lipids, in particular in the deepest layers. 
This may also explain the slightly increased tlag of PABA through the SCS as compared 
with SC. The barrier properties of the SCS to extremely lipophilic and hydrophilic 
compounds, including water, remain to be elucidated.
165Barrier integrity of stratum corneum substitute
4.3 Alteration of lipid composition of SCS affects solute permeation
The LPP is always considered to play an important role in the skin barrier function. 
To date, however, no direct evidence is available from permeability studies that this is 
indeed the case. One of the major advantages of the SCS is that the composition of the 
lipid mixtures can be accurately chosen and modiﬁed. This offers excellent opportunities 
to systemically investigate the role of each lipid subclass for proper lipid organisation 
and barrier function. The results of the present study show that the SCS prepared with 
a ceramide mixture lacking CER(EOS) is more permeable to solute permeation than the 
SCS prepared in the presence of CER(EOS). In previous studies it has been established 
that lipid mixtures lacking CER(EOS) do not form the LPP [24, 27]. These results 
demonstrate that the LPP contributes to the barrier integrity of the SCS. In certain skin 
disorders, such as psoriasis and atopic dermatitis, a marked reduction of CER(EOS) in 
the lesion parts of the SC is observed [23, 37-40]. Extrapolation of the present results 
to the in vivo situation suggests that the observed barrier malfunction in these skin 
diseases can at least in part be explained by a reduced formation of the LPP. 
Ultimately, a SCS may be generated that imitates the lipid composition and 
organisation as observed in various skin diseases. Such studies are of crucial 
importance to elucidate the relationship between lipid composition, organisation and 
barrier function. Moreover, this may provide unique possibilities to more adequately 
predict the permeation of drug substances through diseased skin, for which there is 
currently no alternative.
5. CONCLUSION
The results of the present study convincingly show that the SCS prepared with 
cholesterol, free fatty acids and speciﬁc synthetic ceramides can successfully be used 
to predict solute permeation through the skin. The barrier properties of the SCS can 
easily be adjusted by applying different amounts of lipids or by modifying its lipid 
composition, mimicking that of diseased skin. This demonstrates that this novel SCS 
has a great potential to be used in screening studies. However, further studies are 
required in order to investigate the barrier properties of the SCS to other compounds 
and different formulations, including those with penetration enhancers.
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INTRODUCTION
The outer layer of the skin, the stratum corneum (SC), forms an effective barrier 
to retain water within the body and keep exogenous compounds out of the body. 
It consists of several layers of overlapping corneocytes, which are surrounded by 
a cell envelope and embedded in a matrix of lipid lamellae. Because of the highly 
impermeable character of the corniﬁed envelope, substances that penetrate the SC 
bypass the corneocytes and follow the tortuous intercellular pathway. As a result, the 
SC lipids provide the actual barrier to the permeation of substances through the skin. 
The lipid lamellae, which are oriented approximately parallel to the surface of the 
corneocytes, are predominantly composed of cholesterol, free fatty acids and various 
classes of ceramides. It has been demonstrated that these stacks of lamellar lipid 
layers have repeating patterns of approximately 13 nm (long periodicity phase: LPP) 
and 6 nm (short periodicity phase: SPP), respectively [1]. In particular the LPP and the 
crystalline packing are believed to be critical for the skin barrier function. 
SC, isolated from excised animal or human skin, is often used to study the transport 
of compounds from cosmetic formulations or drug delivery systems into or through 
the skin. However, human and animal skin are notorious for the high intra- and inter-
individual variability. In addition, there is a scarcity of human tissue, in particular 
diseased and dry skin, whereas numerous topical products are especially designed for 
these skin types. Diseased and dry skin often show a defective barrier function, which 
is at least in part attributable to alterations in the SC lipid proﬁle [2-4]. Animal skin, on 
the other hand, is usually more permeable to solute permeation than human skin. It 
can therefore be questioned whether animal skin is a representative model for human 
skin [5-6]. Moreover, due to regulations of  the  European Union, the use of animal skin 
for cosmetic purposes will be prohibited from 2009 [7]. Ultimately, there is an urgent 
demand for novel reproducible screening systems to predict the penetration of drug 
candidates through the skin. 
The research outlined in this thesis is focused on the development of a skin barrier 
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model, which can substitute for SC in diffusion studies. This so-called stratum corneum 
substitute (SCS) consists of reconstituted synthetic SC lipids (cholesterol, ceramides 
and free fatty acids), applied onto a porous substrate. To mimic the barrier properties 
of human skin, the SCS should mimic the composition, organisation and orientation of 
the intercellular lipids in the SC. 
The objectives of this thesis are:
(i) Selection of a synthetic ceramide mixture that mimics the phase behaviour of 
the intercellular lipids in human SC.
(ii) Preparation of a homogeneous SCS in terms of lipid composition, organisation, 
orientation and membrane layer thickness. 
(iii) Evaluation of the permeability barrier of the SCS.
PART I – Selection of a synthetic SC lipid mixture
Ceramides are structurally heterogeneous and consist of two long saturated 
hydrocarbon chains and a small polar head group with several functional groups. Each 
of the 9 ceramides (CER1-CER9) identiﬁed in human SC [8] contains a sphingoid base 
and a fatty acid, which are linked by an amide bond between the carboxyl group 
of the fatty acid and the amino group of the base. The sphingoid moiety can be 
sphingosine, phytosphingosine or 6-hydroxysphingosine, whereas the fatty acid moiety 
is non-hydroxylated or α-hydroxylated with chain lengths of predominantly 24 to 26 
hydrocarbon atoms. The most remarkable ceramides are the acylceramides (CER1, 
CER4 and CER9). These ceramides consist of an unusual long ω-hydroxy fatty acid of 
30 to 34 hydrocarbon atoms to which unsaturated linoleic acid is ester-linked. 
In previous studies it has been demonstrated that mixtures of cholesterol, free fatty 
acids and ceramides isolated from human or pig SC closely resemble the lamellar and 
lateral organisation in native SC, provided that CER1 is present in the mixture [9, 10]. 
In addition, mixtures based on commercially available ceramides have been developed 
to elucidate the unique SC lipid organisation. The most widely studied mixture consists 
of equimolar amounts of cholesterol, palmitic acid and bovine brain ceramide type III 
(structurally similar to CER2, but with shorter fatty acid chain lengths [11]). Although 
some features of the SC lateral organisation appeared to be similar, the characteristic 
long periodicity phase was not formed in mixtures based on bovine brain ceramide type 
III [12, 13]. 
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Chapter 2 serves as a ﬁrst link between the lipid organisation in well-deﬁned 
synthetic ceramide mixtures and the more complex ceramide mixtures isolated from 
native SC. Therefore, the phase behaviour of synthetic ceramides, either single or 
mixed with cholesterol or cholesterol and free fatty acids, was investigated with 
small-angle and wide-angle X-ray diffraction. Four commercially available ceramides 
were selected for that study, namely CER3 with a chain length of 24 carbon atoms 
(CER3(C24)), CER3 with a chain length of 16 carbon atoms (CER3(C16)), bovine brain 
ceramide type III (ΣCERIII) and bovine brain ceramide type IV (ΣCERIV). Whereas 
CER3 contains a phytosphingoid backbone to which fatty acids of a single chain length 
are bound, ΣCERIII and ΣCERIV contain a sphingosine backbone to which fatty acids 
with varying chain lengths are linked. The effects of compositional changes, including 
the addition of synthetic CER1(C30), on the phase behaviour of synthetic ceramide 
mixtures were systematically examined.
In contrast to the observations made with single ΣCERIII or ΣCERIV, two 
coexisting crystalline phases can be detected in CER3(C16) or CER3(C24). This kind 
of polymorphism has previously been reported by Dahlen and Pascher [14]. Due to 
strong intermolecular head group hydrogen bonding, CER3 forms a V-shaped structure 
(the phytosphingosine and fatty acid chain form separate matrices). The difference in 
periodicities between the two phases depends on the tilt angles of the two hydrocarbon 
chains.
It was further demonstrated that both the presence of synthetic CER1 as well as a 
proper composition of the other ceramides in the mixture are crucial for the formation 
of a phase with a long periodicity. Lipid mixtures prepared with a ceramide fraction of 
CER1 and ΣCERIII or CER1 and ΣCERIV do not form the LPP. Only a mixture containing 
synthetic CER1, CER3(C24), cholesterol and free fatty acids shows the formation of 
a lamellar phase with a long periodicity. However, the number and intensities of the 
reﬂections attributed to this phase are rather small, which indicates that only a small 
fraction of lipids participates in the formation of this phase. Moreover, the periodicity 
of 11.6 nm differs from that observed in SC or in lipid mixtures prepared with isolated 
ceramides.
To increase the repeat distance and the fraction of lipids forming the LPP, both the 
preparation method and the composition of the lipid mixtures were optimised. Firstly, 
the inﬂuence of the equilibration temperature during sample preparation and the 
fraction of free fatty acids in the lipid mixture on the phase behaviour was investigated 
(chapter 3). All variations in that study were performed with a ﬁxed composition of 
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synthetic ceramides, namely CER1, CER3(C24) and ΣCERIV in a 1:7:2 molar ratio 
(further referred to as synthCER I). ΣCERIV was incorporated into the mixture to 
introduce some variation in acyl chain length and in head group architecture.
Equimolar mixtures of cholesterol and synthCER I were equilibrated at temperatures 
ranging from 60 to 100°C. The results demonstrate that an increased equilibration 
temperature promotes the formation of the LPP. Whereas no LPP is present in lipid 
mixtures equilibrated at 60°C, a dominant formation of the LPP with a periodicity of 
12.2 nm is observed in lipid mixtures that were equilibrated at 95 or 100°C. Besides, 
an increased equilibration temperature enhances the formation of a phase with a 
periodicity of 4.3 nm at the expense of a phase with a periodicity of 3.7 nm. Both 
phases are attributed to phase-separated CER3 in a V-shaped structure (see chapter 
2) and are not present in native SC.
The inﬂuence of the relative content of free fatty acids on the lipid phase behaviour 
was subsequently investigated by preparing mixtures of cholesterol, synthCER I and 
free fatty acids ranging from a molar ratio of 1:1:0 to 1:1:1.8. Addition of free fatty 
acids to equimolar mixtures of cholesterol and synthCER I obviously increased the 
ﬂuidity of the lipids, as equilibration at 95°C resulted in melting of the lipids. For this 
reason, a lower equilibration temperature was chosen, namely 80°C. Up to an equimolar 
content, systematic increase in the free fatty acids content promotes the formation of 
both LPP (12.2 nm) and SPP (5.5 nm). However, when the relative free fatty acids 
content is further raised, the formation of the LPP is reduced and the SPP dominates. 
Other observations made in the presence of free fatty acids are: (i) The lamellar phases 
are more ordered, as diffraction peaks up to a higher order can be observed for both 
LPP and SPP. (ii) The intensities of the reﬂections attributed to crystalline cholesterol 
and CER3 are reduced. This indicates that free fatty acids increase the solubility of 
cholesterol and CER3 into the lamellar phases. (iii) Only in the presence of free fatty 
acids the lipids are organised in an orthorhombic lateral packing, which is similar to the 
observations made with lipid mixtures prepared with isolated ceramides [15]. 
The main difference between mixtures prepared with synthetic and isolated 
ceramides or SC is the presence of either one or two additional phases in the former. 
These additional phases with repeat distances of approximately 4.3 and 3.7 nm can 
be ascribed to phase-separated CER3 in crystalline domains. In a follow-up study 
(chapter 4), the main focus was to establish the optimal CER3 to ΣCERIV molar ratio 
to minimise the formation of these additional phases and to maximise the fraction 
of lipids forming the LPP. All lipid mixtures in that study were prepared with a ﬁxed 
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CER1 level (10%), whereas the molar ratio between CER3 (uniform chain length) and 
ΣCERIV (chain length variation) ranged from 1:8 to 8:1. In the absence of free fatty 
acids, the optimal CER3 to ΣCERIV ratio is 5:4. A further reduction in the CER3 content 
in favour of the ΣCERIV level reduces the formation of the additional phases. However, 
it also considerably inhibits the formation of the LPP. Identical observations are made 
with lipid mixtures prepared in the presence of free fatty acids. However, in those 
mixtures the optimal CER3 to ΣCERIV molar ratio is found to be 7:2. This shift towards 
an increased CER3 content is most likely due to the chain length variation of the free 
fatty acids (ranging from C16 to C26). 
The results of chapter 3 and chapter 4 demonstrate that the unique SC lipid 
organisation can be reproduced in vitro with mixtures based on cholesterol, free fatty 
acids and a limited number of synthetic ceramides, provided that both the equilibration 
temperature and the acyl chain length variation in the mixture (present in either the 
free fatty acids or the synthetic ceramides) are optimal. The results further reveal that 
the formation of the LPP is rather insensitive towards changes in the total composition 
of cholesterol, synthCER I and free fatty acids over a wide range of molar ratios. This 
is in excellent agreement with the in vivo situation, in which a high inter-individual 
variability in SC lipid composition does usually not lead to substantial changes in the 
lipid organisation. 
To assess the effect of acylceramide type and relative content on the lipid phase 
behaviour, synthetic ceramide mixtures were prepared with various amounts of 
sphingosine based CER1, phytosphingosine based CER9 or combinations of CER1 and 
CER9, thereby maintaining a constant CER3 to ΣCERIV molar ratio (chapter 5). The 
difference between CER1 and CER9 is the presence of an additional hydroxyl group 
at the sphingosine base in the latter. The results reveal that CER9 less efﬁciently 
enhances the formation of the LPP than CER1. This was specially observed in lipid 
mixtures prepared in the absence of free fatty acids, in which CER9 is not able to 
induce the formation of the LPP. Instead, strong reﬂections in the diffraction pattern 
reveal the presence of crystalline CER9 in separate domains. Presumably, the larger 
and more hydrophilic head group of CER9 impedes the formation of the LPP. 
Free fatty acids promote incorporation of CER9 into the lamellar phases. The effect of 
the relative acylceramide content on the lipid organisation was therefore only assessed 
in lipid mixtures prepared in the presence of free fatty acids. The results demonstrate 
that even in the presence of free fatty acids the maximum solubility of CER9 in the 
lamellar phases is lower than that of CER1. Whereas a rise in CER1 content from 0 to 
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20% leads to a consistent enhancement of the LPP formation, a more complex ordering 
is observed in mixtures prepared with CER9. There, a rise in CER9 content up to 10% 
promotes the formation of the LPP. However, a further rise in CER9 content inhibits the 
formation of the LPP and increases the intensities of the reﬂections attributed to phase-
separated CER9. Interestingly, partial replacement of CER1 by CER9 does not affect 
the lipid organisation. This indicates that in addition to free fatty acids, CER1 promotes 
intercalation of CER9 into the lamellar phases.
In contrast to the previous chapters, in which solely mixtures prepared with a limited 
number of synthetic ceramides were studied, chapter 6 focused on the lipid organisation 
in mixtures prepared with various synthetic ceramides (referred to as synthCER II). 
The initial composition of synthCER II was 15% CER1(C30), 51% CER2(C24), 16% 
CER3(C24), 4% CER4(C24), 9% CER3(C16) and 5% CER6(C24), which resembles the 
composition of the ceramides in pig SC. To elucidate the role of the various synthetic 
ceramides in the formation of the LPP, the synthCER II fraction was gradually modiﬁed. 
As the synthetic counterpart of CER5 is not available, all synthCER II mixtures were 
prepared with CER3(C16).
The lipid organisation in equimolar mixtures of cholesterol, synthCER II and free 
fatty acids closely resembles that in SC, as both LPP (12.2. nm) and SPP (5.4 nm) are 
present, the lateral packing of the lipids is orthorhombic, a minor fraction of cholesterol 
phase separates into crystalline domains, and no additional phases are detected. 
Interestingly, free fatty acids are required for proper lipid organisation in synthCER II 
mixtures, as only in their presence the LPP is dominantly present. This might be related 
to the limited acyl chain length distribution present in the synthCER II fraction.
Similarly as observed for synthCER I mixtures (CER1, CER3 and ΣCERIV), no 
LPP is present in mixtures prepared in the absence of any acylceramide. Whereas 
partial substitution of CER1 with CER9 does not affect the lipid organisation, complete 
substitution of CER1 with CER9 slightly reduces the formation of the LPP in synthCER 
II mixtures. Furthermore, exclusion of CER4, CER6, or both CER4 and CER6 from the 
synthCER II fraction or reduction in the CER2 content does not signiﬁcantly affect the 
lipid organisation.
The results of chapter 2 to chapter 6 unequivocally demonstrate that lipid mixtures 
prepared with synthCER I or synthCER II offer an attractive tool to unravel the 
importance of individual ceramides for proper SC lipid organisation. Such studies are 
crucial to increase our insight in the impaired barrier function as observed in diseased 
and dry skin. SynthCER II mixtures most closely mimic the lipid composition and 
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organisation of the intercellular lipids in human SC, as no additional crystalline phases 
are present. For this reason, equimolar mixtures of cholesterol, synthCER II and free 
fatty acids were selected for preparation of the SCS. The lipid organisation in mixtures 
prepared with synthCER I and synthCER II is schematically represented in Figure 1.
Figure 1 – Schematic representation of the lipid organisation in synthCER I and synthCER II mixtures. 
PART II – Preparation and characterisation of the SCS 
 Chapter 7 focused on the preparation and characterisation of circular skin lipid 
membranes on a porous substrate, which can substitute SC in diffusion studies. Firstly, 
an application method was developed, making use of an airbrush spraying device. The 
airbrush, which is connected to gaseous nitrogen, consists of a reservoir, a nozzle, and 
a trigger. Brieﬂy, a polycarbonate ﬁlter, which serves as a porous substrate, is mounted 
in a holder and ﬁxed under the airbrush. The reservoir is subsequently ﬁlled with lipid 
solution. During the spraying period, the trigger is opened pneumatically for a certain 
time period, during which a small fraction of the lipid solution passes the nozzle. Due 
to this nitrogen pressure, the lipid solution is sprayed in very small droplets onto 
the polycarbonate ﬁlter. During the drying stage, the trigger is closed, the organic 
solvent evaporates by the nitrogen ﬂow and the lipids attach to the substrate. This 
procedure can be repeated until the required layer thickness has been obtained. As 
polycarbonate ﬁlters are not resistant towards chloroform, hexane:isopropanol (3:2), 
methanol:ethylacetate (2:1) and hexane:ethanol (2:1) were selected as alternative 
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solvents for chloroform:methanol (2:1). One dimensional high performance thin layer 
chromatography was used to establish the distribution of the various lipid classes over 
the ﬁlter surface. It was demonstrated that the solvent mixture as well as the total lipid 
concentration considerably affect the lipid distribution, in particular that of cholesterol. 
The best results were obtained with hexane:ethanol (2:1) at a total lipid concentration 
of 4.5 mg/ml. 
Cryo-scanning electron microscopy studies on cross-sections of the SCS reveal 
that buffer application immediately after the equilibration step, which is the normal 
procedure to obtain the LPP and SPP in mixtures prepared with synthetic or isolated 
ceramides, results in large open structures in the lipid layer. Smooth and tightly packed 
lipid layers in the absence of holes are only obtained when the SCS is equilibrated 
and subsequently cooled to room temperature in the absence of acetate buffer. X-ray 
diffraction studies on this SCS reveal that even in the absence of acetate buffer two 
crystalline lamellar phases are present with periodicities of 12.2 nm (LPP) and 5.4 nm 
(SPP), respectively. In addition, the lipid lamellae are predominantly oriented parallel 
to the ﬁlter surface, which resembles the orientation of the intercellular lipids in the 
SC. The results of that study demonstrate that the airbrush is a suitable method to 
prepare a homogeneous SCS in terms of lipid composition, organisation, orientation 
and lipid layer thickness.
The ﬁnal objective of this thesis was to evaluate the diffusional resistance of the 
SCS (chapter 8). The barrier function of the skin lipid membrane system was studied in 
a series in vitro passive diffusion studies (see Fig. 2). Human SC isolated from various 
donors was used as a control sample. The effects of compound lipophilicity on the 
diffusion proﬁle were investigated, using three structurally related compounds, namely 
p-aminobenzoic acid (PABA), ethyl-PABA and butyl-PABA. PABA is the most hydrophilic 
compound and its lipophilicity increases with increasing ester chain length. The effects 
of lipid layer thickness and altered lipid composition of the SCS on the diffusion proﬁle 
were investigated with the model compound ethyl-PABA. 
An increased SCS layer thickness is accompanied by an increased barrier efﬁcacy, 
which is reﬂected by a decrease in the steady state ﬂux of ethyl-PABA. However, 
an increased lipid layer thickness does not result in an increased lag time, which is 
different from the observations made with SC. It should be stressed, however, that 
very short lag time values cannot be appropriately determined with the diffusion set 
up used in these studies. As a result, the obtained lag time values of ethyl-PABA across 
the SCS may not reﬂect the real situation. 
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Figure 2 – Schematic representation of a diffusion cell. A diffusion cell consists of a donor and an 
acceptor compartment, separated by the SCS (or SC). In order to travel from the donor compartment 
to the acceptor compartment, a drug needs to diffuse through the SCS (or SC). Analysis of the collected 
fractions of the acceptor compartment enables calculation of the relevant diffusion characteristics. 
The diffusion proﬁles of all three model compounds across the SCS prepared with a 
12 µm thick lipid layer closely resemble those obtained with human SC. The observed 
differences in steady state ﬂux and lag time values between the SCS and human SC are 
much smaller than reported for other compounds when using animal or reconstructed 
human skin [5, 6, 16]. Omission of CER1 from the synthCER II fraction, generating a 
SCS lacking the characteristic LPP, is accompanied by a nearly 2-fold increase in the 
steady state ﬂux of ethyl-PABA. This demonstrates the importance of the LPP for the 
barrier integrity of the SCS. 
CONCLUSION
The results presented in this thesis demonstrate that the SCS offers an attractive tool 
to predict solute permeation through the skin. Moreover, it offers excellent possibilities 
to investigate the role of each lipid subclass for proper membrane organisation and 
barrier function. Such studies are crucial to increase our insight in the impaired barrier 
function as observed in diseased and dry skin. To the best of our knowledge, this is 
the ﬁrst study in which a SCS was prepared that mimics the lipid organisation, lipid 
orientation and the barrier function of SC.
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FUTURE PERSPECTIVES
The ﬁrst series of permeation studies performed with the model compounds PABA, 
ethyl-PABA and butyl-PABA reveal that the permeability barrier of the SCS closely 
mimics that of isolated human SC. However, despite these very encouraging results, 
more studies are required in order to conclusively prove its utility as a skin barrier 
model. Future diffusion studies should therefore be performed with model compounds 
that cover a broad range of molecular weights, charges and polarities. In addition, 
vehicle and dosing effects should be investigated, as in the studies described in this 
thesis solute permeation was only investigated from an acetate buffer at an inﬁnite 
dose.
An important advantage of the SCS is that the composition of the lipid mixtures can 
be accurately chosen and modiﬁed. This offers excellent possibilities to systematically 
investigate the role of each lipid subclass for proper membrane organisation and barrier 
function. It has already been demonstrated that the presence of the LPP is important 
for the barrier function of the SCS and that the formation of this phase depends on 
the presence of CER1. Future research should not only focus on the importance of the 
lamellar organisation, but also on the contribution of the lateral lipid packing on the 
permeability barrier of the SCS. This can be accomplished by preparing the SCS with 
lipid mixtures in which long-chain free fatty acids have been substituted with short-
chain free fatty acids. Previous X-ray diffraction studies on lipid mixtures prepared with 
isolated SC lipids have demonstrated that lipid mixtures prepared with long-chain free 
fatty acids, as observed in healthy SC, predominantly form an orthorhombic packing, 
whereas lipid mixtures prepared with short-chain free fatty acids, as observed in atopic 
dermatitis [3], organise in a hexagonal phase. Another compositional change of interest 
would be the addition of high levels of cholesterol sulphate, as observed in recessive 
X-linked ichthyosis [2], as cholesterol sulphate induces the formation of a ﬂuid phase.
As described above, it is possible to prepare a SCS that mimics the lipid composition 
and organisation of diseased skin. This may provide unique possibilities to more 
adequately predict the permeability of these skin types to a variety of drugs. However, 
it should be kept in mind that in various skin disorders not only the composition and 
organisation of the intercellular lipids is affected, but also the formation of the corniﬁed 
envelope [3]. Abnormalities in the formation and composition of the monolayer of 
covalently bound lipids may decrease the structural and functional integrity of the 
corniﬁed envelope. As a result, substances that penetrate diseased skin may not 
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only bypass, but also travel through the corneocytes (intracellular route). It would 
be very interesting, although experimentally complicated, to incorporate corneocytes 
in the skin lipid membranes. In this way, the permeability in healthy and diseased 
SC may be even more closely mimicked. Furthermore, it would be interesting to 
investigate the effects of increased temperature or different agents (e.g. penetration 
enhancers, iontophoresis, and moisturisers) on the skin lipid membrane organisation 
and permeability of the SCS.
With respect to the application method, future optimisation should be aimed to 
produce the SCS at larger scale under controlled environmental conditions (temperature 
and relative humidity). At present, one lipid membrane is prepared at a time. A challenge 
for the future would therefore be to adapt the application method in order to spray 
a large ﬁlter surface with lipid material in one batch. Firstly, such an adaptation will 
increase the ﬂexibility of the system, as potential users of the SCS are not restricted to 
one particular diffusion area. Secondly, a further increase in reproducibility is desirably 
to minimise the number of replicates required per diffusion experiment. This is especially 
important in screening studies. Hence, an increased ﬂexibility and reproducibility will 
markedly improve the commercial attractiveness of the system. 
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Chapter 10
Samenvatting en toekomstperspectieven
INLEIDING
De huid beschermt het lichaam tegen uitdrogen en het binnendringen van 
ongewenste stoffen. De belangrijkste barrière wordt gevormd door de buitenste 
huidlaag, het stratum corneum (SC). Het SC is opgebouwd uit verhoornde cellen 
(corneocyten), welke zijn ingebed in een matrix van gestapelde lipidenlagen (lamellen). 
Aangezien de wand van de corneocyten een nogal ondoordringbare structuur heeft, 
passeren de meeste stoffen het SC via de ruimte tussen de cellen. Dit betekent dat 
de lipiden, die zowel qua samenstelling als qua structuur uniek zijn voor biologische 
membranen, uitermate belangrijk zijn voor de barrièrefunctie van de huid. De lamellen 
zijn voornamelijk opgebouwd uit cholesterol, diverse soorten ceramiden en vrije 
vetzuren met lange ketens. Verder is aangetoond dat de lipiden gerangschikt zijn in 
twee lamellaire structuren met repeterende afstanden van respectievelijk 13 nm (lange 
periodiciteitsfase: LPP) en 6 nm (korte periodiciteitsfase: SPP) [1]. Algemeen wordt 
aangenomen dat met name de aanwezigheid van de LPP en de kristallijne laterale 
ordening van de lipiden zeer belangrijk zijn voor de barrièrefunctie van de huid. 
Om het transport van stoffen vanuit farmaceutische of cosmetische producten 
door de huid te voorspellen, wordt veelvuldig gebruik gemaakt van SC, geïsoleerd 
van humane of dierlijke huid. Er kleven echter nogal wat nadelen aan deze aanpak, 
zoals grote intra- en interindividuele variatie en de zeer beperkte beschikbaarheid 
van humane huid. Tevens bestaan er geen in vitro modellen voor zieke en droge 
huid, terwijl veel producten juist voor deze huidtypen ontwikkeld worden. In zieke en 
droge huid is de barrièrefunctie vaak verstoord, d.w.z. dat de huid beter doorlaatbaar 
is voor stoffen. Dit kan grotendeels worden toegeschreven aan veranderingen in de 
samenstelling en structuur van de lipiden in het SC [2-4]. Een bijkomend nadeel van het 
gebruik van dierlijke huid is dat dit vaak beter doorlaatbaar is voor stoffen dan humane 
huid [5, 6]. Het is dus de vraag of dierlijke huid daadwerkelijk als geschikt model voor 
humane huid kan worden beschouwd. Bovendien wordt vanaf 2009 binnen de EU een 
verbod van kracht op het gebruik van proefdieren voor het testen van cosmetische 
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producten [7]. Uit bovengenoemde punten blijkt dat er een dringende behoefte bestaat 
aan reproduceerbare testsystemen om het transport van geneesmiddelen door de huid 
te voorspellen. 
Het onderzoek beschreven in dit proefschrift betreft de ontwikkeling van een 
huidbarrièremodel, welke gebruikt kan worden om het transport van geneesmiddelen 
door de huid te voorspellen. Deze zogenaamde SC vervanger (SCS) bestaat uit 
synthetische SC lipiden (cholesterol, ceramiden en vrije vetzuren) op een poreuze 
drager. Om de barrière-eigenschappen van humane huid na te bootsen, moeten de 
samenstelling, de organisatie en de oriëntatie van de synthetische lipiden die van de 
intercellulaire SC lipiden zo dicht mogelijk benaderen.  
De doelstellingen van dit proefschrift zijn:
(i) Selecteren van synthetische lipidenmengsels, welke de lipidenorganisatie in 
humaan SC nabootsen.
(ii) Vervaardigen van een homogeen SCS wat betreft samenstelling, organisatie, 
oriëntatie en laagdikte van het lipidenmembraan.
(iii) Evalueren van de barrièrefunctie van het ontwikkelde huidbarrièremodel.
DEEL I - Selectie van een synthetisch SC lipidenmengsel
Ceramiden bestaan uit twee lange verzadigde koolwaterstofketens en een 
kleine polaire kopgroep. In humaan stratum corneum zijn tenminste 9 verschillende 
ceramiden (CER1-CER9) geïdentiﬁceerd [8]. De structuren van deze ceramiden zijn 
o.a. te zien op pagina 17 van dit proefschrift. Een ceramide bestaat uit een sphingosine, 
phytosphingosine of 6-hydroxysphingosine, waaraan een niet-gehydroxyleerd 
of α-gehydroxyleerd vetzuur (met een ketenlengte van hoofdzakelijk 24 tot 26 
koolwaterstofatomen) chemisch is gebonden. De acylceramiden (CER1, CER4 en CER9) 
zijn uniek, omdat ze bestaan uit een ongebruikelijk lang ω-hydroxyvetzuur van 30 tot 
34 koolwaterstofatomen, waaraan het onverzadigde linolzuur is gebonden. 
Recentelijk is aangetoond dat de lipidenorganisatie in SC kan worden nagebootst 
met een mengsel van cholesterol, vrije vetzuren met lange ketens en uit SC geïsoleerde 
ceramiden. In deze mengsels blijkt de aanwezigheid van CER1 een vereiste te zijn voor 
de vorming van de unieke 13 nm structuur. De lipidenorganisatie is tevens veelvuldig 
onderzocht in mengsels bestaande uit commercieel beschikbare ceramiden. Hoewel 
bepaalde aspecten van de lipidenorganisatie in humaan SC kunnen worden nagebootst 
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met lipidenmengsels gemaakt met cholesterol, palmitinezuur en ceramide type III (een 
gemodiﬁceerd ceramide geïsoleerd uit koeienhersenen welke qua structuur overeenkomt 
met CER2, maar met kortere vetzuurketens [11]), wordt de karakteristieke LPP echter 
niet gevormd [12, 13]. 
In hoofdstuk 2 wordt voor het eerst een verband gelegd tussen de lipidenorganisatie 
in goed gedeﬁnieerde lipidenmengsels (gemaakt met synthetische ceramiden) en de 
complexere lipidenmengsels (gemaakt met geïsoleerde ceramiden). Het fasegedrag van 
enkelvoudige synthetische ceramiden, ceramiden gemengd met cholesterol of gemengd 
met cholesterol en vrije vetzuren, werd onderzocht met kleine hoek en grote hoek 
röntgendiffractie. Voor deze studie werden vier commercieel verkrijgbare ceramiden 
geselecteerd, namelijk CER3 met een acylketenlengte van 24 atomen (CER3(C24)), 
CER3 met een acylketenlengte van 16 koolstofatomen (CER3(C16)), ceramide type 
III (ΣCERIII) en ceramide type IV (ΣCERIV). CER3 bestaat uit een phytosphingosine, 
waaraan een vetzuur met slechts één ketenlengte is gebonden. ΣCERIII en ΣCERIV zijn 
daarentegen opgebouwd uit een sphingosine, waaraan een vetzuur met een variabele 
ketenlengte is gebonden. Er werd systematische onderzocht wat de invloed is van de 
lipidensamenstelling, met inbegrip van toevoeging van synthetisch CER1(C30), op de 
lipidenorganisatie.
In tegenstelling tot de bevindingen met ΣCERIII en ΣCERIV zijn in CER3(C16) 
en CER3(C24) twee fasen aanwezig met verschillende repeterende afstanden. 
Voor CER3(C24) werd dergelijk polymorﬁsme al eerder beschreven door Dahlen en 
Pascher [14]. Door de vorming van waterstofbruggen tussen de kopgroepen van 
naast elkaar gelegen CER3 moleculen vormt CER3 een V-vormige structuur, waarbij 
de phytosphingosineketen en de acylketen zich in afzonderlijke lagen bevinden. Het 
verschil in repeterende afstand tussen beide fasen wordt veroorzaakt door een verschil 
in de kantelhoek tussen de twee koolwaterstofketens.
In hoofdstuk 2 wordt verder voor het eerst aangetoond dat de LPP kan worden 
gevormd in mengsels die zijn bereid met synthetische ceramiden. Een lamellaire 
structuur met een lange periodiciteit werd echter slechts in één mengsel waargenomen, 
bestaande uit synthetisch CER1, CER3 (C24), cholesterol en vrije vetzuren. De lage 
intensiteit van de LPP-reﬂecties duiden er echter op dat slechts een klein deel van 
de lipiden daadwerkelijk de LPP vormt. Verder verschilt de repeterende afstand van 
11.6 nm aanzienlijk van die waargenomen in SC of in lipidenmengsels bereid met 
geïsoleerde ceramiden.
Om de vorming van de LPP te bevorderen en de repeterende afstand te vergroten, 
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werden zowel de bereidingsmethode als de samenstelling van de lipidenmengsels 
geoptimaliseerd. Eerst werd de invloed van de equilibratietemperatuur tijdens de 
monstervoorbereiding onderzocht. Vervolgens werd de invloed van de hoeveelheid 
vrije vetzuren in het lipidenmengsel op het fasegedrag onderzocht (hoofdstuk 3). Alle 
variaties werden uitgevoerd met een ceramidenmengsel bestaande uit CER1, CER3 
(C24) en ΣCERIV in een molverhouding 1:7:2 (verder aangeduid als synthCER I). ΣCERIV 
werd in het ceramidenmengsel opgenomen om meer variatie in de acylketenlengte en 
kopgroepstructuur te introduceren.
Mengsels gemaakt met cholesterol en synthCER I in een gelijke molverhouding 
werden geëquilibreerd bij een temperatuur variërend tussen 60 en 100°C. Uit de 
resultaten blijkt dat een verhoogde equilibratietemperatuur de vorming van de LPP 
bevordert. De LPP is niet aanwezig in lipidenmengsels die geëquilibreerd zijn bij 60°C. 
Wanneer echter een equilibratietemperatuur van 95 of 100°C wordt gekozen, is de 
LPP met een repeterende afstand van 12.2 nm dominant aanwezig. Tevens blijkt een 
verhoogde equilibratietemperatuur de vorming van een fase met een repeterende 
afstand van 4.3 nm te bevorderen ten koste van een fase met repeterende afstand van 
3.7 nm. Beide structuren zijn niet aanwezig in SC en kunnen worden toegeschreven 
aan CER3 dat is uitgekristalliseerd in een V-vormige structuur (zie hoofdstuk 2). 
Vervolgens werd de invloed van de relatieve hoeveelheid vrije vetzuren in het 
lipidenmengsel op de lipidenorganisatie onderzocht. Hiervoor werden mengsels 
gemaakt met cholesterol, synthCER I en vrije vetzuren in een molverhouding variërend 
van 1:1:0 tot 1:1:1.8. Door de toevoeging van vrije vetzuren smolten de lipiden bij 
een equilibratietemperatuur van 95°C. Daarom werden de lipidenmengsels bij een iets 
lagere temperatuur geëquilibreerd, namelijk 80°C. Door de hoeveelheid vrije vetzuren 
systematisch te verhogen, tot een mengsel van cholesterol, synthCER I en vrije vetzuren 
in een 1:1:1 molverhouding, wordt de vorming van zowel de LPP (12.2 nm) als de 
SPP (5.5 nm) bevorderd. Een verdere toename van de fractie vrije vetzuren remt de 
vorming van de LPP en als gevolg daarvan overheerst de SPP. Uit de resultaten blijkt 
verder dat in aanwezigheid van vrije verzuren de lamellaire fasen meer zijn geordend, 
de oplosbaarheid van cholesterol en CER3 in de lamellaire fasen wordt verhoogd en 
dat de lipiden alleen in aanwezigheid van vrije vetzuren een orthorhombische structuur 
vormen. Dit laatste is ook waargenomen voor mengsels gemaakt met geïsoleerde 
ceramiden [15]. 
Het voornaamste verschil tussen lipidenmengsels gemaakt met synthetische 
ceramiden enerzijds en SC of mengsels gemaakt met geïsoleerde ceramiden anderzijds 
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is de aanwezigheid van of één of twee additionele fasen in de eerstgenoemde mengsels. 
Deze additionele fasen met repeterende afstanden van ongeveer 4.3 en 3.7 nm kunnen 
worden toegeschreven aan CER3 dat is uitgekristalliseerd in aparte domeinen. Om de 
vorming van deze additionele fasen te minimaliseren en de vorming van de LPP te 
bevorderen, werd in een vervolgstudie (hoofdstuk 4) de molverhouding tussen CER3 
en ΣCERIV onderzocht. Alle lipidenmengsels in die studie werden bereid met een vaste 
hoeveelheid CER1 (10%), terwijl de molverhouding tussen CER3 (vaste ketenlengte) 
en ΣCERIV (variatie in ketenlengte) varieerde van 1:8 tot 8:1. In lipidenmengsels 
bereid zonder vrije vetzuren blijkt een CER3:ΣCERIV verhouding van 5:4 optimaal 
te zijn. Een verdere verlaging van de hoeveelheid CER3 ten gunste van ΣCERIV 
vermindert de vorming van de additionele fasen, maar leidt tevens tot een aanzienlijke 
afname in de vorming van de LPP. Vergelijkbare waarnemingen werden gedaan met 
lipidenmengsels gemaakt in aanwezigheid van vrije vetzuren. Echter, in die mengsels 
werd een optimale CER3:ΣCERIV verhouding gevonden van 7:2. Deze verschuiving 
naar een grotere hoeveelheid CER3 wordt waarschijnlijk veroorzaakt door de variatie 
in ketenlengten van de vrije vetzuren (variërend van C16 tot C26). 
Uit hoofdstuk 3 en hoofdstuk 4 blijkt dat de unieke SC lipidenorganisatie in vitro 
kan worden nagebootst met mengsels bestaande uit cholesterol, vrije vetzuren en 
een beperkt aantal synthetische ceramiden. Voorwaarde hiervoor is dat zowel de 
equilibratietemperatuur als de variatie in acylketenlengte in het mengsel (aanwezig 
in òf de fractie vrije vetzuren òf de synthetische ceramiden) optimaal zijn. Verder 
blijkt dat de vorming van de LPP redelijk ongevoelig is voor veranderingen in de 
molverhouding tussen cholesterol, synthCER I en vrije vetzuren. Laatstgenoemde 
komt zeer goed overeen met de in vivo situatie, waarin een grote interindividuele 
variatie in de samenstelling van de SC lipiden normaliter niet leidt tot een aanzienlijke 
verandering in de lipidenorganisatie. 
In hoofdstuk 5 werd de invloed van het type en de relatieve hoeveelheid acylceramide 
op de lipidenorganisatie in synthetische lipidenmengsels onderzocht. Hiertoe werden 
synthetische lipidenmengsels gemaakt met verschillende hoeveelheden CER1 
(sphingosine), CER9 (phytosphingosine; met een extra hydroxylgroep aan de kopgroep) 
of combinaties van CER1 en CER9. In al deze mengsels werd de molverhouding tussen 
CER3 en ΣCERIV constant gehouden. De resultaten laten zien dat CER1 beter in staat is 
om de vorming van de LPP te bevorderen dan CER9. In mengsels zonder vrije vetzuren 
kristalliseert CER9 uit in afzonderlijke domeinen en is het niet mogelijk om de LPP te 
vormen. Vermoedelijk belemmert de grotere en meer hydroﬁele kopgroep van CER9 
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de vorming van de LPP.
Aangezien vrije vetzuren de integratie van CER9 in de lamellaire fasen bevorderen, 
werd de invloed van de relatieve hoeveelheid acylceramide op de lipidenorganisatie 
alleen onderzocht in lipidenmengsels die bereid waren in aanwezigheid van vrije 
vetzuren. Uit de resultaten blijkt dat ook in aanwezigheid van vrije vetzuren de 
maximale oplosbaarheid van CER9 in de lamellaire fasen lager is dan die van CER1. 
Een toename van 0 tot 20% CER1 bevordert de vorming van de LPP aanzienlijk. Een 
dergelijk verband werd niet waargenomen voor mengsels die gemaakt waren met CER9. 
Bij een CER9 gehalte hoger dan 10% wordt de vorming van de LPP namelijk geremd 
en kristalliseert CER9 gedeeltelijk apart uit. Opmerkelijk is dat de lipidenorganisatie 
niet verandert indien CER1 slechts gedeeltelijk door CER9 vervangen werd. Dit duidt 
erop dat zowel vrije vetzuren als CER1 de inbouw van CER9 in de lamellaire fasen 
bevorderen.
In tegenstelling tot de voorgaande studies, waarin alleen mengsels zijn onderzocht 
die werden gemaakt met een beperkt aantal synthetische ceramiden, werd het 
onderzoek beschreven in hoofdstuk 6 uitgevoerd met een mengsel bestaande uit 15% 
CER1(C30), 51% CER2(C24), 16% CER3(C24), 4% CER4(C24), 9% CER3(C16) en 5% 
CER6(C24). Deze samenstelling (verder aangeduid als synthCER II) is vergelijkbaar 
met die van de ceramiden in varkenshuid. Aangezien de synthetische tegenhanger van 
CER5 niet voorhanden is, werden alle synthCER II mengsels bereid met CER3(C16). 
Om de invloed van diverse synthetische ceramiden op de vorming van de LPP te 
onderzoeken, werd de fractie synthCER II systematisch gewijzigd. 
De lipidenorganisatie in mengsels gemaakt met cholesterol, synthCER II en vrije 
vetzuren lijkt sterk op die in het SC: (i) zowel de LPP (12.2 nm) als SPP (5.4 nm) zijn 
aanwezig, (ii) de laterale ordening van de lipiden is orthorhombisch, (iii) een klein 
deel van de cholesterol is in aparte domeinen uitgekristalliseerd en iv) er zijn geen 
additionele fasen aanwezig. Opmerkelijk is dat vrije vetzuren noodzakelijk zijn om de 
lipidenorganisatie in het SC na te bootsen. Dit wordt waarschijnlijk veroorzaakt door 
de geringe variatie in de acylketenlengten in het synthCER II mengsel.  
In lipidenmengsels die zijn gemaakt zonder acylceramide wordt de LPP niet 
gevormd. Dit is in overeenstemming met de mengsels gemaakt met het synthCER 
I (CER1, CER3 en ΣCERIV) mengsel. Ook blijkt het mogelijk om CER1 gedeeltelijk 
door CER9 te vervangen. Een volledige vervanging van CER1 door CER9 leidt echter 
wel tot een lichte afname in de vorming van de LPP in de synthCER II mengsels. 
Uitsluiting van CER4, CER6 of beide ceramiden van het synthCER II mengsel beïnvloedt 
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de lipidenorganisatie niet. De lipidenorganisatie wordt evenmin beïnvloed door het 
CER2 gehalte in het synthCER II mengsel te verlagen.
Uit de resultaten beschreven in hoofdstuk 2 tot en met hoofdstuk 6 blijkt dat 
lipidenmengsels gemaakt met synthCER I of synthCER II uitstekend gebruikt kunnen 
worden om de rol van individuele ceramiden in de lipidenorganisatie te onderzoeken. 
Dergelijke studies zijn essentieel om een beter inzicht te krijgen in de verstoorde 
barrièrefunctie zoals aanwezig in zieke en droge huid. Omdat het mengsel gemaakt 
met cholesterol, synthCER II  en vrije vetzuren de lipidenorganisatie in humaan SC 
het dichtst benaderen, werd dit mengsel geselecteerd voor de ontwikkeling van het 
SCS. De lipidenorganisatie in mengsels gemaakt met synthCER I en synthCER II is 
schematisch weergegeven in Figuur 1.
Figuur 1 –  Schematische weergave van de lipidenorganisatie in synthCER I en synthCER II mengsels. 
DEEL II – Ontwikkeling van het SCS met synthetische lipidenmengsels 
Hoofdstuk 7 beschrijft de vervaardiging en karakterisering van het SCS. Allereerst 
werd een methode ontwikkeld, gebruikmakend van een airbrush, om de lipiden op een 
poreuze drager aan te brengen. De airbrush, die aangesloten is op stikstofgas, bestaat 
uit een vloeistofreservoir, een mondstuk en een trekker. Een polycarbonaatﬁlter, dat 
dient als poreuze drager, wordt ingeklemd in een houder en recht onder de airbrush 
geﬁxeerd. Het vloeistofreservoir wordt vervolgens gevuld met een lipidenoplossing. 
Gedurende het spraystadium wordt de trekker pneumatisch geopend voor een 
bepaalde tijdsduur, waardoor een kleine fractie van de lipidenoplossing het mondstuk 
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passeert. Door de stikstofdruk wordt de lipidenoplossing verneveld en hierdoor wordt de 
lipidenoplossing in zeer kleine druppeltjes op het polycarbonaatﬁlter gesproeid. Tijdens 
het droogstadium is de trekker gesloten, verdampt het organisch oplosmiddel door de 
stikstofstroom en hechten de lipiden aan het ﬁlter. Deze procedure kan worden herhaald 
tot de vereiste laagdikte is verkregen. Aangezien de polycarbonaatﬁlters niet bestand 
zijn tegen chloroform, werden hexaan:isopropanol (3:2), methanol:ethylacetaat (2:1) 
en hexaan:ethanol (2:1) geselecteerd als alternatieve oplosmiddelen voor chloroform:
methanol (2:1). Laatstgenoemde mengsel werd in alle voorgaande studies gebruikt 
voor de bereiding van de lipidenmengsels. Dunnelaagchromatograﬁe werd gebruikt om 
de verdeling van de diverse lipidenklassen over het ﬁlteroppervlak vast te stellen. Uit 
de resultaten  blijkt dat de lipidenverdeling, met name die van cholesterol, sterk wordt 
beïnvloed door het gebruikte oplosmiddel en de totale lipidenconcentratie. De beste 
resultaten werden verkregen met hexaan:ethanol (2:1) en een lipidenconcentratie van 
4.5 mg/ml. 
Dwarsdoorsneden van lipidenmembranen werden onderzocht met cryo-
scanning elektronenmicroscopie. Een egale lipidenlaag zonder gaten wordt alleen 
verkregen wanneer het SCS in afwezigheid van een buffer wordt gemaakt. Uit 
röntgendiffractiestudies blijkt dat in het SCS gemaakt zonder buffer twee kristallijne 
lamellaire fasen aanwezig zijn met repeterende afstanden van respectievelijk 12.2 (LPP) 
en 5.4 nm (SPP). Tevens zijn de lamellen parallel aan het ﬁlteroppervlak georiënteerd, 
wat de oriëntatie van de intercellulaire lipiden in het SC zeer dicht benadert. Uit de 
resultaten van hoofdstuk 7 blijkt dat de ontwikkelde spraymethode zeer geschikt is om 
een homogeen SCS te maken.
De laatste doelstelling van het onderzoek beschreven in dit proefschrift was het 
evalueren van de barrièrefunctie van het ontwikkelde huidbarrièremodel (hoofdstuk 
8). De doorlaatbaarheid van het SCS werd onderzocht in een serie in vitro passieve 
diffusiestudies (zie Fig. 2), waarbij geïsoleerd humaan SC werd gebruikt als controle. 
De invloed van de lipoﬁliteit van de modelstof op het diffusieproﬁel werd onderzocht 
met behulp van drie structureel verwante modelstoffen, namelijk p-aminobenzoëzuur 
(PABA), ethyl-PABA en butyl-PABA. PABA is de meest hydroﬁele verbinding en de 
lipoﬁliteit neemt toe met de ketenlengte van de ester. De invloed van de dikte van de 
lipidenlaag en de lipidensamenstelling van het SCS op het diffusieproﬁel werd alleen 
onderzocht met de modelstof ethyl-PABA. 
Een dikkere lipidenlaag resulteert in een verhoogde barrièrefunctie van het SCS, 
welke wordt weerspiegeld in een afname van het transport van ethyl-PABA tijdens 
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de stationaire toestand. De diffusieproﬁelen van de drie modelstoffen door het SCS 
gemaakt met een 12 µm dikke lipidenlaag lijken sterk op die door geïsoleerd humaan 
SC. De waargenomen verschillen tussen het SCS en humaan SC voor wat betreft het 
transport tijdens stationaire toestand en de vertragingstijd zijn veel kleiner dan die 
gerapporteerd in studies waarbij gebruik werd gemaakt van dierlijke huid of humane 
kweekhuid [5, 6, 16]. Het transport tijdens stationaire toestand van ethyl-PABA door 
het SCS gemaakt zonder CER1, waarin de karakteristieke LPP dus ontbreekt, is bijna 
een factor twee hoger dan door het normale SCS. Hieruit blijkt overtuigend het belang 
van de LPP voor een goede barrièrefunctie.
Figuur 2 – Schematische weergave van een diffusiestudie. Een diffusiecel bestaat uit een donor en een 
acceptor compartiment, waartussen het SCS (of SC) is ingeklemd. Vervolgens wordt de te onderzoeken stof in 
het donor compartiment gebracht. Om van het donor compartiment in het acceptor compartiment te komen, 
moet de stof door het SCS (of SC) diffunderen. Door fracties van het acceptor compartiment op te vangen 
en te analyseren kan uitgerekend worden hoeveel stof het SCS (of SC) in stationaire toestand passeert. 
CONCLUSIE
Uit de resultaten gepresenteerd in dit proefschrift blijkt dat het SCS een aantrekkelijk 
hulpmiddel is om het transport van stoffen door de huid te voorspellen. Bovendien 
biedt het uitstekende mogelijkheden om de rol van de afzonderlijke lipiden in zowel 
de lipidenorganisatie als de barrièrefunctie in één model te onderzoeken. Dergelijke 
studies zijn cruciaal om onze kennis over de verstoorde barrièrefunctie, zoals in zieke 
en droge huid, te vergroten. Voor zover bij ons bekend, is dit de eerste studie waarin 
een SCS werd ontwikkeld dat zowel de lipidenorganisatie, de lipidenoriëntatie als de 
barrièrefunctie van SC nabootst. 
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TOEKOMSTPERSPECTIEVEN
Uit de eerste serie diffusiestudies die zijn uitgevoerd met de modelstoffen PABA, 
ethyl-PABA en butyl-PABA blijkt dat de barrière-eigenschappen van het SCS die 
van geïsoleerd humaan SC zeer dicht benaderen. Ondanks deze zeer veelbelovende 
resultaten, zijn er echter meer studies nodig om de bruikbaarheid van het SCS als 
huidbarrièremodel vast te stellen. Toekomstige diffusiestudies zouden daarom moeten 
worden uitgevoerd met modelstoffen die een breed scala aan molecuulgewichten, 
ladingen en polariteiten omvatten. Verder zou de invloed van de formulering en de 
dosering onderzocht moeten worden, aangezien tot op heden alleen de diffusie van 
modelstoffen opgelost in een acetaatbuffer bij een oneindige dosering is onderzocht.
Een belangrijk voordeel van het SCS is dat de samenstelling van de lipidenmengsels 
nauwkeurig kan worden gekozen en gewijzigd. Dit biedt uitstekende mogelijkheden om 
de rol van afzonderlijke lipiden voor een juiste membraanorganisatie en barrièrefunctie 
systematisch te onderzoeken. Er is reeds aangetoond dat de aanwezigheid van de LPP 
belangrijk is voor de barrièrefunctie van het SCS en dat de vorming van deze fase 
afhangt van de aanwezigheid van CER1. In vervolgonderzoek zou niet alleen de rol 
van de lamellaire organisatie op de barrièrefunctie van het SCS onderzocht moeten 
worden, maar ook de bijdrage van de laterale lipidenstructuur. Dit zou kunnen worden 
onderzocht door de vrije vetzuren met lange ketens te vervangen door vrije vetzuren 
met korte ketens. Uit eerdere studies met lipidenmengsels gebaseerd op geïsoleerde SC 
ceramiden is namelijk gebleken dat in mengsels gemaakt met vrije vetzuren met lange 
ketens, zoals in gezond SC, hoofdzakelijk een orthorhombische fase wordt gevormd, 
terwijl in mengsels gemaakt met vrije vetzuren met korte ketens, zoals in atopisch 
dermatitis [3], een hexagonale fase wordt gevormd. Een andere interessante samen-
stellingsverandering is de toevoeging van verhoogde hoeveelheden cholesterolsulfaat, 
zoals in recessieve x-gebonden ichthyosis [2], aangezien cholesterolsulfaat de vorming 
van een vloeibare fase induceert. 
Zoals hierboven beschreven, is het mogelijk om een SCS te produceren die 
de lipidensamenstelling en de organisatie van zieke huid nabootst. Dit kan unieke 
mogelijkheden bieden om de doorlaatbaarheid van deze huidtypen voor diverse 
geneesmiddelen beter te voorspellen. Er dient echter opgemerkt te worden dat in 
diverse huidziekten niet alleen de samenstelling en de organisatie van de intercellulaire 
lipiden is verstoord, maar ook de structuur van de corneocyten [3]. Als gevolg 
hiervan zou het transport van stoffen door SC van zieke huid niet alleen via de 
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ruimte tússen de corneocyten (intercellulaire route), maar ook dóór de corneocyten 
(transcellulaire route) kunnen plaatsvinden. Het zou daarom zeer interessant zijn, 
hoewel experimenteel gecompliceerd, om corneocyten in de lipidenlaag van het SCS 
in te sluiten. Op die manier zou de barrièrefunctie van zowel gezonde als zieke huid 
wellicht nog beter kunnen worden nagebootst en hiermee zal de voorspellende waarde 
van het SCS nog verder toenemen. Voorts zou het zeer interessant zijn om de invloed 
van de temperatuur of verschillende andere aspecten (bijv. penetratiebevorderaars, 
iontoforese, en moisturisers) op de lipidenorganisatie en de doorlaatbaarheid van het 
SCS te onderzoeken.
Met het oog op de applicatiemethode zou in de toekomst getracht moeten worden 
om het SCS op grotere schaal en onder gecontroleerde klimaatomstandigheden 
(temperatuur en relatieve vochtigheid) te produceren. Momenteel worden de ﬁlters 
één voor één bedekt met een lipidenlaag. Een uitdaging voor de toekomst zou daarom 
zijn om de applicatiemethode zodanig aan te passen dat in één keer een groot 
ﬁlteroppervlak met lipidenmateriaal kan worden bedekt. Allereerst zal een dergelijke 
aanpassing de ﬂexibiliteit van het systeem vergroten, aangezien potentiële gebruikers 
van het SCS niet meer gebonden zijn aan een bepaald diffusieoppervlak. Ten tweede 
is een verdere verhoging van de reproduceerbaarheid wenselijk om het vereiste aantal 
replica’s per diffusie-experiment te minimaliseren, wat met name belangrijk is voor 
screening-studies. Derhalve zal een verhoogde ﬂexibiliteit en reproduceerbaarheid de 
commerciële aantrekkelijkheid van het SCS aanzienlijk verhogen. 
REFERENTIES
1. Bouwstra J.A., Gooris G.S., van der Spek 
J.A., Bras W. The structure of human stratum 
corneum as determined by small angle X-ray 
scattering. J. Invest. Dermatol. 96 (1991) 
1006-1014.
2. Zettersten E., Man M.Q., Sato J., Denda M., 
Farrell A., Ghadially R., Williams M.L., Feingold 
K.R., Elias P.M. Recessive x-linked ichthyosis: 
role of cholesterol-sulfate accumulation in the 
barrier abnormality. J Invest. Dermatol. 111 
(1998) 784-790.
3. Macheleidt O., Kaiser H.W., Sandhoff K. 
Deﬁciency of epidermal protein-bound omega-
hydroxyceramides in atopic dermatitis. J. Invest. 
Dermatol. 119 (2002) 166-173.
4. Lavrijsen A.P.M., Bouwstra J.A., Gooris 
G.S., Weerheim A., Bodde H.E., Ponec M. 
Reduced skin barrier function parallels abnormal 
stratum corneum lipid organization in patients 
with lamellar ichthyosis. J. Invest. Dermatol. 105 
(1995) 619-624.
194 Chapter 10
5. Schmook F.P., Meingassner J.G., Billich A. 
Comparison of human skin or epidermis models with 
human and animal skin in in-vitro percutaneous 
absorption. Int. J. Pharm. 215 (2001) 51-56.
6. Catz P., Friend D.R. Transdermal delivery 
of levonorgestrel. VII. Effect of enhancers on rat 
skin, hairless mouse skin, hairless guinea pig 
skin, and human skin. Int. J. Pharm. 58 (1990) 
93-102.
7. Council Directive 2003/15/EEC of 27 
February 2003 (amending for the seventh time 
Directive 76/6/768/EEC), Ofﬁcial Journal L 66, 
11.3.2003, pp 26-35.
8. Ponec M., Weerheim A., Lankhorst 
P., Wertz P. New acylceramide in native and 
reconstructed epidermis. J. Invest. Dermatol. 120 
(2003) 581-588.
9. Bouwstra J.A., Gooris G.S., Dubbelaar 
F.E.R., Weerheim A.M., IJzerman A.P., Ponec M. 
Role of ceramide 1 in the molecular organization of 
the stratum corneum lipids. J. Lipid Res. 39 (1998) 
186-196.
10. McIntosh T.J., Stewart M.E., Downing D.T., 
1996. X-ray diffraction analysis of isolated skin 
lipids: reconstitution of intercellular lipid domains. 
Biochemistry 35 (1996) 3649-3653.
11. ten Grotenhuis E., Demel R.A., Ponec M., 
Boer D.R., van Miltenburg J.C., Bouwstra J.A. 
Phase-behavior of stratum corneum lipids in mixed 
langmuir-blodgett monolayers. Biophys. J. 71 
(1996) 1389-1399. 
12. Bouwstra J.A., Thewalt J., Gooris G.S., Kitson 
N. A model membrane approach to the epidermal 
permeability barrier: an X-ray diffraction study. 
Biochemistry 36 (1997) 7717-7725.
13. Lieckfeldt R., Villalain J., Gomez-Fernandez 
J.C., Lee G. Diffusivity and structural polymorphism 
in some model stratum corneum lipid systems. 
Biochim. Biophys. Acta 1151 (1993) 182-188.
14. Dahlen B., and Pascher I. Molecular 
arrangements in sphingolipids. Thermotropic 
phase   behaviour of tetracosanoylphytosphingos
ine. Chem. Phys. Lipids 24 (1979) 119-133.
15. Bouwstra, J.A., Gooris G.S., Cheng K., 
Weerheim A., Bras W., Ponec M. Phase behavior 
of isolated skin lipids. J. Lipid Res. 37 (1996) 
999-1011.
16. Wagner H., Kosta K.H., Lehr K.M., Schaefer 
U.F. Interrelation of permeation and penetration 
parameters obtained from in vitro experiments 
with human skin and skin equivalents J. Control. 
Release 75 (2001) 283-295.
195Publications
List of publications
Published papers
M.W. de Jager, G.S. Gooris, I.P. Dolbnya, W. Bras, M. Ponec, J.A. Bouwstra. The phase 
behaviour of skin lipid mixtures based on synthetic ceramides. Chem. Phys. Lipids 124 
(2003) 123-134.
M.W. de Jager, G.S. Gooris, I.P. Dolbnya, W. Bras, M. Ponec, J.A. Bouwstra. Novel lipid 
mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid 
organization. J. Lipid Res. 45 (2004) 923-932. 
M.W. de Jager, G.S. Gooris, I.P Dolbnya, M. Ponec, J.A. Bouwstra. Modelling the stratum 
corneum lipid organisation with synthetic lipid mixtures: the importance of synthetic 
ceramide composition. Biochim. Biophys. Acta 1664 (2004) 132-140.
M. de Jager, G. Gooris, M. Ponec, J. Bouwstra. Acylceramide head group architecture 
affects lipid organization in synthetic ceramide mixtures. J. Invest. Dermatol. 123 
(2004) 911-916.
M.W. de Jager, G.S. Gooris, M. Ponec, J.A. Bouwstra. Lipid mixtures prepared with 
well-deﬁned synthetic ceramides closely mimic the unique stratum corneum lipid phase 
behavior. J. Lipid Res. 46 (2005) 2649-2656.
M. de Jager, W. Groenink, J. van der Spek, C. Janmaat, G.Gooris, M. Ponec, J. 
Bouwstra. Preparation and characterization of a stratum corneum substitute for in vitro 
percutaneous penetration studies. Biochim. Biophys. Acta, in press.
M. de Jager, W. Groenink, R. Bielsa i Guivernau, E. Andersson, N. Angelova, M. Ponec, 
J. Bouwstra. A novel in vitro percutaneous penetration model: evaluation of barrier 
properties with p-aminobenzoic acid and two of its derivatives. Pharm. Res., in press.
Patent application
M.W. de Jager, J.A. Bouwstra, M. Ponec. NL1027178 (2004).
Acknowledgements 
Chapter 2 has been reprinted from Chemistry and Physics of Lipids, Vol. 124, M.W. de Jager, G.S. Gooris, 
I.P. Dolbnya, W. Bras, M. Ponec, J.A. Bouwstra, The phase behaviour of skin lipid mixtures based on 
synthetic ceramides, 123-134, Copyright (2003), with permission from Elsevier.
Chapter 3 has been reprinted from Journal of Lipid Research, M.W. de Jager, G.S. Gooris, I.P. Dolbnya, W. 
Bras, M. Ponec, J.A. Bouwstra, Novel lipid mixtures based on synthetic ceramides reproduce the unique 
stratum corneum lipid organization, 923-932, Copyright (2004), with permission from The American 
Society for Biochemistry and Molecular Biology. 
Chapter 4 has been reprinted from Biochimica et Biophysica Acta, M.W. de Jager, G.S. Gooris, I.P Dolbnya, 
M. Ponec, J.A. Bouwstra, Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: 
the importance of synthetic ceramide composition, 132-140, Copyright (2004), with permission from 
Elsevier.
Chapter 5 has been reprinted from Journal of Investigative Dermatology, M. de Jager, G. Gooris, M. 
Ponec, J. Bouwstra. Acylceramide head group architecture affects lipid organization in synthetic ceramide 
mixtures, 911-916, Copyright (2004), Nature Publishing Group.
Chapter 6 has been reprinted from Journal of Lipid Research, M.W. de Jager, G.S. Gooris, M. Ponec, 
J.A. Bouwstra, Lipid mixtures prepared with well-deﬁned synthetic ceramides closely mimic the unique 
stratum corneum lipid phase behavior, 2649-2656, Copyright (2005), with permission from The American 
Society for Biochemistry and Molecular Biology. 
Chapter 7 is in press at Biochimica et Biophysica Acta, M. de Jager, W. Groenink, J. van der Spek, 
C. Janmaat, G.Gooris, M. Ponec, J. Bouwstra, Preparation and characterization of a stratum corneum 
substitute for in vitro percutaneous penetration studies, with permission from Elsevier.
Chapter 8 is in press at Pharmaceutical Research, M. de Jager, W. Groenink, R. Bielsa i Guivernau, 
E. Andersson, N. Angelova, M. Ponec, J. Bouwstra, A novel in vitro percutaneous penetration model: 
evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives. with kind permission 
from Springer Science and Business Media.
Stellingen
behorende bij het proefschrift
Development of a stratum corneum substitute for in vitro 
percutaneous penetration studies
a skin barrier model comprising synthetic stratum corneum lipids
Cholesterol, synthetische ceramiden en vrije vetzuren, aangebracht 
op een poreuze drager, vormen een aantrekkelijk hulpmiddel om het 
geneesmiddelentransport door de huid te onderzoeken.
Dit proefschrift
De doorlaatbaarheid van het ontwikkelde huidbarrièremodel kan worden 
aangepast door de hoeveelheid òf de samenstelling van het lipidenmateriaal 
op de poreuze drager te veranderen.
Dit proefschrift
De lamellaire en laterale lipidenorganisatie in synthetische lipidenmengsels, 
bestaande uit cholesterol, ceramiden en vrije vetzuren, worden niet beïnvloed 
door het achterwege laten van de hydratatiestap direct na equilibratie.
Dit proefschrift
De diffusieweglengte in stratum corneum is ongeveer 10 maal groter dan in 
het ontwikkelde huidbarrièremodel.
Dit proefschrift
Naast de kristallijne laterale structuur is de aanwezigheid van een vloeibare 
laterale fase een voorwaarde voor de vorming van de unieke lamellaire 
structuur met lange periodiciteit aanwezig in stratum corneum.
Bouwstra J.A., et al. J. Invest. Dermatol. 118 (2002) 606-617
De impact die huidaandoeningen hebben op de kwaliteit van leven wordt 
vaak onderschat.  
Finlay A.Y. Indian J. Dermatol. Venereol. Leprol. 70 (2004) 143-148
“Although, by deﬁnition, the stratum corneum cannot be considered a viable 
tissue, it is nevertheless a dynamic structure in which many enzymatic 
reactions are carefully regulated to ensure full functionality.” 
Harding C.R., Watkinson A., Rawlings A.V. Int. J. Cosm. Sci. 22 (2000) 21-52 
Hoewel de huid ons voortreffelijk beschermt tegen allerlei schadelijke 
invloeden van buitenaf, vormt zij een slechte barrière tegen kwetsende 
uitspraken van anderen. 
1.
2.
3.
4.
5.
6.
7.
8.
Onderzoek doen is vergelijkbaar met transdermaal geneesmiddelentransport: 
resultaten worden vaak pas zichtbaar na een lange “lag time”. 
(Mogelijke) patentaanvragen vormen een niet te onderschatten belemmering 
voor de ontwikkeling van jonge onderzoekers.
Happiness always looks small while you hold it in your hands, but let it go, 
and you learn at once how big and precious it is. 
Maxim Gorky 
Iemand die altijd alles zwart op wit wil hebben, leeft een kleurloos 
bestaan. 
Miranda de Jager
Leiden, 27 april 2006
9.
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